INGERSOLL RAND INC., 10-K filed on 2/17/2026
Annual Report
v3.25.4
Cover Page - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2025
Feb. 13, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-38095    
Entity Registrant Name Ingersoll Rand Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 46-2393770    
Entity Address, Address Line One 525 Harbour Place Drive    
Entity Address, Address Line Two Suite 600    
Entity Address, City or Town Davidson    
Entity Address, State or Province NC    
Entity Address, Postal Zip Code 28036    
City Area Code 704    
Local Phone Number 655-4000    
Title of 12(b) Security Common Stock, $0.01 Par Value per share    
Trading Symbol IR    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 33.0
Entity Common Stock, Shares Outstanding   391,617,994  
Documents Incorporated by Reference
Portions of the Proxy Statement for the registrant’s 2026 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.
   
Entity Central Index Key 0001699150    
Amendment Flag false    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
v3.25.4
Audit Information
12 Months Ended
Dec. 31, 2025
Audit Information [Abstract]  
Auditor Firm ID 34
Auditor Name DELOITTE & TOUCHE LLP
Auditor Location Charlotte, NC
v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenues $ 7,650,900,000 $ 7,235,000,000 $ 6,876,100,000
Cost of sales 4,314,600,000 4,065,000,000 3,993,900,000
Gross Profit 3,336,300,000 3,170,000,000 2,882,200,000
Selling and administrative expenses 1,439,300,000 1,344,400,000 1,272,700,000
Amortization of intangible assets 387,500,000 373,000,000.0 367,500,000
Impairment of goodwill 229,700,000 0 0
Impairment of other intangible assets 43,700,000 13,900,000 0
Other operating expense, net 91,500,000 138,600,000 77,700,000
Operating Income 1,144,600,000 1,300,100,000 1,164,300,000
Interest expense 253,900,000 213,200,000 156,700,000
Loss on extinguishment of debt 0 3,000,000.0 13,500,000
Other income, net (44,600,000) (48,900,000) (37,000,000.0)
Income Before Income Taxes 935,300,000 1,132,800,000 1,031,100,000
Provision for income taxes 219,400,000 262,500,000 240,000,000.0
Loss on equity method investments (127,100,000) (24,000,000.0) (6,000,000.0)
Net Income 588,800,000 846,300,000 785,100,000
Less: Net income attributable to noncontrolling interests 7,400,000 7,700,000 6,400,000
Net Income Attributable to Ingersoll Rand Inc. $ 581,400,000 $ 838,600,000 $ 778,700,000
Basic earnings per share (in USD per share) $ 1.46 $ 2.08 $ 1.92
Diluted earnings per share (in USD per share) $ 1.45 $ 2.06 $ 1.90
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Comprehensive Income Attributable to Ingersoll Rand Inc.      
Net income attributable to Ingersoll Rand Inc. $ 581.4 $ 838.6 $ 778.7
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustments, net 330.5 (231.6) 34.8
Unrecognized loss on cash flow hedges (5.8) (9.1) (3.8)
Pension and other postretirement prior service cost and gain (loss), net (4.5) (0.2) (6.9)
Other comprehensive income (loss), net of tax 320.2 (240.9) 24.1
Comprehensive income attributable to Ingersoll Rand Inc. 901.6 597.7 802.8
Comprehensive Income Attributable to Noncontrolling Interests      
Net income attributable to noncontrolling interests 7.4 7.7 6.4
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustments, net (2.4) 2.7 1.7
Total other comprehensive income (loss), net of tax (2.4) 2.7 1.7
Comprehensive income attributable to noncontrolling interests 5.0 10.4 8.1
Total Comprehensive Income $ 906.6 $ 608.1 $ 810.9
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 1,248.8 $ 1,541.2
Accounts receivable, net of allowance for credit losses of $66.8 and $57.3, respectively 1,518.0 1,335.4
Inventories 1,172.9 1,055.0
Other current assets 308.3 231.9
Total current assets 4,248.0 4,163.5
Property, plant and equipment, net of accumulated depreciation of $689.6 and $567.5, respectively 930.3 842.1
Goodwill 8,484.1 8,148.1
Other intangible assets, net 4,240.3 4,372.8
Deferred tax assets 38.7 26.1
Other assets 355.8 457.2
Total assets 18,297.2 18,009.8
Current liabilities    
Short-term borrowings and current maturities of long-term debt 1.4 3.1
Accounts payable 996.1 843.6
Accrued liabilities 1,068.8 972.2
Total current liabilities 2,066.3 1,818.9
Long-term debt, less current maturities 4,783.3 4,754.4
Pensions and other postretirement benefits 134.2 139.3
Deferred income tax liabilities 696.9 757.6
Other liabilities 462.5 294.3
Total liabilities 8,143.2 7,764.5
Commitments and contingencies (Note 21)
Stockholders’ equity    
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 431,753,302 and 430,745,964 shares issued as of December 31, 2025 and 2024, respectively 4.3 4.3
Capital in excess of par value 9,699.9 9,633.6
Retained earnings 3,053.1 2,503.5
Accumulated other comprehensive loss (148.3) (468.5)
Treasury stock at cost; 40,631,613 and 27,865,885 shares as of December 31, 2025 and 2024, respectively (2,519.2) (1,493.9)
Total Ingersoll Rand Inc. stockholders’ equity 10,089.8 10,179.0
Noncontrolling interests 64.2 66.3
Total equity 10,154.0 10,245.3
Total liabilities and equity $ 18,297.2 $ 18,009.8
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 66.8 $ 57.3
Accumulated depreciation on property, plant and equipment $ 689.6 $ 567.5
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 1,000,000,000 1,000,000,000
Common stock issued (in shares) 431,753,302 430,745,964
Treasury stock (in shares) 40,631,613 27,865,885
v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Total Ingersoll Rand Inc. Stockholders’ Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2022     426,300,000          
Balance at beginning of period at Dec. 31, 2022 $ 9,257.2 $ 9,195.8 $ 4.3 $ 9,476.8 $ 950.9 $ (251.7) $ (984.5) $ 61.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 785.1 778.7     778.7     6.4
Dividends declared (32.4) (32.4)     (32.4)      
Issuance of common stock for stock-based compensation plans (in shares)     2,300,000          
Issuance of common stock for stock-based compensation plans 27.8 27.8   27.8        
Purchases of treasury stock (264.1) (264.1)         (264.1)  
Issuance of treasury stock for stock-based compensation plans 2.8 2.8   (4.9)     7.7  
Stock-based compensation 51.1 51.1   51.1        
Other comprehensive income (loss), net of tax 25.8 24.1       24.1   1.7
Dividends attributable to noncontrolling interests (6.6)             (6.6)
Balance at end of period (shares) at Dec. 31, 2023     428,600,000          
Balance at end of period at Dec. 31, 2023 9,846.7 9,783.8 $ 4.3 9,550.8 1,697.2 (227.6) (1,240.9) 62.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 846.3 838.6     838.6     7.7
Dividends declared (32.3) (32.3)     (32.3)      
Issuance of common stock for stock-based compensation plans (in shares)     2,100,000          
Issuance of common stock for stock-based compensation plans 30.1 30.1   30.1        
Purchases of treasury stock (261.2) (261.2)         (261.2)  
Issuance of treasury stock for stock-based compensation plans 2.1 2.1   (6.1)     8.2  
Stock-based compensation 58.8 58.8   58.8        
Other comprehensive income (loss), net of tax (238.2) (240.9)       (240.9)   2.7
Dividends attributable to noncontrolling interests $ (7.0)             (7.0)
Balance at end of period (shares) at Dec. 31, 2024 402,880,079   430,700,000          
Balance at end of period at Dec. 31, 2024 $ 10,245.3 10,179.0 $ 4.3 9,633.6 2,503.5 (468.5) (1,493.9) 66.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 588.8 581.4     581.4     7.4
Dividends declared (31.8) (31.8)     (31.8)      
Issuance of common stock for stock-based compensation plans (in shares)     1,100,000          
Issuance of common stock for stock-based compensation plans 14.9 14.9   14.9        
Purchases of treasury stock (1,027.3) (1,027.3)         (1,027.3)  
Issuance of treasury stock for stock-based compensation plans 0.4 0.4   (1.6)     2.0  
Stock-based compensation 53.0 53.0   53.0        
Other comprehensive income (loss), net of tax 317.8 320.2       320.2   (2.4)
Dividends attributable to noncontrolling interests $ (7.1)             (7.1)
Balance at end of period (shares) at Dec. 31, 2025 391,121,689   431,800,000          
Balance at end of period at Dec. 31, 2025 $ 10,154.0 $ 10,089.8 $ 4.3 $ 9,699.9 $ 3,053.1 $ (148.3) $ (2,519.2) $ 64.2
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows From Operating Activities      
Net Income $ 588.8 $ 846.3 $ 785.1
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of intangible assets 387.5 373.0 367.5
Depreciation 118.3 109.0 91.6
Impairment of goodwill and other intangible assets 273.4 13.9 0.0
Non-cash restructuring charges 0.0 1.6 2.7
Stock-based compensation expense 53.0 58.8 51.9
Loss on equity method investments 127.1 24.0 6.0
Foreign currency transaction losses, net 18.6 3.2 5.1
Non-cash adjustments to carrying value of LIFO inventories 17.8 6.7 12.0
Loss on extinguishment of debt 0.0 3.0 13.5
Loss on sale of asbestos-related assets and liabilities 0.0 33.7 0.0
Deferred income taxes (79.4) (33.1) (76.9)
Other non-cash adjustments 9.9 7.7 8.3
Changes in assets and liabilities:      
Receivables (59.1) (45.1) (48.6)
Inventories (26.1) 39.8 117.3
Accounts payable 78.7 13.3 (23.9)
Accrued liabilities (35.3) (34.5) 94.8
Other assets and liabilities, net (117.5) (24.6) (29.0)
Net cash provided by operating activities 1,355.7 1,396.7 1,377.4
Cash Flows From Investing Activities      
Capital expenditures (135.6) (149.1) (105.4)
Net cash paid in acquisitions (525.0) (2,958.7) (963.0)
Disposals of property, plant and equipment 0.0 6.1 7.6
Other investing 0.0 (6.0) 0.3
Net cash provided by (used in) investing activities (660.6) (3,107.7) (1,060.5)
Cash Flows From Financing Activities      
Principal payments on long-term debt 0.0 (1,242.7) (1,518.0)
Proceeds from long-term debt 0.0 3,296.9 1,490.4
Purchases of treasury stock (1,018.0) (260.7) (263.0)
Cash dividends on common stock (31.8) (32.3) (32.4)
Proceeds from stock option exercises 15.3 32.2 30.3
Payments to settle cross-currency swaps 0.0 (19.9) 0.0
Payments of deferred and contingent acquisition consideration (8.0) (23.4) (17.5)
Payments of debt issuance costs 0.0 (32.3) (18.5)
Other financing (11.3) (10.3) (8.8)
Net cash provided by (used in) financing activities (1,053.8) 1,707.5 (337.5)
Effect of exchange rate changes on cash and cash equivalents 66.3 (50.8) 3.1
Net decrease in cash and cash equivalents (292.4) (54.3) (17.5)
Cash and cash equivalents, beginning of year 1,541.2 1,595.5 1,613.0
Cash and cash equivalents, end of year 1,248.8 1,541.2 1,595.5
Supplemental Cash Flow Information      
Cash paid for income taxes, net of refunds 269.3 276.7 302.0
Cash paid for interest, net of interest rate derivative settlements $ 249.0 $ 209.0 $ 100.5
v3.25.4
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Overview and Basis of Presentation
Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and life science and industrial solutions. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”).
Principles of Consolidation
The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows.
Foreign Currency Translation
Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income, and are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.”
Revenue Recognition
The Company recognizes revenue when the Company has satisfied its obligation and control is transferred to the customer. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company also has certain contracts in which revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations. See Note 15 “Revenue from Contracts with Customers” for additional information regarding revenue recognition.
Cost of Sales
Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers.
Selling and Administrative Expenses
Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses.
Cash and Cash Equivalents
Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value. As of December 31, 2025 and 2024, cash of $8.1 million and $10.5 million, respectively, was pledged to financial institutions as collateral to support the issuance of standby letters of credit and similar instruments on behalf of the Company.
Accounts Receivable
Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment.
Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions.
Inventories
Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred.
Property, Plant and Equipment
Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years.
Goodwill and Indefinite-Lived Intangible Assets
Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value.
The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively.
Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of
long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value.
The Company tests intangible assets with indefinite lives annually for impairment and whenever events or changes in circumstances indicate that the carrying value may not be recoverable, using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates.
See Note 8 “Goodwill and Other Intangible Assets” for additional information related to impairment testing for goodwill and other intangible assets.
Long-Lived Assets Including Intangible Assets With Finite Useful Lives
Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection.
The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose.
Warranty Reserves
Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure.
Stock-Based Compensation
Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units and performance share units with internal performance metrics (i.e. EPS) are valued at the share price on the date of grant. The grant date fair value of performance share units with external performance metrics (i.e. TSR) is determined using a Monte Carlo simulation pricing model.
See Note 18 “Stock-Based Compensation Plans” for additional information regarding the Company’s equity compensation plans.
Pension and Other Postretirement Benefits
The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2025 and 2024 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost.
See Note 12 “Benefit Plans” for disclosures related to the Company’s benefit plans, including quantitative disclosures reflecting the impact that changes in certain assumptions would have on service and interest costs and benefit obligations.
Income Taxes
The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income tax liabilities are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized.
Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed.
The Tax Cuts and Jobs Act (“Tax Act”), enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above). The Company recorded a tax expense of $13.0 million in 2025 for the GILTI provisions of the Tax Act.
Research and Development
For the years ended December 31, 2025, 2024 and 2023, the Company spent $114.3 million, $116.6 million, and $108.2 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations.
Derivative Financial Instruments
All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument
may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or (3) as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. For derivative instruments designated as net investment in a foreign operation, gains or losses are reported as currency translation adjustments. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations.
Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period.
When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations.
Comprehensive Income
The Company’s comprehensive income consists of net income (loss) and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 14 “Accumulated Other Comprehensive Income (Loss).”
Restructuring Charges
The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.
A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred.
Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations.
Business Combinations
The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable
assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred.
Earnings per Share
The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.
Leases
The Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROU assets in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets.
At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. An incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread.

The Company does not recognize leases with an original term of less than 12 months on its balance sheet and continues to expense such leases. The Company also elected the practical expedient allowing the Company to account for each separate lease component of a contract and its associated non-lease component as a single lease component. This practical expedient was applied to all underlying asset classes. Variable lease expense was not material.
v3.25.4
New Accounting Standards
12 Months Ended
Dec. 31, 2025
Accounting Standards Update and Change in Accounting Principle [Abstract]  
New Accounting Standards New Accounting Standards
Recently Adopted Accounting Standard Updates (“ASU”)
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update are effective for annual periods beginning after December 15, 2024. The amendments in this update were applied prospectively. The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segments expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The amendments in this update were applied retrospectively to all prior periods presented in the financial statements. The segment expense categories and amounts disclosed in the prior periods were based on the significant segment expense categories identified and disclosed in Note 23 “Segment Reporting.” The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements.
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of additional disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, amortization, and depletion. The amendment is effective for fiscal years beginning after December 15, 2026. Early adoption is permitted. The amendment should be applied prospectively; however,
retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient to assume that conditions as of the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606. The amendment is effective for fiscal years beginning after December 15, 2025. Early adoption is permitted. The amendments in this update should be applied on a prospective basis. Management is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements and related disclosures.
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which amends guidance related to the accounting for internal-use software development costs. The amendment is intended to modernize the recognition and capitalization framework to reflect current software development practices. The amendment is effective for fiscal years beginning after December 15, 2027. The amendment can be applied on a prospective basis, a modified basis for in-process projects, or a retrospective basis. Early adoption is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements and related disclosures.
In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements, which more closely aligns hedge accounting with the economics of an entity’s risk management activities to better reflect those strategies in financial reporting by enabling entities to achieve and maintain hedge accounting for highly effective economic hedges of forecasted transactions. The amendment is effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements and related disclosures.
v3.25.4
Acquisitions
12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions Acquisitions
2025 Acquisitions
On February 3, 2025, the Company completed the acquisition of SSI Aeration, Inc. (“SSI”) for cash consideration of $97.8 million. The business is a manufacturer of wastewater treatment plant equipment. The acquisition will enable Ingersoll Rand to combine several technologies like low pressure compressors with SSI’s aeration offerings to provide a comprehensive, end-to-end solution. SSI has been reported within the Industrial Technologies and Services segment.
On February 3, 2025, the Company completed the acquisition of Excelsior Blower Systems, Inc. (“Excelsior”) for cash consideration of $17.5 million. The business is a manufacturer of blower packages. Excelsior has been reported within the Industrial Technologies and Services segment.
On February 3, 2025, the Company completed the acquisition of Cullum & Brown of Kansas City, Inc. (“Cullum & Brown”) for initial cash consideration of $50.7 million and contingent consideration of up to $10.0 million. The business is a provider of compressors, blowers, pumps and associated parts and services. Cullum & Brown has been reported within the Industrial Technologies and Services segment.
On April 1, 2025, the Company completed the acquisition of G & D Chillers, Inc. (“G & D”) for cash consideration of $20.9 million. The business is a manufacturer of glycol chillers. G & D has been reported within the Industrial Technologies and Services segment.
On June 3, 2025, the Company completed the acquisition of Lead Fluid (Baoding) Intelligent Equipment Manufacturing Co., Ltd. (“Lead Fluid”) for cash consideration of $18.0 million and contingent consideration of up to approximately $4.2 million. The business designs and manufactures fluid-handling products, including peristaltic pumps, syringe pumps, gear pumps, and pump heads, used for life science applications. Lead Fluid has been reported within the Precision and Science Technologies segment.
On July 1, 2025, the Company completed the acquisition of Termomeccanica Industrial Compressors S.p.A. (“TMIC”) and its subsidiary Adicomp S.p.A. (“Adicomp”) (collectively “TMIC/Adicomp”) for cash consideration of $193.2 million. TMIC is an international leader in the design and production of air and gas compressors and its subsidiary Adicomp provides engineered-to-order solutions in the renewable natural gas industry. TMIC/Adicomp has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes.
On August 4, 2025, the Company completed the acquisition of Dave Barry Plastics Ltd. (“Dave Barry Plastics”) for cash consideration of $26.9 million and contingent consideration of up to approximately $8.2 million. Dave Barry Plastics designs and manufactures plastic product solutions for life science and healthcare technology industries. Dave Barry Plastics has been reported within the Precision and Science Technologies segment.
On November 3, 2025, the Company completed the acquisition of Transvac Systems Ltd. (“Transvac”) for cash consideration of $71.0 million and contingent consideration of up to approximately $56.5 million. Transvac is a global supplier of ejector solutions and sustainable process technologies used to move, mix, and compress fluids and gases. Transvac has been reported within the Industrial Technologies and Services segment.
Other acquisitions completed during the year ended December 31, 2025 include seven sales and service businesses, which have been reported within the Industrial Technologies and Services segment, and one manufacturing business, which has been reported within the Precision and Science Technologies segment. The aggregate consideration for these acquisitions was $56.9 million.
The following table summarizes the allocation of consideration for all businesses acquired in 2025 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for certain of these acquisitions is preliminary, and amounts assigned to acquired assets and liabilities assumed are subject to change as information necessary to complete the analysis is obtained.
TMIC/AdicompAll OthersTotal
Accounts receivable$22.8 $29.6 $52.4 
Inventories34.4 30.2 64.6 
Other current assets4.7 3.3 8.0 
Property, plant and equipment30.8 12.8 43.6 
Goodwill99.6 261.8 361.4 
Other intangible assets80.6 106.0 186.6 
Other assets0.1 7.3 7.4 
Total current liabilities(54.1)(37.3)(91.4)
Deferred tax liabilities(22.7)(14.4)(37.1)
Other noncurrent liabilities(3.0)(4.9)(7.9)
Total consideration$193.2 $394.4 $587.6 
Acquisition Revenues and Operating Income
The revenues and operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $172.4 million and $16.1 million, respectively, for the year ended December 31, 2025.
2024 Acquisitions
On February 1, 2024, the Company completed the acquisition of Friulair S.r.l. (“Friulair”) for initial cash consideration of $143.3 million and contingent consideration of up to approximately $11.0 million. The business is a manufacturer of dryers, filters, aftercoolers, and accessories for the treatment of compressed air and its chiller product line. The acquisition is intended to increase the scale of the Company’s air dryer business and will add new chiller production capabilities. Friulair has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes.
On April 1, 2024, the Company completed the acquisition of Controlled Fluidics, LLC (“Controlled Fluidics”) for initial cash consideration of $49.9 million and contingent consideration of up to $2.0 million. The business specializes in thermoplastic, high-performance plastic bonding and custom plastic assembly products for life sciences, medical, aerospace, and industrial applications. The acquisition will complement Ingersoll Rand’s current life sciences offerings and increase the Company’s market share in high-growth, sustainable end markets. Controlled Fluidics has been reported within the Precision and Science Technologies segment.
On April 2, 2024, the Company completed the acquisition of Ethafilter s.r.l. (“Ethafilter”) for cash consideration of $15.5 million. The business primarily produces filters and filter elements that can be used with all major brands in the compressed air sector. The acquisition will expand Ingersoll Rand’s product portfolio, extend its reach in highly attractive end markets with the
addition of sterile filter technology, and drive ongoing growth from aftermarket services and offerings. Ethafilter has been reported within the Industrial Technologies and Services segment.
On May 1, 2024, the Company completed the acquisition of Air Systems, LLC (“Air Systems”) for cash consideration of $34.9 million. The business is a provider of compressed air services. Air Systems has been reported within the Industrial Technologies and Services segment.
On May 31, 2024, the Company completed the acquisition of Complete Air and Power Solutions (“CAPS”) for cash consideration of $99.3 million. The business is a provider of compressed air and power generation services. The acquisition is expected to expand the Company’s channel within Australia. CAPS has been reported within the Industrial Technologies and Services segment.
On May 31, 2024, the Company completed the acquisition of Fruvac Ltd. (“Fruitland Manufacturing”) for cash consideration of $28.0 million. The business is a manufacturer of mobile and truck mounted vacuum pumps, systems, and peripheral parts. The acquisition is expected to expand the Company’s capabilities to include low flow applications in the mobile vacuum market. Fruitland Manufacturing has been reported within the Industrial Technologies and Services segment.
On June 1, 2024, the Company completed the acquisition of Del PD Pumps & Gear Pvt Ltd. (“Del Pumps”) for cash consideration of $25.2 million. The business is a manufacturer of rotary, twin, and triple gear pumps for the loading, unloading, transfer, and pressurization of liquids. The acquisition will complement the Company’s portfolio of mission critical, high margin pumping solutions across life science, food and beverage, medical, natural gas, and wastewater treatment industries. Del Pumps has been reported within the Precision and Science Technologies segment.
On June 3, 2024, the Company completed the acquisition of Astronaut Topco, LP and Astronaut Topco GP, LLC (collectively “ILC Dover”) for initial cash consideration of $2,349.7 million and contingent consideration of up to $75.0 million. ILC Dover’s offerings include solutions for biopharmaceutical, pharmaceutical, and medical device markets as well as products for the space industry and has been reported in the Precision and Science Technologies segment. The amount allocated to definite-lived intangible assets represents the estimated fair values of customer relationships of $620.5 million and technology of $142.0 million and will be amortized over the weighted average useful lives of 14 years and 8 years, respectively. The amount allocated to indefinite-lived intangible assets represents the estimated fair value of tradenames of $207.5 million and goodwill of $1,300.0 million. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. The majority of this goodwill is not expected to be deductible for tax purposes.
On October 1, 2024, the Company completed the acquisition of Air Power Systems Co LLC (“APSCO”) for cash consideration of $113.2 million. The business is a provider of hydraulic and pneumatic products and engineered solutions serving diverse specialty work truck vehicles. APSCO’s offerings include hydraulic coolers, systems, and components in addition to pneumatic consoles, cylinders, valves, and switches. The acquisition will expand Ingersoll Rand’s position in the dry and liquid bulk markets with energy efficient, innovative solutions. APSCO has been reported within the Industrial Technologies and Services segment. The majority of this goodwill is expected to be deductible for tax purposes.
On October 1, 2024, the Company completed the acquisition of Blutek S.r.l. (“Blutek”) for cash consideration of $10.3 million. The business specializes in the design and production of highly engineered solutions for compressed air and nitrogen generation in mission-critical environments. The acquisition will increase Ingersoll Rand’s ability to compete in high specification projects, adding technology capabilities, expertise, and aftermarket potential in high-growth end markets including biogas and carbon capture. Blutek has been reported within the Industrial Technologies and Services segment.
On October 1, 2024, the Company completed the acquisition of UT Pumps & Systems Private Ltd. (“UT Pumps”) for cash consideration of $11.9 million. The business is a manufacturer of screw pumps and triplex plunger pumps. The acquisition adds new pump technology to Ingersoll Rand’s portfolio. Its high-pressure pumps are mainly focused on attractive end markets including water, wastewater, food and beverage, pharmaceuticals, general industrial, and chemicals. UT Pumps has been reported within the Precision and Science Technologies segment.
On October 31, 2024, the Company completed the acquisition of Penn Valley Pump Co., LLC (“Penn Valley Pumps”) for cash consideration of $33.5 million. The business is a manufacturer of positive displacement pumps with its Double Disc Pump technology for use in the municipal, industrial, chemical, and food industries. Penn Valley Pumps has been reported within the Precision and Science Technologies segment.
Other acquisitions completed during the year ended December 31, 2024 include several sales and service businesses and manufacturers of vacuum pumps and accessories, substantially all of which have been reported within the Industrial Technologies and Services segment. The aggregate consideration for these acquisitions was $55.4 million.
The following table summarizes the allocation of consideration for all businesses acquired in 2024 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Purchase accounting for all 2024 acquisitions is complete.
ILC DoverFriulairAPSCOAll othersTotal Consideration
Accounts receivable$41.2 $14.2 $6.4 $37.3 $99.1 
Inventories78.1 13.2 7.5 45.0 143.8 
Other current assets37.5 0.5 0.5 4.7 43.2 
Property, plant and equipment89.2 7.2 2.3 18.5 117.2 
Goodwill1,300.0 69.2 51.6 251.0 1,671.8 
Other intangible assets972.6 84.5 48.1 80.5 1,185.7 
Other noncurrent assets15.8 — 3.5 5.9 25.2 
Total current liabilities(32.4)(11.6)(3.7)(55.7)(103.4)
Deferred tax liabilities(131.2)(24.6)— (17.2)(173.0)
Other noncurrent liabilities(21.1)(2.8)(3.0)(5.8)(32.7)
Total consideration$2,349.7 $149.8 $113.2 $364.2 $2,976.9 
Acquisition Revenues and Operating Income
The revenues included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $627.4 million and $349.6 million, respectively, for the years ended December 31, 2025 and 2024. The operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date was $49.4 million and $5.6 million, respectively, for the years ended December 31, 2025 and 2024.
2023 Acquisitions
On January 3, 2023, the Company completed the acquisition of SPX FLOW’s Air Treatment business (“Air Treatment”) for cash consideration of $519.0 million. The business is a manufacturer of desiccant and refrigerated dryers, filtration systems and purifiers for dehydration in compressed air. The acquisition is intended to expand the Company’s offerings of compressor system components through globally recognized brands. The Air Treatment business has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes.
On February 1, 2023, the Company acquired Paragon Tank Truck Equipment (“Paragon”), a provider of solutions used for loading and unloading dry bulk and liquid tanks on and off of trucks, for cash consideration of $42.2 million. Paragon has been reported within the Industrial Technologies and Services segment.
On April 1, 2023, the Company acquired EcoPlant Technological Innovation Ltd. (“EcoPlant”), for initial cash consideration of $29.5 million and contingent consideration of up to $17.0 million. EcoPlant is a provider of a software-as-a-service platform that dynamically controls compressed air systems to optimize performance and resource consumption. EcoPlant has been reported within the Industrial Technologies and Services segment.
On August 18, 2023, the Company completed the acquisition of Howden Roots LLC (“Roots”), for cash consideration of $292.5 million. Roots is a leading manufacturer of engineered rotary and centrifugal blowers with an iconic brand developed over more than 160 years. The acquisition is intended to expand the Company’s blower product portfolio and benefit from Roots’ robust technical capabilities and exposure to growing sustainability-related applications. Roots has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. This goodwill is expected to be deductible for tax purposes.
The Company acquired 10 additional businesses in 2023 for aggregate consideration of $83.3 million. These primarily consist of manufacturers and distributors of existing and adjacent offerings in the Industrial Technologies and Services segment.
Of the goodwill recognized on our 2023 acquisitions, $159.9 million is expected to be deductible for tax purposes.
The following table summarizes the allocation of consideration for all businesses acquired in 2023 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Purchase accounting for all 2023 acquisitions is complete.
Air TreatmentRootsAll OthersTotal
Accounts receivable$26.1 $14.5 $11.7 $52.3 
Inventories43.9 34.2 21.0 99.1 
Other current assets2.1 2.9 6.2 11.2 
Property, plant and equipment18.4 42.0 5.0 65.4 
Goodwill279.9 105.6 126.7 512.2 
Other intangible assets238.6 116.9 25.4 380.9 
Other noncurrent assets7.6 3.1 0.4 11.1 
Total current liabilities(35.9)(26.9)(19.5)(82.3)
Deferred tax liabilities(54.8)— (3.9)(58.7)
Other noncurrent liabilities(6.9)(2.3)(4.5)(13.7)
Total consideration$519.0 $290.0 $168.5 $977.5 
Acquisition Revenues and Operating Income
The revenues included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $429.3 million, $408.0 million and $293.7 million, respectively, for the years ended December 31, 2025, 2024 and 2023. The operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date was $93.0 million, $58.8 million and $16.1 million, respectively, for the years ended December 31, 2025, 2024 and 2023.
v3.25.4
Restructuring
12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
2025, 2024 and 2023 Actions
The Company continues to undertake restructuring actions to optimize our cost structure. Charges incurred from actions taken in 2025, 2024 and 2023 include workforce restructuring, facility consolidation and other exit and disposal costs.
For the years ended December 31, 2025, 2024 and 2023, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following.
202520242023
Industrial Technologies and Services$37.7 $20.6 $15.1 
Precision and Science Technologies10.5 7.9 4.1 
Corporate3.2 2.7 0.7 
Restructuring charges, net$51.4 $31.2 $19.9 
The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2025 and 2024.
20252024
Balance at beginning of period$22.3 $15.5 
Charged to expense - termination benefits48.8 27.1 
Charged to expense - other(1)
2.6 2.5 
Payments(35.5)(21.6)
Foreign currency translation and other1.7 (1.2)
Balance at end of period$39.9 $22.3 
(1)Excludes $1.6 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the year ended December 31, 2024.
v3.25.4
Allowance for Credit Losses
12 Months Ended
Dec. 31, 2025
Receivables [Abstract]  
Allowance for Credit Losses Allowance for Credit Losses
The following table summarized the activity associated with allowance for credit losses for the years ended December 31, 2025, 2024 and 2023.
202520242023
Balance at beginning of period$57.3 $53.8 $47.2 
Provision charged to expense11.6 7.5 9.4 
Write-offs, net of recoveries(5.7)(3.3)(3.3)
Foreign currency translation and other3.6 (0.7)0.5 
Balance at end of period$66.8 $57.3 $53.8 
v3.25.4
Inventories
12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
Inventories Inventories
Inventories as of December 31, 2025 and 2024 consisted of the following.
20252024
Raw materials, including parts and subassemblies$737.3 $675.1 
Work-in-process128.7 116.3 
Finished goods403.9 342.8 
1,269.9 1,134.2 
LIFO reserve(97.0)(79.2)
Inventories$1,172.9 $1,055.0 
At December 31, 2025 and 2024, 32% and 34%, respectively, of total inventory is accounted for on a last-in, first-out (“LIFO”) basis.
v3.25.4
Property, Plant and Equipment
12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Property, Plant and Equipment
Property, plant and equipment, net as of December 31, 2025 and 2024 consisted of the following.
20252024
Land and land improvements$70.0 $62.3 
Buildings436.1 385.6 
Machinery and equipment909.6 792.6 
Office furniture and equipment87.9 76.8 
Construction in progress116.3 92.3 
1,619.9 1,409.6 
Accumulated depreciation(689.6)(567.5)
Property, plant and equipment, net$930.3 $842.1 
v3.25.4
Goodwill and Other Intangible Assets
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
Goodwill
The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2025 and 2024 are as follows.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
Balance as of December 31, 2023
$4,753.5 $1,856.2 $6,609.7 
Acquisitions263.9 1,404.3 1,668.2 
Foreign currency translation and other(1)
(86.7)(43.1)(129.8)
Balance as of December 31, 2024
4,930.7 3,217.4 8,148.1 
Acquisitions310.1 51.3 361.4 
Impairments— (229.7)(229.7)
Foreign currency translation and other(1)
144.7 59.6 204.3 
Balance as of December 31, 2025
$5,385.5 $3,098.6 $8,484.1 
(1)Includes measurement period adjustments.
The Company acquired multiple businesses during the year ended December 31, 2025. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The allocation of the purchase price is preliminary for certain of these acquisitions and is subject to refinement based on final fair values of the identified assets acquired and liabilities assumed. The goodwill attributable to these businesses is as follows. 
2025 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
TMIC/Adicomp$99.6 $— $99.6 
Other acquisitions210.5 51.3 261.8 
$310.1 $51.3 $361.4 
The Company acquired several businesses during the year ended December 31, 2024. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The goodwill attributable to these businesses is as follows. 
2024 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
ILC Dover$— $1,309.8 $1,309.8 
Friulair69.2 — 69.2 
APSCO51.6 — 51.6 
Other acquisitions143.1 94.5 237.6 
$263.9 $1,404.3 $1,668.2 
Accumulated impairment losses within the Industrial Technologies and Services segment was $220.6 million as of both December 31, 2025 and 2024. Accumulated impairment losses within the Precision and Science Technologies segment was $229.7 million and $0.0 million as of December 31, 2025 and 2024, respectively.
Goodwill Impairment Tests
During the second quarter of 2025, certain organizational changes occurred that impacted the composition of all reporting units within our Precision and Science Technologies segment. As a result of these changes, the Company performed an interim goodwill impairment test for all affected reporting units, utilizing a combination of an income and market approach weighted 75% and 25%, respectively, to determine the fair value.
In the second quarter of 2025, the Company recognized non-cash impairments of $170.3 million and $59.4 million to reduce the carrying value of goodwill of our Biopharma and Aerospace & Defense reporting units, respectively. Both the Biopharma and Aerospace & Defense reporting units were comprised entirely of businesses acquired in the recent ILC Dover acquisition.
The impairment of the Biopharma reporting unit was primarily attributable to an increase in the discount rate and contraction in market multiples. The impairment of the Aerospace & Defense reporting unit was primarily attributable to a reduction in the long-term forecast associated with a reduction in business with a significant customer of the reporting unit.
Consistent with our accounting policy described in Note 1, we performed our annual goodwill impairment testing as of the first day of our fiscal fourth quarters of 2025, 2024 and 2023. For the years ended December 31, 2025, 2024 and 2023, each reporting unit’s fair value was in excess of its net carrying value, and therefore, no goodwill impairment was recorded other than those discussed above.
Other Intangible Assets
Other intangible assets as of December 31, 2025 and 2024 consisted of the following.
December 31, 2025December 31, 2024
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Amortized intangible assets:
Customer lists and relationships$4,292.9 $(2,186.3)$2,106.6 $4,010.1 $(1,830.1)$2,180.0 
Technology573.5 (325.2)248.3 549.1 (243.3)305.8 
Tradenames327.6 (53.1)274.5 63.6 (32.4)31.2 
Backlog— — — 4.3 (4.2)0.1 
Other163.4 (125.0)38.4 128.5 (112.1)16.4 
Unamortized intangible assets:
Tradenames1,572.5 — 1,572.5 1,839.3 — 1,839.3 
Total other intangible assets$6,929.9 $(2,689.6)$4,240.3 $6,594.9 $(2,222.1)$4,372.8 
Amortization of intangible assets was $387.5 million, $373.0 million and $367.5 million for the years ended December 31, 2025, 2024 and 2023, respectively. Amortization of intangible assets is anticipated to be approximately $390 million in 2026, $385 million in 2027, $350 million in 2028, $255 million in 2029 and $220 million in 2030 based upon currency exchange rates as of December 31, 2025.
During the fourth quarter of 2025, the Company reassessed its brand architecture and as a result, certain tradenames with aggregate carrying value of $255.1 million were no longer deemed to have indefinite lives. These tradenames are now being amortized over remaining useful lives ranging from 3 years to 10 years.
Other Intangible Asset Impairment Tests
Consistent with our accounting policy described in Note 1, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate an assets carrying amount may not be recoverable.
During the second quarter of 2025, due to the reduction in the forecast for Aerospace & Defense and the increase in discount rates, the Company quantitatively tested the relevant indefinite lived tradename for impairment which resulted in a non-cash charge of $36.1 million within the Precision and Science Technologies segment.
During the fourth quarter of 2025, the Company rebranded a business resulting in the retirement of a tradename within the Industrial Technologies and Services segment. As a result, the Company recognized an impairment of $7.6 million to reduce the carrying value of the retired tradename.
During the fourth quarter of 2024, the Company decided to rationalize a business within the Precision and Science Technologies segment. As a result, the Company recognized an impairment of $13.9 million to reduce the carrying value of a technology asset.
Annual Intangible Asset Impairment Tests
Consistent with our accounting policy described in Note 1, we performed our annual indefinite-lived intangible asset impairment testing as of the first day of our fiscal fourth quarters of 2025, 2024 and 2023. For the years ended December 31, 2025, 2024 and 2023, each tradename’s fair value was in excess of its net carrying value, and therefore, no impairment was recorded.
v3.25.4
Supply Chain Finance Program
12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Supply Chain Finance Program Supply Chain Finance Program
The Company has agreements with financial institutions to facilitate a supply chain finance program (the “SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company to the financial institution. Participating suppliers negotiate arrangements for sale of their receivables directly with the financial institution, and the terms of the Company’s payment obligations are not impacted by a supplier’s participation in the SCF Program. Once a qualifying supplier elects to participate in the SCF Program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices they sell to the financial institution. However, all of the Company’s payments to participating suppliers are paid to the financial institution on the invoice due date, regardless of whether the individual invoice is sold by the supplier to the financial institution. The Company has not pledged any assets as security or provided other forms of guarantees. All outstanding amounts related to suppliers participating in the SCF Program are recorded within “Accounts payable” in our Consolidated Balance Sheets, and the associated payments are included in “Net cash provided by operating activities” within our Consolidated Statements of Cash Flows.
The following table summarizes the activity associated with the Company’s SCF Program for the years ended December 31, 2025 and 2024.
20252024
Confirmed obligations outstanding at beginning of period$24.5 $24.3 
Invoices confirmed122.8 117.0 
Confirmed invoices paid(119.0)(116.8)
Confirmed obligations outstanding at end of period$28.2 $24.5 
v3.25.4
Accrued Liabilities
12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Accrued Liabilities Accrued Liabilities
Accrued liabilities as of December 31, 2025 and 2024 consisted of the following:
20252024
Salaries, wages and related fringe benefits$238.1 $229.5 
Contract liabilities347.2 318.6 
Product warranty54.1 67.9 
Operating lease liabilities64.8 56.3 
Restructuring39.9 22.3 
Taxes108.5 72.5 
Accrued interest33.1 33.2 
Other183.1 171.9 
Total accrued liabilities$1,068.8 $972.2 
A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2025 and 2024 is as follows.
20252024
Balance at beginning of period$67.9 $61.9 
Product warranty accruals11.8 37.5 
Acquired warranty6.5 0.7 
Settlements(34.6)(30.7)
Foreign currency translation and other2.5 (1.5)
Balance at end of period$54.1 $67.9 
v3.25.4
Debt
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Debt Debt
Debt as of December 31, 2025 and 2024 consisted of the following.
20252024
Short-term borrowings$— $1.7 
Long-term debt
5.197% Senior Notes due June 2027(1)
$700.0 $699.9 
5.400% Senior Notes due August 2028(1)
499.0 498.6 
5.176% Senior Notes due June 2029(1)
750.0 750.0 
5.314% Senior Notes due June 2031(1)
500.0 500.0 
5.700% Senior Notes due August 2033(1)
994.1 993.4 
5.450% Senior Notes due June 2034(1)
749.6 749.5 
5.700% Senior Notes due June 2054(1)
597.7 597.6 
Finance leases and other long-term debt13.2 14.1 
Swap valuation adjustments19.8 (0.3)
Unamortized debt issuance costs(38.7)(47.0)
Total long-term debt, net, including current maturities4,784.7 4,755.8 
Current maturities of long-term debt1.4 1.4 
Total long-term debt, net$4,783.3 $4,754.4 
(1)This amount is net of unamortized discounts. Total unamortized discounts were $9.7 million and $11.0 million as of December 31, 2025 and 2024, respectively.
Senior Notes
On May 10, 2024, the Company issued $3,300.0 million in aggregate principal amount of senior unsecured notes comprised of $700.0 million aggregate principal amount of 5.197% Senior Notes due 2027 (the “2027 Notes”), $750.0 million aggregate principal amount of 5.176% Senior Notes due 2029 (the “2029 Notes”), $500.0 million aggregate principal amount of 5.314% Senior Notes due 2031 (the “2031 Notes”), $750.0 million aggregate principal amount of 5.450% Senior Notes due 2034 (the “2034 Notes”) and $600.0 million aggregate principal amount of 5.700% Senior Notes due 2054 (the “2054 Notes” and, together with the 2027 Notes, 2029 Notes, 2031 Notes and 2034 Notes, the “New Notes,” and collectively with the existing senior unsecured notes, the “Senior Notes”). The Company used the net proceeds of the 2034 Notes and the 2054 Notes to repay in full all indebtedness under, and terminate all commitments and discharge and release all guarantees in respect of, the Company’s former senior secured credit facilities and used the remaining net proceeds of such New Notes for general corporate purposes. The Company used the net proceeds of the 2027 Notes, the 2029 Notes and the 2031 Notes to partially fund the cash consideration of the acquisition of ILC Dover, with any remaining cash consideration funded with cash on hand. The New Notes were issued pursuant to a base indenture, dated as of August 14, 2023 (the “Base Indenture”), between the Company and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”), as supplemented by the third supplemental indenture (the “Supplemental Indenture” and, together with the Base Indenture, the “New Indenture”) dated as of May 10, 2024, between the Company and the Trustee. The interest payment dates for the New Notes are June 15 and December 15 of each year, with interest payable in arrears.
On August 14, 2023, the Company completed its issuance of $1,500.0 million in aggregate principal amount of senior unsecured notes comprised of $500.0 million aggregate principal amount of 5.400% Senior Notes due August 2028 (the “2028 Senior Notes”) and $1,000.0 million aggregate principal amount of 5.700% Senior Notes due August 2033 (the “2033 Senior Notes” and, together with the 2028 Senior Notes, the “Existing Notes”). The Company used the proceeds of the offering of the Existing Notes to repay a portion of the amounts outstanding under its former senior secured credit facilities. The Existing Notes were issued pursuant to the Base Indenture, as supplemented by a 2028 Supplemental Indenture No. 1 with respect to the 2028 Senior Notes and a 2033 Senior Notes Supplemental Indenture No. 1 with respect to the 2033 Senior Notes, each dated as of August 14, 2023, between the Company and the Trustee (collectively, the “Existing Indenture”). The interest payment dates for the Senior Notes are February 14 and August 14 of each year, with interest payable in arrears.
Prior to (i) May 15, 2027, in the case of the 2027 Notes, (ii) July 14, 2028, in the case of the 2028 Senior Notes, (iii) May 15, 2029, in the case of the 2029 Notes, (iv) April 15, 2031, in the case of the 2031 Notes, (v) May 14, 2033, in the case of the 2033 Senior Notes, (vi) March 15, 2034, in the case of the 2034 Notes, and (vii) December 15, 2053, in the case of the 2054 Notes, the Company may redeem the Senior Notes of a series at its option, in whole or in part, at any time from time to time, at a “make-whole” premium, plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after (i) May
15, 2027, in the case of the 2027 Notes, (ii) July 14, 2028, in the case of the 2028 Senior Notes, (iii) May 15, 2029, in the case of the 2029 Notes, (iv) April 15, 2031, in the case of the 2031 Notes, (v) May 14, 2033, in the case of the 2033 Senior Notes, (vi) March 15, 2034, in the case of the 2034 Notes, and (vii) December 15, 2053, in the case of the 2054 Notes, the Company may redeem the New Notes of a series at its option, in whole or in part, at any time from time to time, at a price equal to 100% of the principal amount of the New Notes of such series to be redeemed, plus accrued and unpaid interest thereon to, but not including, the redemption date.
The Senior Notes are senior unsecured obligations of the Company and rank equally in right of payment with all of the Company’s other senior unsecured indebtedness from time to time outstanding, senior in right of payment to all of the Company’s subordinated indebtedness from time to time outstanding, and effectively junior to all of the indebtedness and other liabilities of the Company’s subsidiaries from time to time outstanding and to all of the Company’s secured indebtedness from time to time outstanding to the extent of the value of the assets securing such secured indebtedness.
Additionally, if the Company experiences certain types of change of control transactions, the Company must offer to repurchase the Senior Notes at 101% of the aggregate principal amount of the Senior Notes repurchased (or such higher amount as the Company may determine) plus accrued and unpaid interest thereon to, but not including, the date of repurchase.
The Existing Indenture and New Indenture contain covenants that limit the Company’s (and its subsidiaries’) ability to, among other things: (i) create liens on certain assets; (ii) consolidate, merge, sell or otherwise dispose of all or substantially all of its consolidated assets; and (iii) enter into sale and leaseback transactions with respect to certain assets, as well as customary events of default and covenants for an issuer of investment grade debt securities.
Revolving Credit Facility
On May 10, 2024, the Company entered into a credit agreement (the “Revolving Credit Facility”), with the lenders party thereto and Citibank, N.A., as administrative agent. The Revolving Credit Facility provides for a senior unsecured revolving facility in an aggregate committed amount of $2,600 million, a portion of which is available for the issuance of letters of credit in U.S. dollars, EUR or GBP. The Revolving Credit Facility will mature on May 10, 2029, subject to up to two additional one-year extensions pursuant to the terms of the Revolving Credit Facility.
Borrowings under the Revolving Credit Facility (other than borrowings in EUR or GBP) bear interest at a rate determined, at the Company’s option, based on either (i) an alternate base rate or (ii) a Term SOFR rate with a 0.10% per annum Term SOFR adjustment, plus, in each case, an applicable margin that varies depending on the credit rating of the Company. Borrowings under the Revolving Credit Facility in EUR (if any) bear interest at a EURIBOR rate, plus, in each case, an applicable margin that varies depending on the credit rating of the Company. Borrowings under the Revolving Credit Facility in GBP (if any) bear interest at a daily simple SONIA rate plus, in each case, an applicable margin that varies depending on the credit rating of the Company.
The financial covenant in the Revolving Credit Facility requires the Company to maintain, as of the last day of each fiscal quarter, a ratio of adjusted consolidated total net debt to consolidated adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) of not more than 3.50 to 1.00, provided that the Company may elect to increase such ratio to 4.00 to 1.00 following a qualified acquisition up to two times, each for a period of four fiscal quarters beginning with the quarter during which such qualified acquisition is consummated (and if the second election occurs during the first increase period, such increase will be effective for a total of eight consecutive fiscal quarters).
As of December 31, 2025, the aggregate amount of commitments under the Revolving Credit Facility was $2,600.0 million and the capacity under the Revolving Credit Facility to issue letters of credit was $200.0 million. As of December 31, 2025, the Company had no outstanding borrowings under the Revolving Credit Facility, no outstanding letters of credit under the Revolving Credit Facility and unused availability under the Revolving Credit Facility of $2,600.0 million.
As of December 31, 2025, we were in compliance with all covenants under our Senior Notes and Revolving Credit Facility.
Former Senior Secured Credit Facilities
The former Senior Secured Credit Facilities provided senior secured financing consisting of (i) a senior secured term loan facility denominated in U.S. dollars (as refinanced and otherwise modified from time to time prior to February 28, 2020, the “Original Dollar Term Loan”), (ii) a senior secured term loan facility denominated in U.S. dollars (entered into at the time of the merger with Ingersoll Rand Industrial, the “Dollar Term Loan B”), and (iii) a senior secured revolving credit facility (as refinanced and otherwise modified from time to time, the “Revolving Credit Facility”). The Revolving Credit Facility was available to be drawn in U.S. dollars (“USD”), Euros (“EUR”), Great British Pounds (“GBP”) and other reasonably accepted foreign currencies, subject to certain sublimits for the foreign currencies.
On April 21, 2023, the Company entered into Amendment No. 9 to the Credit Agreement, which (a) extended the maturity date for the revolving credit commitments from June 28, 2024 to April 21, 2028, (b) increased the aggregate revolving credit commitments from $1,100.0 million to $2,000.0 million, and (c) made certain other corresponding changes and updates. The amendment resulted in the write-off of unamortized debt issuance costs of $0.9 million which was recognized in “Loss on extinguishment of debt” in the Consolidated Statements of Operations. In August 2023, the Company repaid a portion of the Dollar Term Loan B and in May 2024, the Company repaid the remaining portion of the Dollar Term Loan B and Dollar Term Loan. These repayments resulted in the write-off of unamortized discounts and debt issuance costs of $3.0 million and $12.6 million, respectively, for the years ended December 31, 2024 and 2023, which was recognized in “Loss on extinguishment of debt” in the Consolidated Statements of Operations.
Commercial Paper Program
On August 13, 2024, the Company established a commercial paper program (the “Commercial Paper Program”), pursuant to which it may issue short-term, unsecured commercial paper notes in a maximum aggregate principal amount of $2,600 million, with maturities of up to 397 days from the date of issuance. The proceeds of the notes issued under the Commercial Paper Program may be used for various purposes including acquisitions. The Company had no outstanding borrowings under the Commercial Paper Program as of December 31, 2025.
Fair Value of Debt
The fair value of the Company’s debt instruments was $5.0 billion and $4.9 billion at December 31, 2025 and 2024, respectively. The Company measures the fair value of its debt instruments for disclosure purposes based upon observable market prices quoted on public exchanges for similar assets. These fair value inputs are considered Level 2 within the fair value hierarchy. See Note 20, “Fair Value Measurements” for information on the fair value hierarchy.
Total Debt Maturities
Total debt maturities for the five years subsequent to December 31, 2025 and thereafter are $1.4 million, $702.1 million, $501.6 million, $751.6 million, $1.6 million and $2,855.0 million, respectively.
v3.25.4
Benefit Plans
12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Benefit Plans Benefit Plans
Pension and Postretirement Benefit Plans
The Company sponsors a number of pension and postretirement plans worldwide. Pension plan benefits are provided to employees under defined benefit pay-related and service-related plans, which are non-contributory in nature. The Company’s funding policy for the U.S. defined benefit pension plans is to contribute at least the minimum required contribution required by Employee Retirement Income Security Act (“ERISA”), as amended by the Pension Protection Act of 2016 (as amended by MAP-21, HAFTA, and BBA 15). The Company intends to make contributions, as necessary, to prevent benefit restrictions in the plans. The Company’s annual contributions to the non-U.S. pension plans are consistent with the requirements of applicable local laws.
The Company also provides postretirement healthcare and life insurance benefits to a limited group of current and retired employees, primarily in the United States. All of the Company’s postretirement benefit plans are unfunded.
The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202520242025202420252024
Reconciliation of Benefit Obligations:
Beginning balance$264.7 $294.0 $251.4 $263.2 $5.9 $18.3 
Service cost0.1 0.1 3.2 2.9 — — 
Interest cost13.5 13.4 11.6 10.7 0.2 0.8 
Participant contributions— — 0.3 0.2 — — 
Plan amendments— — — — — (10.9)
Actuarial losses (gains)(1)
9.0 (18.1)(14.7)(11.3)0.4 0.2 
Benefit payments(24.9)(22.2)(13.2)(14.5)(2.3)(2.4)
Acquisitions— — — 10.2 — — 
Plan settlements— (2.5)(6.7)— — — 
Other— — 1.0 0.6 — — 
Effect of foreign currency exchange rate changes— — 24.9 (10.6)0.1 (0.1)
Benefit obligations ending balance$262.4 $264.7 $257.8 $251.4 $4.3 $5.9 
Reconciliation of Fair Value of Plan Assets:
Beginning balance$206.9 $237.5 $194.6 $206.0 
Actual return on plan assets17.4 (6.0)5.4 (7.1)
Employer contributions10.3 0.1 7.6 6.5 
Participant contributions— — 0.3 0.2 
Acquisitions— — — 8.5 
Benefit payments(24.9)(22.2)(13.2)(14.5)
Plan settlements— (2.5)(6.7)— 
Other— — 1.0 0.6 
Effect of foreign currency exchange rate changes— — 16.8 (5.6)
Fair value of plan assets ending balance$209.7 $206.9 $205.8 $194.6 
Funded Status as of Period End$(52.7)$(57.8)$(52.0)$(56.8)$(4.3)$(5.9)
(1)Actuarial losses (gains) primarily resulted from changes in discount rates.
Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2025 and 2024 that have not been recognized as a component of net periodic benefit cost are presented in the following table.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202520242025202420252024
Net actuarial losses (gains)$(8.3)$(10.8)$(2.0)$7.6 $(2.2)$(3.2)
Prior service cost— — 2.7 2.7 — (10.9)
Amounts included in accumulated other comprehensive income (loss)$(8.3)$(10.8)$0.7 $10.3 $(2.2)$(14.1)
Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2025 and 2024.
20252024
Other assets$23.5 $18.5 
Accrued liabilities(4.6)(6.4)
Pension and other postretirement benefits(127.9)(132.6)
The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2025 and 2024.
U.S. Pension PlansNon-U.S. Pension Plans
2025202420252024
Projected benefit obligations$262.3 $264.7 $116.3 $119.7 
Accumulated benefit obligation262.3 264.7 109.0 112.7 
Fair value of plan assets209.7 206.9 39.0 42.8 
The accumulated benefit obligation for all U.S. defined benefit pension plans was $262.3 million and $264.7 million as of December 31, 2025 and 2024, respectively. The accumulated benefit obligation for all non-U.S. defined benefit pension plans was $249.4 million and $243.3 million as of December 31, 2025 and 2024, respectively.
The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2025, 2024 and 2023.
U.S. Pension Plans
202520242023
Net Periodic Benefit Cost:
Service cost$0.1 $0.1 $0.1 
Interest cost13.5 13.4 15.7 
Expected return on plan assets(11.0)(12.7)(13.2)
Amortization of net actuarial loss0.1 — 0.1 
Net periodic benefit cost2.7 0.8 2.7 
Loss (gain) due to settlement— 0.4 (0.4)
Total net periodic benefit cost recognized$2.7 $1.2 $2.3 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss$2.6 $0.6 $0.5 
Amortization of net actuarial gain (loss)(0.1)(0.4)0.3 
Total recognized in other comprehensive income (loss)$2.5 $0.2 $0.8 
Total recognized in net periodic benefit cost and other comprehensive income (loss)$5.2 $1.4 $3.1 
Non-U.S. Pension Plans
202520242023
Net Periodic Benefit Cost:
Service cost$3.2 $2.9 $2.6 
Interest cost11.6 10.7 11.1 
Expected return on plan assets(9.7)(11.2)(11.0)
Amortization of prior service cost0.2 0.2 0.1 
Amortization of net actuarial gain(1.0)(1.3)(1.7)
Net periodic benefit cost4.3 1.3 1.1 
Loss due to settlements(0.2)— — 
Total net periodic benefit cost recognized$4.1 $1.3 $1.1 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$(10.4)$7.0 $7.5 
Amortization of net actuarial gain1.2 1.3 1.7 
Prior service cost— — 0.3 
Amortization of prior service cost(0.2)(0.2)(0.1)
Effect of foreign currency exchange rate changes(0.2)0.4 0.3 
Total recognized in other comprehensive income (loss)$(9.6)$8.5 $9.7 
Total recognized in net periodic benefit cost and other comprehensive income (loss)$(5.5)$9.8 $10.8 
Other Postretirement Benefits
202520242023
Net Periodic Benefit Cost (Income):
Interest cost$0.2 $0.8 $0.9 
Amortization of prior service cost(10.9)0.1 0.1 
Amortization of net actuarial gain(0.6)(0.8)(1.1)
Total net periodic benefit cost (income) recognized$(11.3)$0.1 $(0.1)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$0.4 $0.2 $(1.0)
Amortization of net actuarial loss0.6 0.8 1.1 
Prior service cost— (10.9)— 
Amortization of prior service cost10.9 (0.1)(0.1)
Total recognized in other comprehensive income (loss)$11.9 $(10.0)$— 
Total recognized in net periodic benefit cost (income) and other comprehensive income (loss)$0.6 $(9.9)$(0.1)
The discount rate selected to measure the present value of the Company’s benefit obligations was derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under a plan. The Company selects the expected long-term rate of return on plan assets in consultation with the plans’ advisors. This rate is intended to reflect the expected average rate of earnings on the funds invested or to be invested to provide plan benefits and the Company’s most recent plan assets target allocations. In estimating the expected long-term rate of return on plan assets, appropriate consideration is given to historical performance of the major asset classes held or anticipated to be held by the plans and to current forecasts of future rates of return for those asset classes. Because assets are held in qualified trusts, expected returns are not adjusted for taxes.
The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2025, 2024 and 2023.
U.S. Pension PlansNon-U.S. Pension Plans
202520242023202520242023
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate5.5 %5.0 %5.2 %4.5 %4.2 %4.5 %
Expected long-term rate of return on plan assets5.7 %5.8 %5.4 %4.8 %5.5 %5.5 %
Rate of compensation increasesN/AN/A— %5.0 %5.0 %4.3 %
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate5.1 %5.5 %5.0 %4.6 %4.5 %4.2 %
Rate of compensation increasesN/AN/AN/A5.0 %5.0 %5.0 %
The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2025, 2024 and 2023.
Other Postretirement Benefits
202520242023
Discount rate used to determine net periodic benefit cost
4.4% - 5.4%
4.9% - 5.1%
4.9% - 5.2%
Discount rate used to determine benefit obligations
4.5% - 5.1%
4.4% - 5.4%
4.9% - 5.1%
Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations:
Healthcare cost trend rate assumed for next year4.4 %5.1 %6.8 %
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)4.0 %4.0 %4.4 %
Year that the date reaches the ultimate trend rate204020402035
The following table reflects the estimated benefit payments for the next five years and for the years 2031 through 2035. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2025.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
2026$24.7 $16.4 $0.4 
202725.0 15.4 0.4 
202823.8 16.0 0.4 
202923.7 17.9 0.3 
203023.9 17.9 0.3 
Aggregate 2031-2035
98.5 92.1 1.4 
In 2026, the Company expects to contribute $8.7 million to the U.S. pension plans, $7.8 million to the non-U.S. pension plans, and $0.4 million to the other postretirement benefit plans.
Plan Asset Investment Strategy
The Company’s overall investment strategy and objectives for its pension plan assets is to (i) meet current and future benefit payment needs through diversification across asset classes, investing strategies and investment managers to achieve an optimal balance between risk and return and between income and growth of assets through capital appreciation, (ii) secure participant retirement benefits, (iii) minimize reliance on contributions as a source of benefit security, and (iv) maintain sufficient liquidity to pay benefit obligations and proper expenses. The composition of the actual investments in various securities changes over time based on short and long-term investment opportunities. None of the plan assets of Ingersoll Rand’s defined benefit plans are invested in the Company’s common stock. The Company uses both active and passive investment strategies.
Plan Asset Risk Management
The target financial objectives for the pension plans are established in conjunction with periodic comprehensive reviews of each plan’s liability structure. The Company’s asset allocation policy is based on detailed asset and liability model (“ALM”) analyses. A formal ALM study of each major plan is undertaken every 2-5 years or whenever there has been a material change in plan demographics, benefit structure, or funded status. In order to determine the recommended asset allocation, the advisors model varying return and risk levels for different theoretical portfolios, using a relative measure of excess return over treasury bills, divided by the standard deviation of the return (the “Sharpe Ratio”). The Sharpe Ratio for different portfolio options was used to compare each portfolio’s potential return, on a risk-adjusted basis. The Company selected a recommended portfolio that achieved the targeted composite return with the least amount of risk.
The Company’s primary pension plans are in the U.S. and UK which together comprise 75% of the total benefit obligations and 87% of total plan assets as of December 31, 2025. The following table presents the long-term target allocations for these plans as of December 31, 2025.
U.S. PlansUK Plan
Asset category:
Equity32 %11 %
Fixed income66 %58 %
Real estate and other%31 %
Total100 %100 %
Fair Value Measurements
The following tables present the fair values of the Company’s pension plan assets as of December 31, 2025 and 2024 by asset category within the ASC 820 hierarchy (as defined in Note 20 “Fair Value Measurements”).
December 31, 2025
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$3.5 $— $— $— $3.5 
Equity funds:
U.S. mid-cap— — — 1.7 1.7 
U.S. large-cap— 3.7 — 18.3 22.0 
International equity(2)
— 25.2 — 54.9 80.1 
Total equity funds— 28.9 — 74.9 103.8 
Fixed income funds:
Corporate bonds - international— 25.3 — 17.7 43.0 
UK index-linked gilts— 71.8 — — 71.8 
U.S. fixed income - government securities— — — 47.5 47.5 
U.S. fixed income - short duration— — — 1.7 1.7 
U.S. fixed income - intermediate duration— — — 24.5 24.5 
U.S. fixed income - long duration— — — 58.8 58.8 
Global fixed income— — — 2.4 2.4 
Total fixed income funds— 97.1 — 152.6 249.7 
Other types of investments:
International real estate(3)
— 12.5 — — 12.5 
Other(4)
— 39.6 6.4 46.0 
Total$3.5 $138.5 $39.6 $233.9 $415.5 
December 31, 2024
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$5.1 $— $— $— $5.1 
Equity funds:
U.S. small-cap— — — 0.9 0.9 
U.S. mid-cap— — — 2.6 2.6 
U.S. large-cap— 2.5 — 11.6 14.1 
International equity(2)
— 23.2 — 26.5 49.7 
Total equity funds— 25.7 — 41.6 67.3 
Fixed income funds:
Corporate bonds - international— 23.8 — 15.8 39.6 
UK index-linked gilts— 66.0 — — 66.0 
U.S. fixed income - government securities— — — 20.5 20.5 
U.S. fixed income - short duration— — — 1.8 1.8 
U.S. fixed income - intermediate duration— — — 25.2 25.2 
U.S. fixed income - long corporate— — — 122.7 122.7 
Global fixed income— — — 1.8 1.8 
Total fixed income funds— 89.8 — 187.8 277.6 
Other types of investments:
International real estate(3)
— 11.6 — — 11.6 
Other(4)
— 38.1 1.8 39.9 
Total$5.1 $127.1 $38.1 $231.2 $401.5 
(1)Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets.
(2)The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors.
(3)International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties.
(4)Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services.
(5)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.
Defined Contribution Plans
The Company also sponsors defined contribution plans at various locations throughout the world. Benefits are determined and funded regularly based on terms of the plans or as stipulated in a collective bargaining agreement. The Company’s full-time salaried and hourly employees in the U.S. are eligible to participate in Company-sponsored defined contribution savings plans, which are qualified plans under the requirements of Section 401(k) of the Internal Revenue Code. The Company’s contributions to the savings plans are in the form of cash. The Company’s total contributions to all worldwide defined contribution plans for the years ended December 31, 2025, 2024, and 2023 were $53.5 million, $49.1 million and $47.0 million, respectively.
Other Benefit Plans
There are various other employment contracts, deferred compensation arrangements, covenants not to compete, and change in control agreements with certain employees and former employees. The Company offers a long-term service award program for qualified employees at certain of its non-U.S. locations. Under this program, qualified employees receive a service gratuity (“Jubilee”) payment once they have achieved a certain number of years of service. The liabilities associated with such arrangements are not material to the Company’s consolidated financial statements.
v3.25.4
Stockholders' Equity and Noncontrolling Interests
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders' Equity and Noncontrolling Interests Stockholders’ Equity and Noncontrolling Interests
Stockholders’ Equity
As of December 31, 2025 and 2024, 1,000,000,000 shares of voting common stock were authorized. Shares of common stock outstanding wer391,121,689 and 402,880,079 as of December 31, 2025 and 2024, respectively. The Company is governed by the General Corporation Law of the State of Delaware. All authorized shares of voting common stock have a par value of $0.01. Shares of common stock reacquired are considered issued and reported as Treasury shares.
Noncontrolling Interests
The Company has a controlling interest of approximately 75% of the common shares of Ingersoll-Rand India Limited. The remaining shares are owned by unaffiliated shareholders and traded on India stock exchanges regulated by Securities and Exchange Board of India.
Share Repurchase Program
On August 24, 2021, the Board of Directors of Ingersoll Rand authorized a share repurchase program pursuant to which the Company may repurchase up to $750.0 million of its common stock, and on April 25, 2024, the Company announced that our Board of Directors approved an incremental $1.0 billion increase to the share repurchase authorization, and on May 1, 2025, the Company announced that its Board of Directors authorized a $1.0 billion increase to the share repurchase authorization. (the “Repurchase Program”). Under the repurchase program, Ingersoll Rand is authorized to repurchase shares through open market purchases, privately-negotiated transactions or otherwise in accordance with all applicable securities laws and regulations, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Securities Exchange Act of 1934, as amended.
Under the Repurchase Program, the Company repurchased 12,687,461 shares, 2,665,262 shares, and 3,963,243 shares during the years ended December 31, 2025, 2024, and 2023, respectively, at an average price per share of $79.40, $93.80, and $62.98 for an aggregate value of $1,007.4 million, $250.0 million, and $249.6 million, respectively.
v3.25.4
Accumulated Other Comprehensive Income (Loss)
12 Months Ended
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
The Company’s other comprehensive income (loss) consists of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and certain hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 12 “Benefit Plans” and Note 19 “Hedging Activities, Derivative Instruments and Credit Risk.”
The before tax income (loss) and related income tax effect are as follows.
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Before tax income (loss)23.0 (5.1)(10.5)7.4 
Income tax effect11.8 1.3 3.6 16.7 
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Before tax income (loss)(218.6)(14.1)1.3 (231.4)
Income tax effect(13.0)5.0 (1.5)(9.5)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
Before tax income (loss)294.4 (5.8)(5.2)283.4 
Income tax effect36.1 — 0.7 36.8 
Other comprehensive income (loss)330.5 (5.8)(4.5)320.2 
Balance as of December 31, 2025$(149.1)$(2.7)$3.5 $(148.3)
The tables above include only the other comprehensive income (loss), net of tax, attributable to Ingersoll Rand Inc. Other comprehensive income (loss), net, attributable to noncontrolling interest holders was $(2.4) million, $2.7 million and $1.7
million for the years ended December 31, 2025, 2024 and 2023, respectively, and related entirely to foreign currency translation adjustments.
Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table(1).
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Other comprehensive income (loss) before reclassifications49.0 7.9 (4.7)52.2 
Amounts reclassified from accumulated other comprehensive income (loss)(14.2)(11.7)(2.2)(28.1)
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Other comprehensive income (loss) before reclassifications(218.3)2.7 0.8 (214.8)
Amounts reclassified from accumulated other comprehensive income (loss)(13.3)(11.8)(1.0)(26.1)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
Other comprehensive income (loss) before reclassifications344.1 (1.5)4.8 347.4 
Amounts reclassified from accumulated other comprehensive income (loss)(13.6)(4.3)(9.3)(27.2)
Other comprehensive income (loss)330.5 (5.8)(4.5)320.2 
Balance as of December 31, 2025$(149.1)$(2.7)$3.5 $(148.3)
(1)All amounts are net of tax. Amounts in parentheses indicate debits.
Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2025, 2024 and 2023 are presented in the following table.
Amount Reclassified from Accumulated Other Comprehensive Income (Loss)
Details about Accumulated Other Comprehensive Income (Loss) Components202520242023Affected Line(s) in the Statement Where Net Income is Presented
Cash flow hedges (interest rate swaps and caps)$(5.8)$(15.7)$(15.6)Interest expense
Provision for income taxes1.5 3.9 3.9 Provision for income taxes
Cash flow hedges (interest rate swaps and caps), net of tax$(4.3)$(11.8)$(11.7)
Net investment hedges$(18.2)$(17.7)$(19.0)Interest expense
Provision for income taxes4.6 4.4 4.8 Provision for income taxes
Net investment hedges, net of tax$(13.6)$(13.3)$(14.2)
Amortization of defined benefit pension and other postretirement benefit items(1)
$(12.4)$(1.4)$(2.9)
Cost of sales and Selling and administrative expenses
Provision for income taxes3.1 0.4 0.7 Provision for income taxes
Amortization of defined benefit pension and other postretirement benefit items, net of tax$(9.3)$(1.0)$(2.2)
Total reclassifications for the period$(27.2)$(26.1)$(28.1)
(1)These components are included in the computation of net periodic benefit cost. See Note 12 “Benefit Plans” for additional details.
v3.25.4
Revenue from Contracts with Customers
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
Overview
The Company recognizes revenue when it has satisfied its obligation and control is transferred to the customer. The amount of revenue recognized includes adjustments for any variable consideration, such as rebates, sales discounts and liquidated damages, which are included in the transaction price, and allocated to each performance obligation. The variable consideration is estimated throughout the course of the contract using the Company’s best estimates. Judgments impacting variable consideration related to material rebate and sales discount programs, and significant contracts containing liquidated damage clauses are governed by management review processes.
The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered.
The Company has certain long duration engineered to order (“ETO”) contracts that require highly-engineered solutions designed to customer specific applications. For contracts where the contractual deliverables have no alternative use and the contract termination clauses provide for the recovery of cost plus a reasonable margin, revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations, generally measured as the ratio of actual costs incurred to date to the estimated total costs to complete the contract. For contracts with termination provisions that do not provide for recovery of cost and a reasonable margin, revenue is recognized at a point in time, generally at shipment or delivery to the customer. Identification of performance obligations, determination of alternative use, assessment of contractual language regarding termination provisions, and estimation of total project costs are all significant judgments required in the application of ASC 606.
Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification either creates new or changes the existing enforceable rights and obligations. In the event a contract modification is for goods or services that are not distinct in the contract, and therefore, form part of a single performance obligation that is partially satisfied as of the modification date, the effect of the contract modification on the transaction price and the Company’s measure of progress for the performance obligation to which it relates, is recognized on a cumulative catch-up basis.
Taxes assessed by a government authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Sales commissions are due at either collection of payment from customers or recognition of revenue. Applying the practical expedient from ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in “Selling and administrative expenses” in the Consolidated Statements of Operations.
Disaggregation of Revenue
The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2025 and 2024.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202520242025202420252024
Primary Geographic Markets
United States$2,473.5 $2,461.2 $716.4 $651.1 $3,189.9 $3,112.3 
Other Americas488.5 452.9 123.6 88.3 612.1 541.2 
Total Americas2,962.0 2,914.1 840.0 739.4 3,802.0 3,653.5 
EMEIA2,008.0 1,854.9 593.5 520.0 2,601.5 2,374.9 
China672.3 680.8 117.2 113.8 789.5 794.6 
Other Asia Pacific414.1 368.3 43.8 43.7 457.9 412.0 
Total Asia Pacific1,086.4 1,049.1 161.0 157.5 1,247.4 1,206.6 
Total$6,056.4 $5,818.1 $1,594.5 $1,416.9 $7,650.9 $7,235.0 
Product Categories
Original equipment(1)
$3,595.3 $3,494.0 $1,266.5 $1,110.2 $4,861.8 $4,604.2 
Aftermarket(2)
2,461.1 2,324.1 328.0 306.7 2,789.1 2,630.8 
Total$6,056.4 $5,818.1 $1,594.5 $1,416.9 $7,650.9 $7,235.0 
Pattern of Revenue Recognition
Revenue recognized at point in time(3)
$5,432.0 $5,295.6 $1,495.9 $1,376.4 $6,927.9 $6,672.0 
Revenue recognized over time(4)
624.4 522.5 98.6 40.5 723.0 563.0 
Total$6,056.4 $5,818.1 $1,594.5 $1,416.9 $7,650.9 $7,235.0 
(1)Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment.
(2)Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment.
(3)Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered.
(4)Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed.
Performance Obligations
The majority of the Company’s contracts have a single performance obligation as the promise to transfer goods and/or services. For contracts with multiple performance obligations, the Company utilizes observable prices to determine standalone selling price or cost plus margin if a standalone price is not available. The Company has elected to account for shipping and handling activities as fulfillment costs and not a separate performance obligation. If control transfers and related revenue is recognized for the related good before the shipping and handling activities occur, the related costs of those shipping and handling activities are accrued.
The Company’s primary performance obligations include delivering standard or configured to order (“CTO”) goods to customers, designing and manufacturing a broad range of equipment customized to a customer’s specifications in ETO arrangements, rendering of services (maintenance and repair contracts), and certain extended or service type warranties. For incidental items that are immaterial in the context of the contract, costs are expensed as incurred or accrued at delivery.
As of December 31, 2025, for contracts with an original duration greater than one year, the Company expects to recognize revenue in the future related to unsatisfied (or partially satisfied) performance obligations of $743.2 million in the next twelve months and $807.9 million in periods thereafter. The performance obligations that are unsatisfied (or partially satisfied) are primarily related to orders for goods or services that were placed prior to the end of the reporting period and have not been delivered to the customer, on-going work on ETO contracts where revenue is recognized over time and service contracts with an original duration greater than one year.
Contract Balances
The following table provides the contract balances as of December 31, 2025 and 2024 presented in the Consolidated Balance Sheets.
December 31, 2025December 31, 2024
Accounts receivable, net$1,518.0 $1,335.4 
Contract assets163.9 111.2 
Contract liabilities - current347.2 318.6 
Contract liabilities - noncurrent1.1 0.9 
Accounts receivable, net – Amounts due where the Company’s right to receive cash is unconditional. Customer receivables are recorded at face amount less an allowance for credit losses. The Company maintains an allowance for credit losses as a result of customers’ inability to make required payments. Management evaluates the aging of customer receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of customer receivables that may not be collected in the future and records the appropriate provision.
Contract assets – The Company’s rights to consideration for the satisfaction of performance obligations subject to constraints apart from timing. Contract assets are transferred to receivables when the right to collect consideration becomes unconditional. Contract assets are presented net of progress billings and related advances from customers.
Contract liabilities – Advance payments received from customers for contracts for which revenue is not yet recognized. Contract liability balances are generally recognized in revenue within twelve months. Of the $319.5 million in contract liabilities as of December 31, 2024, we recognized substantially all as revenue in the year ended December 31, 2025.
Contract assets and liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period. Contract assets and liabilities are presented net on a contract level, where required.
Payments from customers are generally due 30 to 60 days after invoicing. Invoicing for sales of standard products generally coincides with shipment or delivery of goods. Invoicing for CTO and ETO contracts typically follows a schedule for billing at contractual milestones. Payment milestones normally include down payments upon the contract signing, completion of product design, completion of customer’s preliminary inspection, shipment or delivery, completion of installation, and customer’s on-site inspection. The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets.
The Company has elected the practical expedient from ASC 606-10-32-18 and does not adjust the transaction price for the effects of a financing component if, at contract inception, the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
v3.25.4
Income Taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income before income taxes for the years ended December 31, 2025, 2024 and 2023 consisted of the following.
202520242023
U.S.$220.3 $383.7 $356.0 
Non-U.S.715.0 749.1 675.1 
Income before income taxes$935.3 $1,132.8 $1,031.1 
The following table details the components of the Provision for income taxes for the years ended December 31, 2025, 2024 and 2023.
202520242023
Current:
U.S. federal$81.2 $87.5 $111.5 
U.S. state and local24.0 22.8 23.7 
Non-U.S.193.6 185.3 181.7 
Deferred:
U.S. federal(26.2)(9.7)(44.0)
U.S. state and local(6.5)(5.7)(6.9)
Non-U.S.(46.7)(17.7)(26.0)
Provision for income taxes$219.4 $262.5 $240.0 
The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the year ended December 31, 2025 after the adoption of ASU 2023-09 as follows.
2025
U.S. federal corporate statutory rate$196.4 21.0 %
State and local taxes, less federal tax benefit (1)
13.3 1.4 
Foreign tax effects
China
Withholding tax16.6 1.8 
Other4.9 0.5 
India10.3 1.1 
Malta
Interest on equity(24.2)(2.6)
Other7.6 0.8 
Switzerland(13.4)(1.4)
Other foreign jurisdictions16.4 1.7 
Effect of cross-border tax laws
Foreign Derived Intangible Income (“FDII”) deduction(14.4)(1.5)
Repatriation cost2.5 0.3 
Global Intangible Low-Tax Income (“GILTI”)13.0 1.4 
Tax credits
Foreign tax credits(23.8)(2.5)
Other(3.8)(0.4)
Changes in valuation allowances4.4 0.5 
Nontaxable and nondeductible items18.7 2.0 
Changes in unrecognized tax benefits4.2 0.4 
Other adjustments(9.3)(1.0)
Effective income tax rate$219.4 23.5 %
(1)During the year ended December 31, 2025, state taxes in California, Florida, Georgia, Illinois, Indiana, Minnesota, Pennsylvania, Tennessee and Texas comprised greater than 50% of the tax effect in this category.
The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2024 and 2023, prior to the adoption of ASU 2023-09 as follows.
20242023
U.S. federal corporate statutory rate21.0 %21.0 %
State and local taxes, less federal tax benefit1.4 1.3 
Net effects of foreign tax rate differential2.5 1.8 
Withholding tax1.3 1.5 
Repatriation cost(1.5)(2.0)
Global Intangible Low-Tax Income (“GILTI”)0.4 0.7 
ASC 740-30 (formerly APB 23)1.5 1.7 
Changes in valuation allowances0.4 1.7 
Changes in unrecognized tax benefits0.9 0.9 
Equity compensation(1.3)(0.6)
Nondeductible acquisition costs0.3 0.4 
Foreign Derived Intangible Income (“FDII”) deduction(1.1)(1.4)
Tax credits(0.6)(0.7)
Income not subject to tax(0.3)(1.6)
Amortization of goodwill and other intangible assets(1.3)(0.8)
Interest on equity(1.8)(0.7)
Return to provision adjustment(0.2)0.1 
Loss on sale1.1 — 
Other, net0.5 — 
Effective income tax rate23.2 %23.3 %
The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2025 and 2024 are as follows.
20252024
Deferred Tax Assets:
Reserves and accruals$95.3 $83.4 
Allowance for credit losses9.8 7.4 
Inventory reserve9.6 9.0 
Pension and postretirement benefit plans
18.6 20.0 
Tax loss carryforwards94.1 112.4 
Deferred taxes recorded in other comprehensive income36.2 1.4 
Foreign tax credit carryforwards50.9 50.7 
Other12.7 22.4 
Total deferred tax assets327.2 306.7 
Valuation allowance(107.4)(125.6)
Deferred Tax Liabilities:
LIFO inventory(19.6)(20.3)
Investment in partnership— (30.2)
Property, plant and equipment(44.3)(50.0)
Intangible assets(763.7)(770.4)
Unremitted foreign earnings(50.4)(41.8)
Total deferred tax liabilities(878.0)(912.7)
Net deferred income tax liability$(658.2)$(731.6)
The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2025 were as follows.
Tax BenefitValuation AllowanceCarryforward Period Ends
Tax Attributes to be Carried Forward
U.S. federal net operating loss$1.9 $(0.1)2032-2038
U.S. federal capital loss0.6 (0.6)2028
U.S. federal tax credit50.9 (50.9)2026-2035
Alternative minimum tax credit0.4 (0.4)Unlimited
U.S. state and local net operating losses6.2 (0.7)2027-2042
U.S. state capital loss0.3 (0.1)2028
Non U.S. net operating losses70.3 (36.8)2026-Unlimited
Non U.S. capital losses0.7 — Unlimited
Excess interest14.1 (12.9)Unlimited
Other deferred tax assets4.9 (4.9)Unlimited
Total tax carryforwards$150.3 $(107.4)
A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2025, 2024 and 2023 are as follows.
202520242023
Beginning balance$125.6 $115.7 $107.3 
Revaluation or additions due to acquisitions or mergers(1)
(15.6)22.9 — 
Charged to tax expense (benefit)(5.9)(10.8)6.4 
Charged to other accounts3.3 (2.2)2.0 
Ending balance$107.4 $125.6 $115.7 
(1)Revaluation for the tax year ended December 31, 2024 relates to the inclusion of ILC Dover’s opening balance sheet beginning valuation allowance.
Total unrecognized tax benefits were $32.8 million, $26.4 million and $19.1 million for the years ended December 31, 2025, 2024 and 2023, respectively. The net increase in this balance primarily relates to current year additions to previously established reserves. Included in total unrecognized benefits at December 31, 2025 is $32.8 million of unrecognized tax benefits that would affect the Company’s effective tax rate if recognized. Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2025, 2024 and 2023.
202520242023
Beginning balance$26.4 $19.1 $10.8 
Gross increases for tax positions of prior years0.1 0.8 0.4 
Gross decreases for tax positions of prior years— (0.3)— 
Gross increases for tax positions of current year4.6 8.1 7.9 
Lapse of statute of limitations(0.1)(0.6)(0.2)
Changes due to currency fluctuations1.8 (0.7)0.2 
Ending balance$32.8 $26.4 $19.1 
The Company includes interest expense and penalties related to unrecognized tax benefits as part of the provision for income taxes. The Company’s income tax liabilities at December 31, 2025 and 2024 include accrued interest and penalties of $5.9 million and $3.2 million, respectively.
The statutes of limitations for U.S. Federal tax returns are open beginning with the 2020 tax year, and state returns are open beginning with the 2015 tax year. The Internal Revenue Service (“IRS”) has completed its examination of the 2020 tax year, but it is not yet settled. There are no material adjustments proposed. The Company is currently under U.S. Federal income tax audit for the 2021 and 2022 tax years and no material adjustments are known.
The Company is subject to income tax in 49 jurisdictions outside the U.S. The statute of limitations varies by jurisdiction with 2013 being the oldest year still open. Note that any liabilities arising from legacy Ingersoll Rand Industrial entities for tax years prior to the merger with Ingersoll Rand Industrial would be indemnified.
The Company does not assert the ASC 740-30 (formerly APB 23) indefinite reinvestment of the Company’s historical non-U.S. earnings or future non-U.S. earnings. The Company records a deferred foreign tax liability to cover all estimated withholding, state income tax and foreign income tax associated with repatriating all non-U.S. earnings back to the United States. The Company’s deferred income tax liability as of December 31, 2025 was $50.4 million.
The amounts of cash income taxes paid by the Company were as follows:
2025
Federal$40.3 
State and local22.7 
Foreign
China54.2 
France18.4 
India23.5 
Italy30.7 
All other foreign79.5 
Cash paid for income taxes, net of refunds$269.3 
The amount of cash income taxes paid by the Company during the years ended December 31, 2024 and 2023 was $276.7 million and $302.0 million, respectively.
v3.25.4
Leases
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases Leases
The components of lease expense for the years ended December 31, 2025 and 2024 are as follows.
20252024
Operating lease cost$78.6 $64.5 
Finance lease cost
Amortization of right-of-use assets$1.4 $1.5 
Interest on lease liabilities0.8 0.9 
Total finance lease cost$2.2 $2.4 
Short-term lease cost$2.5 $2.2 
Supplemental cash flow information related to leases for the years ended December 31, 2025 and 2024 is as follows.
20252024
Supplemental Cash Flows Information
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases$77.4 $63.8 
Operating cash flows from finance leases0.8 0.9 
Financing cash flows from finance leases1.3 1.3 
Leased Assets Obtained in Exchange for New Operating Lease Liabilities55.0 96.2 
Supplemental balance sheet information related to leases is as follows.
December 31, 2025December 31, 2024
Operating leases
Other assets$236.4 $226.6 
Accrued liabilities$64.8 $56.3 
Other liabilities168.0 165.5 
Total operating lease liabilities$232.8 $221.8 
Finance Leases
Property, plant and equipment$9.7 $11.1 
Short-term borrowings and current maturities of long-term debt$1.3 $1.3 
Long-term debt, less current maturities11.2 12.6 
Total finance lease liabilities$12.5 $13.9 
Weighted Average Remaining Lease Term (in years)
Operating leases5.05.2
Finance leases8.79.4
Weighted Average Discount Rate
Operating leases4.2 %4.1 %
Finance leases6.5 %6.5 %
Maturities of lease liabilities as of December 31, 2025 are as follows.
Operating LeasesFinance Leases
2026$73.3 $2.1 
202757.9 2.1 
202842.9 2.1 
202927.9 2.1 
203018.0 2.1 
Thereafter38.9 6.3 
Total lease payments$258.9 $16.8 
Less imputed interest(26.1)(4.3)
Total$232.8 $12.5 
Leases Leases
The components of lease expense for the years ended December 31, 2025 and 2024 are as follows.
20252024
Operating lease cost$78.6 $64.5 
Finance lease cost
Amortization of right-of-use assets$1.4 $1.5 
Interest on lease liabilities0.8 0.9 
Total finance lease cost$2.2 $2.4 
Short-term lease cost$2.5 $2.2 
Supplemental cash flow information related to leases for the years ended December 31, 2025 and 2024 is as follows.
20252024
Supplemental Cash Flows Information
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases$77.4 $63.8 
Operating cash flows from finance leases0.8 0.9 
Financing cash flows from finance leases1.3 1.3 
Leased Assets Obtained in Exchange for New Operating Lease Liabilities55.0 96.2 
Supplemental balance sheet information related to leases is as follows.
December 31, 2025December 31, 2024
Operating leases
Other assets$236.4 $226.6 
Accrued liabilities$64.8 $56.3 
Other liabilities168.0 165.5 
Total operating lease liabilities$232.8 $221.8 
Finance Leases
Property, plant and equipment$9.7 $11.1 
Short-term borrowings and current maturities of long-term debt$1.3 $1.3 
Long-term debt, less current maturities11.2 12.6 
Total finance lease liabilities$12.5 $13.9 
Weighted Average Remaining Lease Term (in years)
Operating leases5.05.2
Finance leases8.79.4
Weighted Average Discount Rate
Operating leases4.2 %4.1 %
Finance leases6.5 %6.5 %
Maturities of lease liabilities as of December 31, 2025 are as follows.
Operating LeasesFinance Leases
2026$73.3 $2.1 
202757.9 2.1 
202842.9 2.1 
202927.9 2.1 
203018.0 2.1 
Thereafter38.9 6.3 
Total lease payments$258.9 $16.8 
Less imputed interest(26.1)(4.3)
Total$232.8 $12.5 
v3.25.4
Stock-Based Compensation Plans
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Plans Stock-Based Compensation Plans
The Company has outstanding stock-based compensation awards granted under the 2013 Stock Incentive Plan (“2013 Plan”) and the 2017 Omnibus Incentive Plan, (as amended by the First Amendment, dated April 27, 2021, “2017 Plan”). Following the Company’s initial public offering, the Company grants stock-based compensation awards pursuant to the 2017 Plan and ceased granting new awards pursuant to the 2013 Plan.
2017 Omnibus Incentive Plan
In May 2017, the Company’s Board approved the 2017 Plan, and in February 2020, the Company’s stockholders approved the amendment and restatement of the 2017 Plan. Under the terms of the Plan, the Company’s Board may grant up to 19.6 million stock based and other incentive awards. Any shares of common stock subject to outstanding awards granted under the Company’s 2013 plan that, after the effective date of the 2017 Plan, expire or are otherwise forfeited or terminated in accordance with their terms are also available for grant under the 2017 Plan. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards typically vest over four years or five years and expire ten years from the date of grant.
2013 Stock Incentive Plan
The Company adopted the 2013 Plan on October 14, 2013 as amended on April 27, 2015 under which the Company had the ability to grant stock-based compensation awards to employees, directors and advisors. The total number of shares available for grant under the 2013 Plan and reserved for issuance was 20.9 million shares. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards vested over either five years, four years, or three years with 50% of each award vesting based on time and 50% of each award vesting based on the achievement of certain financial targets.
Stock-Based Compensation Expense
Stock-based compensation expense for the years ended December 31, 2025, 2024 and 2023 was $53.0 million, $58.8 million and $51.9 million, respectively, and is included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations.
As of December 31, 2025, there was $98.9 million of total unrecognized compensation expense related to outstanding stock option, restricted stock unit and performance share unit awards granted to employees and non-employee directors, as well as 100,000 conditional stock options awarded during the third quarter of 2022 to our Chairman and CEO in which the service date precedes the grant date, and will be granted upon achievement of certain performance targets. These 100,000 stock options have not been included in the Stock Option Awards section below since the grant date has not occurred.
Stock Option Awards
A summary of the Company’s stock option activity for the year ended December 31, 2025 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Exercise Price
(per share)
Wtd. Avg. Remaining Contractual Term (years)Aggregate Intrinsic Value of In-The-Money Options
(in millions)
Outstanding at December 31, 20244,185 $43.33 
Granted
700 83.15 
Exercised or Settled(454)33.76 
Forfeited
(104)78.33 
Expired
(13)85.72 
Outstanding at December 31, 20254,314 49.83 5.3$135.5 
Vested at December 31, 20252,765 34.60 3.7$124.7 
The per-share weighted average grant date fair value of stock options granted during the years ended December 31, 2025, 2024 and 2023 was $34.93, $38.97 and $25.28, respectively.
The intrinsic value of stock options exercised was $22.0 million, $114.8 million and $75.0 million during the years ended December 31, 2025, 2024 and 2023, respectively.
The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2025, 2024 and 2023.
202520242023
Expected life of options (in years)
6.3 - 7.5
6.3 - 7.5
6.3 - 7.5
Risk-free interest rate
3.8% - 4.2%
3.7% - 4.3%
3.8% - 4.6%
Assumed volatility
34.0% - 34.3%
34.9% - 35.2%
35.6% - 36.6%
Expected dividend rate
0.1%
0.0% - 0.1%
0.0% - 0.1%
Restricted Stock Unit Awards
Restricted stock units are typically granted in the first quarter of the year to employees and non-employee directors based on the market price of the Company’s common stock on the grant date and recognized in compensation expense over the vesting period. In some instances, such as death, awards may vest concurrently with or following an employee’s termination.
A summary of the Company’s restricted stock unit activity for the year ended December 31, 2025 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 2024834 $73.00 
Granted491 82.40 
Vested(334)63.87 
Forfeited(99)82.40 
Non-vested as of December 31, 2025892 80.55 
Performance Share Unit Awards (“PSUs”)
Annually, during the first quarter, the Company grants TSR PSUs to certain employees in which the number of shares issued at the end of the performance period is determined by the Company’s total shareholder return percentile rank versus the S&P 500 index for the three year performance period. The grant date fair value of these awards is determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a three year period.
During the third quarter of 2022, the Company granted Special TSR PSUs to its Chairman and CEO under which the market condition is achieved on the first date during the five year performance period on which the sum of (i) the 60-day volume-weighted average closing price of the Company’s common stock, plus (ii) the cumulative value of any dividends paid during the five year performance period equals or exceeds $81.85. Vesting of this award is conditional upon the service condition even though the market condition was achieved prior to the end of the performance period. The grant date fair value of these awards was determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a five year period. The Company also granted its Chairman and CEO Special EPS PSUs that are eligible to vest based on the level of compounded annual growth rate of the Company’s Adjusted EPS during the five year performance period. The grant date fair value of these awards is based on the market price of the Company’s common stock on the grant date and recognized as a compensation expense over a 4.3 year period, when it is probable the performance target will be met.
A summary of the Company’s performance stock unit activity for the year ended December 31, 2025 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 20241,339 $54.28 
Granted152 69.69 
Change in units based on performance127 63.39 
Vested(255)63.39 
Forfeited(16)94.27 
Non-vested as of December 31, 20251,347 54.67 
The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2025, 2024 and 2023 using the Monte Carlo simulation pricing model.
202520242023
Expected term (in years)
2.4 - 2.8
2.8
2.9
Risk-free interest rate
3.6% - 4.0%
4.5%
4.4%
Assumed volatility
28.2% - 28.6%
28.9%
31.8%
Expected dividend rate0.1 %0.1 %0.1 %
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Activities, Derivative Instruments and Credit Risk Hedging Activities, Derivative Instruments and Credit Risk
Hedging Activities
The Company is exposed to certain market risks during the normal course of its business arising from adverse changes in interest rates and foreign currency exchange rates. The Company selectively uses derivative financial instruments (“derivatives”), including cross-currency interest rate swap and foreign currency forward contracts, and interest rate swap and
cap contracts, to manage the risks from fluctuations in foreign currency exchange rates and interest rates, respectively. The Company does not purchase or hold derivatives for trading or speculative purposes. Fluctuations in interest rates and foreign currency exchange rates can be volatile, and the Company’s risk management activities do not totally eliminate these risks. Consequently, these fluctuations could have a significant effect on the Company’s financial results.
The Company manages its debt centrally, considering tax consequences and its overall financing strategies. The Company manages its exposure to interest rate risk by using interest rate derivatives as cash flow hedges of variable rate debt or fair value hedges of fixed rate debt in order to adjust the relative fixed and variable proportion. The Company’s exposure to interest rate risk results primarily from its fixed rate to floating rate interest rate swap contracts.
A substantial portion of the Company’s operations is conducted by its subsidiaries outside of the United States in currencies other than the USD. Almost all of the Company’s non-U.S. subsidiaries conduct their business primarily in their local currencies, which are also their functional currencies. The USD, the EUR, GBP, Chinese Renminbi, and Indian rupee are the principal currencies in which the Company and its subsidiaries enter into transactions. The Company is exposed to the impacts of changes in foreign currency exchange rates on the translation of its non-U.S. subsidiaries’ assets, liabilities and earnings into USD. The Company manages this exposure by having certain U.S. subsidiaries borrow in currencies other than the USD or utilizing cross-currency interest rate swaps as net investment hedges.
The Company and its subsidiaries are also subject to the risk that arises when they, from time to time, enter into transactions in currencies other than their functional currency. To mitigate this risk, the Company and its subsidiaries typically settle intercompany trading balances at least quarterly. The Company also selectively uses forward currency contracts to manage this risk. These contracts for the sale or purchase of European and other currencies generally mature within one year.
Derivative Instruments
The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2025 and 2024.
December 31, 2025
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsFair value$1,000.0 $4.5 $15.3 $— $— 
Cross-currency interest rate swap contractsNet investment1,332.7 10.7 — — 130.5 
Derivatives Not Designated as Hedging Instruments
Foreign currency forwardsFair value$15.3 $— $— $— $— 
Foreign currency forwardsFair value171.6 — — 0.9 — 
December 31, 2024
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsCash flow$750.0 $— $1.4 $0.9 $0.9 
Cross-currency interest rate swap contractsNet investment1,074.3 11.5 15.8 — — 
Derivatives Not Designated as Hedging Instruments
Foreign currency forwardsFair value$124.3 $1.8 $— $— $— 
Foreign currency forwardsFair value69.0 — — 1.2 — 
(1)Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively.
Payments to settle cross-currency swaps are classified as financing cash flows in the Consolidated Statements of Cash Flows. All other cash flows related to derivatives are classified as operating cash flows in the Consolidated Statements of Cash Flows.
There were no off-balance sheet derivative instruments as of December 31, 2025 or 2024.
Interest Rate Swap Contracts Designated as Fair Value Hedges
As of December 31, 2025, the Company was the variable rate payor on four interest rate swap contracts that effectively convert a total of $400.0 million of the Company’s fixed rate borrowings to variable rate borrowings. These contracts expire in May 2029. These swap agreements qualify as hedging instruments and have been designated as fair value hedges of $400.0 million of the 2029 Notes, and were considered to be perfectly effective under the shortcut method.
As of December 31, 2025, the Company was the variable rate payor on two interest rate swap contracts that effectively convert a total of $250.0 million of the Company’s fixed rate borrowings to variable rate borrowings. These contracts expire in April 2031. These swap agreements qualify as hedging instruments and have been designated as fair value hedges of $250.0 million of the 2031 Notes, and were considered to be perfectly effective under the shortcut method.
As of December 31, 2025, the Company was the variable rate payor on two interest rate swap contracts that effectively convert a total of $250.0 million of the Company’s fixed rate borrowings to variable rate borrowings. These contracts expire in May 2033. These swap agreements qualify as hedging instruments and have been designated as fair value hedges of $250.0 million of the 2033 Notes, and were considered to be perfectly effective under the shortcut method.
As of December 31, 2025, the Company was the variable rate payor on one interest rate swap contract that effectively convert a total of $100.0 million of the Company’s fixed rate borrowings to variable rate borrowings. This contract expires in March 2034. This swap agreement qualifies as a hedging instrument and has been designated as a fair value hedge of $100.0 million of the 2034 Notes, and were considered to be perfectly effective under the shortcut method.
December 31, 2025December 31, 2024
Long-term debt:
Carrying amount of hedged debt$1,019.8 $749.7 
Cumulative hedging adjustments, included in carrying amount19.8 (0.3)
Interest Rate Swap and Cap Contracts Designated as Cash Flow Hedges
In April 2024, the Company entered into forward-starting interest rate swap agreements to hedge against changes in future cash flows resulting from changes in interest rates from the trade date through the forecasted issuance date of debt. During the second quarter of 2024, the Company entered into and terminated cash flow hedges with notional value of $750.0 million in connection with the 2034 Notes and $500.0 million in connection with the 2054 Notes, both of which were issued on May 10, 2024. The Company and its counterparties terminated these contracts in May 2024. Prior to their termination, these swap agreements qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. These forecasted interest payments are still expected to occur as specified in the Company’s hedge designations; therefore, the unrecognized loss at the time of termination will be reclassified into earnings over the term of the respective notes. The unrecognized loss in AOCI as of December 31, 2025 was $3.9 million, of which $0.3 million is expected to be reclassified into earnings as an increase to interest expense during the next 12 months.
The Company was previously the fixed rate payor on two interest rate swap contracts that effectively fixed the SOFR-based index used to determine the interest rates charged on a total of $528.5 million of the Company’s SOFR-based variable rate borrowings. These contracts carried a fixed rate of 3.2%. The Company and its counterparties terminated these contracts in May 2024. Prior to their termination, these swap agreements qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. These forecasted interest payments were still expected to occur as specified in the Company’s hedge designations; therefore, the unrecognized gain at the time of termination was reclassified into earnings over the remaining period of original term of the contracts, which ended in June 2025.
The Company was previously a party to interest rate cap contracts that effectively limited the SOFR-based interest rates charged on a portion of the Company’s variable rate borrowings to 4.0%. The Company and its counterparties terminated these contracts in August 2023. Prior to their termination, these cap contracts qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. These forecasted interest payments were still expected to occur as specified in
the Company’s hedge designations; therefore, the unrecognized gain at the time of termination was reclassified into earnings over the remaining period of original term of the contracts, which ended in June 2025.
Gains on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2025, 2024 and 2023 are presented in the table below.
202520242023
Gain recognized in OCI on derivatives$— $1.6 $10.5 
Gain reclassified from AOCI into income (effective portion)(1)
5.8 15.7 15.6 
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Cross-Currency Interest Rate Swap Contracts Designated as Net Investment Hedges
In February 2025, the Company entered into a cross-currency interest rate swap contract that replace a fixed rate of 5.2% on a total of $129.2 million with a fixed rate of 3.1% on a total of €125.0 million. These contracts expire in February 2028 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
In February 2025, the Company entered into a cross-currency interest rate swap contract that replace a fixed rate of 5.3% on a total of $129.2 million with a fixed rate of 3.4% on a total of €125.0 million. These contracts expire in February 2030 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
As of December 31, 2025, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.4% on a total of $428.9 million with a fixed rate of 3.7% on a total of €400.0 million. These contracts expire in May 2027 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
As of December 31, 2025, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.7% on a total of $322.7 million with a fixed rate of 4.1% on a total of €300.0 million. These contracts expire in May 2029 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
As of December 31, 2025, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.7% on a total of $322.7 million with a fixed rate of 4.1% on a total of €300.0 million. These contracts expire in May 2031 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
The Company was previously the fixed rate payor on two cross-currency interest rate swap contracts that replaced a fixed rate of 3.2% on a total of $528.5 million with a fixed rate of 1.6% on a total of €500.0 million. These contracts were designated as net investment hedges of our Euro denominated subsidiaries until May 10, 2024 when they were terminated for $10.0 million. The payments to settle the termination of the cross currency interest rate swaps are included in “Payments to settle cross-currency swaps” within our Consolidated Statements of Cash Flows. The recorded AOCI at the termination of the cross-currency interest rate swaps will remain in AOCI until there is a substantial liquidation of the Company’s net investment in subsidiaries with EUR functional currencies.
The Company was previously a party to three cross-currency interest rate swap contracts where we received SOFR on a total of $525.7 million and paid EURIBOR on a total of €500.0 million. These contracts were designated as net investment hedges of our Euro denominated subsidiaries until May 10, 2024 when they were terminated for $9.9 million. The payments to settle the termination of the cross currency interest rate swaps are included in “Payments to settle cross-currency swaps” within our Consolidated Statements of Cash Flows. The recorded AOCI at the termination of the cross-currency interest rate swaps will remain in AOCI until there is a substantial liquidation of the Company’s net investment in subsidiaries with EUR functional currencies.
Gains (losses) on derivatives designated as net investment hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2025, 2024 and 2023 are presented in the table below.
202520242023
Gain (loss) recognized in OCI on derivatives$(128.9)$72.5 $(17.5)
Gain reclassified from AOCI into income (effective portion)(1)
18.2 17.7 19.0 
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Foreign Currency Forwards Not Designated as Hedging Instruments
The Company had ten foreign currency forward contracts outstanding as of December 31, 2025 with notional amounts ranging from $4.4 million to $73.4 million. These contracts are sometimes used to hedge the change in fair value of recognized foreign currency denominated assets or liabilities caused by changes in currency exchange rates. The changes in the fair value of these contracts generally offset the changes in the fair value of a corresponding amount of the hedged items, both of which are included within “Other operating expense, net” in the Consolidated Statements of Operations. The Company’s foreign currency forward contracts are subject to master netting arrangements or agreements between the Company and each counterparty for the net settlement of all contracts through a single payment in a single currency in the event of default on or termination of any one contract with that certain counterparty. It is the Company’s practice to recognize the gross amounts in the Consolidated Balance Sheets. The amount available to be netted is not material.
The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2025, 2024 and 2023 were as follows.
202520242023
Foreign currency forward contracts gains4.5 0.1 0.3 
Total foreign currency transaction losses, net(18.6)(3.2)(5.1)
Credit Risk
Credit risk related to derivatives arises when amounts receivable from a counterparty exceed those payable. Because the notional amount of the derivative instruments only serves as a basis for calculating amounts receivable or payable, the risk of loss with any counterparty is limited to a fraction of the notional amount. The Company minimizes the credit risk related to derivatives by transacting only with multiple, high-quality counterparties that are major financial institutions with investment-grade credit ratings. The Company has not experienced any financial loss as a result of counterparty nonperformance in the past. The majority of the derivative contracts to which the Company is a party, settle monthly or quarterly, or mature within one year. Because of these factors, the Company believes it has minimal credit risk related to derivative contracts as of December 31, 2025.
Concentrations of credit risk with respect to trade receivables are limited due to the wide variety of customers and industries to which the Company’s products and services are sold, as well as their dispersion across many different geographic areas. As a result, the Company does not believe it has any significant concentrations of credit risk as of December 31, 2025 or 2024.
v3.25.4
Fair Value Measurements
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
A financial instrument is defined as cash or cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivables, trade accounts payables, deferred compensation assets and obligations, derivatives and debt instruments. The carrying values of cash and cash equivalents, trade accounts receivables, trade accounts payables, and variable rate debt instruments are a reasonable estimate of their respective fair values.
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or more advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows.
Level 1    Quoted prices (unadjusted) in active markets for identical assets or liabilities as of the reporting date.
Level 2    Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.
Level 3    Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Refer to Note 1 “Summary of Significant Accounting Policies” for a discussion of the valuation assumptions utilized in the valuation of goodwill and indefinite-lived intangible assets.
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis.
December 31, 2025
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$24.4 $— $— $24.4 
Interest rate swaps(2)
— 19.8 — 19.8 
Cross-currency interest rate swaps(3)
— 10.7 — 10.7 
Foreign currency forwards(4)
— — — — 
Total$24.4 $30.5 $— $54.9 
Financial Liabilities
Deferred compensation plan(1)
$30.8 $— $— $30.8 
Cross-currency interest rate swaps(3)
— 130.5 — 130.5 
Contingent consideration(5)
— — 44.0 44.0 
Foreign currency forwards(4)
— 0.9 — 0.9 
Total$30.8 $131.4 $44.0 $206.2 
December 31, 2024
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$21.0 $— $— $21.0 
Interest rate swaps(2)
— 1.4 — 1.4 
Cross-currency interest rate swaps(3)
— 27.3 — 27.3 
Foreign currency forwards(4)
— 1.8 — 1.8 
Total$21.0 $30.5 $— $51.5 
Financial Liabilities
Deferred compensation plan(1)
$28.7 $— $— $28.7 
Interest rate swaps(2)
— 1.8 — 1.8 
Contingent consideration(5)
— — 22.2 22.2 
Foreign currency forwards(4)
— 1.2 — 1.2 
Total$28.7 $3.0 $22.2 $53.9 
(1)Based on the quoted price of publicly traded mutual funds and other equity securities which are classified as trading securities and accounted for using the mark-to-market method.
(2)Measured as the present value of all expected future cash flows based on the SOFR-based swap yield curves. The present value calculation uses discount rates that have been adjusted to reflect the credit quality of the Company and its counterparties.
(3)Measured as the present value of all expected future cash flows on each leg of the contracts. The model utilizes inputs of observable market data including interest yield curves and foreign currency exchange rates. The present value calculation uses cross-currency basis-adjusted discount factors that have been adjusted to reflect the credit quality of the Company and its counterparties.
(4)Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates.
(5)Measured as the present value of expected consideration payable for completed acquisitions, generally derived using probability-weighted analysis of achieving projected revenue or EBITDA targets.
Contingent Consideration
Certain of the Company’s acquisitions may result in payments of consideration in future periods that are contingent upon the achievement of certain targets, generally measures of revenue and EBITDA. As part of the initial accounting for the acquisition, a liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is re-measured at each reporting period, and the change in fair value is recognized within “Other operating expense, net” in the Consolidated Statements of Operations. This fair value measurement of contingent consideration
is categorized within Level 3 of the fair value hierarchy, as the measurement amount is based primarily on significant inputs that are not observable in the market.
The following table provides a reconciliation of the activity for contingent consideration for the years ended December 31, 2025 and 2024.
20252024
Balance at beginning of period$22.2 $42.2 
Acquisitions36.7 6.7 
Changes in fair value(16.7)(15.3)
Payments— (10.0)
Foreign currency translation and other1.8 (1.4)
Balance at end of period$44.0 $22.2 
As of December 31, 2025, the contingent consideration included in “Accrued liabilities” and “Other liabilities” on the Consolidated Balance Sheets were $3.5 million and $40.5 million, respectively.
Goodwill and Other Intangible Assets
Certain of our non-financial assets are subject to impairment analysis, including indefinite-lived intangible assets and goodwill. We review the carrying amounts of such assets whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable or at least annually. Any resulting impairment would require that the asset be recorded at its fair value. At December 31, 2024, we did not have any significant non-financial assets or liabilities that were required to be measured at fair value on a recurring or non-recurring basis. See Note 8, “Goodwill and Other Intangible Assets” for further discussion pertaining to our annual and interim evaluation of goodwill and other intangible assets for impairment, including the goodwill and other intangible asset impairment charges recognized during the year ended December 31, 2025.
v3.25.4
Contingencies
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is a party to various legal proceedings, lawsuits and administrative actions, which are of an ordinary or routine nature for a company of its size and sector. The Company believes that such proceedings, lawsuits and administrative actions will not materially adversely affect its operations, financial condition, liquidity or competitive position. A more detailed discussion of certain of these proceedings, lawsuits and administrative actions is set forth below.
Environmental Matters
The Company has been identified as a potentially responsible party (“PRP”) with respect to several sites designated for cleanup under U.S. federal “Superfund” or similar state laws that impose liability for cleanup of certain waste sites and for related natural resource damages. Persons potentially liable for such costs and damages generally include the site owner or operator and persons that disposed or arranged for the disposal of hazardous substances found at those sites. Although these laws impose joint and several liability on PRPs, in application the PRPs typically allocate the investigation and cleanup costs based upon the volume of waste contributed by each PRP. Based on currently available information, the Company was only a small contributor to these waste sites, and the Company has, or is attempting to negotiate, de minimis settlements for their cleanup. The cleanup of the remaining sites is substantially complete and the Company’s future obligations entail a share of the sites’ ongoing operating and maintenance expense. The Company is also addressing several on-site cleanups for which it is the primary responsible party.
The Company has undiscounted liabilities of $10.6 million and $13.6 million as of December 31, 2025 and 2024, respectively, on its Consolidated Balance Sheets to the extent costs are known or can be reasonably estimated for its remaining financial obligations for the environmental matters discussed above and does not anticipate that any of these matters will result in material additional costs beyond amounts accrued. Based upon consideration of currently available information, the Company does not anticipate any material adverse effect on its results of operations, financial condition, liquidity or competitive position as a result of compliance with federal, state, local or foreign environmental laws or regulations, or cleanup costs relating to these matters.
The Company has an insurance recovery receivable for probable environmental related recoveries of $1.7 million as of December 31, 2025 which was included in “Other assets” in the Consolidated Balance Sheets. There were no material recoveries received in the years ended December 31, 2025, 2024 and 2023.
Asbestos and Silica Related Litigation
On June 5, 2024, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Onyx TopCo LLC (the “Buyer”), a wholly owned subsidiary of Delticus Holdings LLC (“Delticus”), which is an entity owned by entities affiliated with Third Point LLC. Under the Purchase Agreement, the Company transferred 100% of the equity interests of three wholly-owned subsidiaries that hold asbestos liabilities and certain assets, including the related insurance assets, to the Buyer, effective as of June 10, 2024. In connection with the divestiture (the “Asbestos Portfolio Sale”), the divested entities were capitalized with a total of $188.5 million, including $143.5 million from insurance settlement proceeds, $35.0 million from affiliates of Delticus, and $10.0 million from Ingersoll Rand. As these subsidiaries were the obligors for the Company’s asbestos-related liabilities and policyholders of the related insurance assets, the rights and obligations related to these items transferred upon the sale. The divested subsidiaries have agreed to indemnify us and our affiliates for their asbestos-related liabilities, which encompassed all of our consolidated asbestos-related liabilities and contingent liabilities immediately prior to the sale. The Purchase Agreement contains customary representations and warranties with respect to the divested subsidiaries, the Company, and Delticus. Pursuant to the Purchase Agreement, the Company and Delticus will each indemnify the other for breaches of representation and warranties or breaches of covenants, subject to certain limitations as set forth in the agreement. In connection with the sale, the Company and its Board of Directors received a solvency opinion from an independent advisory firm that the divested entities were solvent and adequately capitalized immediately prior to, at the time of, and after giving effect to, the sale.
Following the completion of the transfer, the Company no longer has any obligation with respect to pending and future asbestos claims. As such, the divested entities have been deconsolidated from the financial results of the Company as we no longer maintain control of the entities. Therefore, all associated assets and liabilities are no longer reported on the Consolidated Balance Sheet. For the year ended December 31, 2024, the transaction resulted in a pre-tax loss of $58.8 million, recorded to “Other operating expense, net.” Additionally, the Company recorded a tax benefit as a result of the reversal of previously recorded net deferred tax liabilities of $7.6 million, resulting in an after-tax loss of $51.2 million recorded in the second quarter of 2024.
The following table summarizes the impacts of the divestiture.
Assets divested:
Cash and cash equivalents$153.5 
Insurance recovery receivable13.9 
Liabilities divested:
Asbestos indemnity liability - current(12.3)
Asbestos indemnity liability - noncurrent(111.4)
Loss on Asbestos Sale, before transaction costs43.7 
Transaction costs15.1 
Loss on Asbestos Sale58.8 
Income tax benefit(7.6)
Loss on Asbestos Sale, net of tax$51.2 
v3.25.4
Other Operating Expense, Net
12 Months Ended
Dec. 31, 2025
Other Income and Expenses [Abstract]  
Other Operating Expense, Net Other Operating Expense, Net
The components of “Other operating expense, net” for the years ended December 31, 2025, 2024 and 2023 were as follows.
202520242023
Other Operating Expense, Net
Foreign currency transaction losses, net$18.6 $3.2 $5.1 
Restructuring charges, net(1)
51.4 31.2 19.9 
Acquisition and other transaction related expenses(2)
22.0 47.1 52.2 
Loss on asbestos sale(3)
— 58.8 — 
Other, net
(0.5)(1.7)0.5 
Total other operating expense, net$91.5 $138.6 $77.7 
(1)See Note 4 “Restructuring.”
(2)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(3)See Note 21 “Contingencies.”
v3.25.4
Segment Reporting
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
A description of the Company’s two reportable segments, including the specific products manufactured and sold follows below. When determining the reportable segments, we aggregate operating segments based on their similar economic and operating characteristics.
In the Industrial Technologies and Services segment, the Company designs, manufactures, markets and services a broad range of compression and vacuum equipment as well as fluid transfer equipment and loading systems. The Company’s compression and vacuum products are used worldwide in industrial manufacturing, transportation, chemical processing, food and beverage production, clean energy, environmental and other applications. In addition to equipment sales, the Company offers a broad portfolio of service options tailored to customer needs and complete range of aftermarket parts, air treatment equipment, controls and other accessories. The Company’s engineered loading systems and fluid transfer equipment ensure the safe handling and transfer of crude oil, liquefied natural gas, compressed natural gas, chemicals, and bulk materials.
In the Precision and Science Technologies segment, the Company designs, manufactures and markets a broad range of specialized positive displacement pumps, fluid management equipment, single-use powder handling systems, and contract design and production services for silicone, thermoplastic, and specialty components and assemblies for medical devices. These products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. The Company’s products are used for a diverse set of applications including precision dosing, liquid and solid transfer, dispensing, gas compression, gas sampling, pressure management, flow control, and powder handling, amongst other applications. The Company sells primarily through a broad global network of specialized and national distributors and original equipment manufacturers who integrate the Company’s products into their devices and systems.
Ingersoll Rand’s Chief Operating Decision Maker (“CODM”) is our Chief Executive Officer. The CODM evaluates the performance of the Company’s segments based on Segment Adjusted EBITDA. The CODM closely monitors the Segment Adjusted EBITDA of each segment to evaluate past performance and actions required to improve profitability. Inter-segment sales and transfers are not significant. Certain administrative expenses related to the Company’s corporate offices and shared service centers in the United States and Europe, which includes transaction processing, accounting and other business support functions, are allocated to the segments and are included in Segment selling and administrative expenses. Certain other administrative expenses, including senior management compensation, treasury, internal audit, tax compliance, certain information technology, and other corporate functions, are not allocated to the segments to determine Segment Adjusted EBITDA.
The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income Before Income Taxes for the years ended December 31, 2025, 2024 and 2023.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202520242023202520242023202520242023
Revenue$6,056.4 $5,818.1 $5,632.8 1,594.5 1,416.9 1,243.3 $7,650.9 $7,235.0 $6,876.1 
Segment cost of sales(1)
3,346.8 3,193.3 3,225.0 825.6 736.2 648.8 4,172.4 3,929.5 3,873.8 
Segment selling and administrative expenses(2)
963.5 868.5 818.5 291.2 264.6 222.5 1,254.7 1,133.1 1,041.0 
Other segment items(3)
(1.8)1.5 2.0 (0.3)(2.7)(0.8)(2.1)(1.2)1.2 
Segment Adjusted EBITDA$1,747.9 $1,754.8 $1,587.3 478.0 418.8 372.8 2,225.9 2,173.6 1,960.1 
(1)Segment cost of sales excludes adjustments to LIFO inventories, depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(2)Segment selling and administrative expenses excludes depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(3)Other miscellaneous segment expenses.
202520242023
Total Segment Adjusted EBITDA$2,225.9 $2,173.6 $1,960.1 
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes:
Corporate expenses not allocated to segments
132.1 155.5 173.3 
Interest expense253.9 213.2 156.7 
Depreciation and amortization expense(1)
501.3 478.0 455.4 
Impairment of goodwill and other intangible assets273.4 13.9 — 
Restructuring and related business transformation costs(2)
51.7 32.3 22.9 
Acquisition and other transaction related expenses and non-cash charges(3)
26.0 59.8 63.9 
Stock-based compensation
53.0 58.8 51.9 
Foreign currency transaction losses, net18.6 3.2 5.1 
Loss on extinguishment of debt
— 3.0 13.5 
Adjustments to LIFO inventories17.8 6.7 12.0 
Cybersecurity incident costs(4)
(1.3)0.5 2.3 
Loss on asbestos sale— 58.8 — 
Interest income on cash and cash equivalents(30.0)(43.3)(28.8)
Other adjustments(5)
(5.9)0.4 0.8 
Income Before Income Taxes$935.3 $1,132.8 $1,031.1 
(1)Depreciation and amortization expense excludes $4.5 million, $4.0 million and $3.7 million of depreciation of rental equipment for the years ended December 31, 2025, 2024 and 2023, respectively.
(2)Restructuring and related business transformation costs consist of the following.
202520242023
Restructuring charges$51.4 $31.2 $19.9 
Facility reorganization, relocation and other costs0.3 1.1 3.0 
Total restructuring and related business transformation costs$51.7 $32.3 $22.9 
(3)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(4)Represents expected non-recoverable costs associated with a cybersecurity event, net of insurance recoveries.
(5)Includes (i) pension and other postretirement benefits (“OPEB”) plan costs other than service cost and (ii) other miscellaneous adjustments.
The following tables provide summarized information about the Company’s reportable segments.
Depreciation and Amortization Expense
202520242023
Industrial Technologies and Services$282.1 $296.0 $313.8 
Precision and Science Technologies219.1 177.1 135.4 
Corporate and other4.6 8.9 9.9 
Total depreciation and amortization expense$505.8 $482.0 $459.1 
Capital Expenditures
202520242023
Industrial Technologies and Services$92.5 $83.0 $83.9 
Precision and Science Technologies36.9 21.3 18.5 
Corporate and other6.2 44.8 3.0 
Total capital expenditures$135.6 $149.1 $105.4 
Identifiable Assets
20252024
Industrial Technologies and Services$11,266.4 $10,369.6 
Precision and Science Technologies5,656.4 5,884.1 
Corporate and other1,374.4 1,756.1 
Total identifiable assets$18,297.2 $18,009.8 
The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2025, and 2024.
20252024
United States$383.8 $381.8 
Other Americas50.1 38.1 
Total Americas433.9 419.9 
EMEIA(1)
328.3 256.5 
China149.9 152.3 
Other Asia Pacific18.2 13.4 
Total Asia Pacific168.1 165.7 
Total$930.3 $842.1 
(1)Europe, Middle East, India and Africa (“EMEIA”)
v3.25.4
Earnings Per Share
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The calculation of earnings per share is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all potentially dilutive shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the dilutive effect of outstanding share-based compensation awards. The number of weighted-average shares outstanding used in the computations of basic and diluted earnings per share for the years ended December 31, 2025, 2024 and 2023 were as follows.
202520242023
Weighted-average shares outstanding - Basic398.1 403.4 404.8 
Dilutive effect of outstanding share-based compensation awards2.9 3.8 4.2 
Weighted-average shares outstanding - Diluted401.0 407.2 409.0 
For the years ended December 31, 2025, 2024 and 2023, there were 1.1 million, 0.5 million and 1.3 million anti-dilutive shares that were not included in the computation of diluted earnings per share, respectively.
v3.25.4
Equity Method Investment
12 Months Ended
Dec. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investment Equity Method Investment
The Company previously sold its majority interest in the legacy High Pressure Solutions (“HPS”) upstream oil and gas business while retaining a 45% common equity interest. The Company expects to maintain its minority investment indefinitely and is unable to estimate when this interest may be disposed.
The Company accounts for this investment as an equity method investment and evaluates the investment each reporting period for evidence of a loss in value. During the second quarter of 2025, the Company received an updated long-term forecast which indicated a decline in value that was determined to be other than temporary. A valuation of the investment was performed using a discounted cash flow model. After completing its impairment assessment, management determined that the carrying amount exceeded its estimated fair value and the assumptions that most significantly affected the fair value determination included projected cash flows and the discount rate which were unobservable inputs. As a result, the Company recognized an impairment charge of $120.9 million in the three month period ended June 30, 2025, which is included in “Loss on equity method investments” on our Consolidated Statement of Operations. The carrying value of this equity method investment was $0.0 million and $128.6 million at December 31, 2025 and December 31, 2024, respectively, and is included in “Other assets” in our Consolidated Balance Sheets.
v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
The Company has implemented controls based on the National Institute of Standards and Technology Cybersecurity Framework (the “NIST CSF”) and the Sarbanes-Oxley Act of 2002. Our Information Technology organization is led by the Chief Information Officer (“CIO”) who is responsible for cybersecurity risk management. The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments. Our CISO reports directly to the CIO and has over 25 years of cyber security experience, including cyber leadership roles at various companies. The CISO reports to the Audit Committee on the effectiveness of the Company’s cybersecurity program controls aligned to the NIST CSF framework. We periodically engage external subject matter experts who provide independent qualitative and quantitative assessments of the cybersecurity program maturity and response
readiness. We also use processes to oversee and identify material risks from cybersecurity threats associated with our use of third-party technology and systems. In addition, the Company leverages a monthly cybersecurity awareness training program for all employees that is further reinforced through frequent phishing simulations.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
The Company has implemented controls based on the National Institute of Standards and Technology Cybersecurity Framework (the “NIST CSF”) and the Sarbanes-Oxley Act of 2002. Our Information Technology organization is led by the Chief Information Officer (“CIO”) who is responsible for cybersecurity risk management. The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments. Our CISO reports directly to the CIO and has over 25 years of cyber security experience, including cyber leadership roles at various companies.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually.
Cybersecurity Risk Role of Management [Text Block]
Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments. Our CISO reports directly to the CIO and has over 25 years of cyber security experience, including cyber leadership roles at various companies. The CISO reports to the Audit Committee on the effectiveness of the Company’s cybersecurity program controls aligned to the NIST CSF framework. We periodically engage external subject matter experts who provide independent qualitative and quantitative assessments of the cybersecurity program maturity and response
readiness. We also use processes to oversee and identify material risks from cybersecurity threats associated with our use of third-party technology and systems. In addition, the Company leverages a monthly cybersecurity awareness training program for all employees that is further reinforced through frequent phishing simulations.
Quarterly updates are provided by the CISO to the Cybersecurity Governance Committee regarding the effectiveness of cybersecurity program and its ability to monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. Cross functional senior management comprise our Cybersecurity Governance Committee, which is responsible for monitoring and coordinating enterprise cybersecurity policy and strategy, and for providing guidance to key management and oversight bodies. Our cybersecurity program includes a risk-based incident response plan that provides a documented framework for handling incidents including coordination across multiple parts of the Company.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our CISO reports directly to the CIO and has over 25 years of cyber security experience, including cyber leadership roles at various companies.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Quarterly updates are provided by the CISO to the Cybersecurity Governance Committee regarding the effectiveness of cybersecurity program and its ability to monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. Cross functional senior management comprise our Cybersecurity Governance Committee, which is responsible for monitoring and coordinating enterprise cybersecurity policy and strategy, and for providing guidance to key management and oversight bodies. Our cybersecurity program includes a risk-based incident response plan that provides a documented framework for handling incidents including coordination across multiple parts of the Company.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Overview and Basis of Presentation
Overview and Basis of Presentation
Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and life science and industrial solutions. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”).
Principles of Consolidation
Principles of Consolidation
The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows.
Foreign Currency Translation
Foreign Currency Translation
Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income, and are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.”
Revenue Recognition
Revenue Recognition
The Company recognizes revenue when the Company has satisfied its obligation and control is transferred to the customer. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company also has certain contracts in which revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations.
Cost of Sales
Cost of Sales
Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers.
Selling and Administrative Expenses
Selling and Administrative Expenses
Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value.
Accounts Receivable
Accounts Receivable
Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment.
Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions.
Inventories
Inventories
Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years.
Goodwill and Indefinite-Lived Intangible Assets
Goodwill and Indefinite-Lived Intangible Assets
Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value.
The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively.
Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of
long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value.
The Company tests intangible assets with indefinite lives annually for impairment and whenever events or changes in circumstances indicate that the carrying value may not be recoverable, using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates.
Long-Lived Assets Including Intangible Assets With Finite Useful Lives
Long-Lived Assets Including Intangible Assets With Finite Useful Lives
Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection.
The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose.
Warranty Reserves
Warranty Reserves
Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure.
Stock-Based Compensation
Stock-Based Compensation
Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units and performance share units with internal performance metrics (i.e. EPS) are valued at the share price on the date of grant. The grant date fair value of performance share units with external performance metrics (i.e. TSR) is determined using a Monte Carlo simulation pricing model.
Pension and Other Postretirement Benefits
Pension and Other Postretirement Benefits
The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2025 and 2024 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost.
Income Taxes
Income Taxes
The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income tax liabilities are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized.
Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed.
The Tax Cuts and Jobs Act (“Tax Act”), enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above).
Research and Development
Research and Development
For the years ended December 31, 2025, 2024 and 2023, the Company spent $114.3 million, $116.6 million, and $108.2 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations.
Derivative Financial Instruments
Derivative Financial Instruments
All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument
may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or (3) as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. For derivative instruments designated as net investment in a foreign operation, gains or losses are reported as currency translation adjustments. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations.
Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period.
When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations.
Comprehensive Income
Comprehensive Income
The Company’s comprehensive income consists of net income (loss) and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes.
Restructuring Charges
Restructuring Charges
The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.
A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred.
Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations.
Business Combinations
Business Combinations
The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable
assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred.
Earnings per Share
Earnings per Share
The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.
Leases
Leases
The Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROU assets in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets.
At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. An incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread.

The Company does not recognize leases with an original term of less than 12 months on its balance sheet and continues to expense such leases. The Company also elected the practical expedient allowing the Company to account for each separate lease component of a contract and its associated non-lease component as a single lease component. This practical expedient was applied to all underlying asset classes. Variable lease expense was not material.
Recently Adopted Accounting Standards Updates ("ASU") / Recently Issued Accounting Pronouncements
Recently Adopted Accounting Standard Updates (“ASU”)
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update are effective for annual periods beginning after December 15, 2024. The amendments in this update were applied prospectively. The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segments expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The amendments in this update were applied retrospectively to all prior periods presented in the financial statements. The segment expense categories and amounts disclosed in the prior periods were based on the significant segment expense categories identified and disclosed in Note 23 “Segment Reporting.” The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements.
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of additional disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, amortization, and depletion. The amendment is effective for fiscal years beginning after December 15, 2026. Early adoption is permitted. The amendment should be applied prospectively; however,
retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient to assume that conditions as of the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606. The amendment is effective for fiscal years beginning after December 15, 2025. Early adoption is permitted. The amendments in this update should be applied on a prospective basis. Management is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements and related disclosures.
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which amends guidance related to the accounting for internal-use software development costs. The amendment is intended to modernize the recognition and capitalization framework to reflect current software development practices. The amendment is effective for fiscal years beginning after December 15, 2027. The amendment can be applied on a prospective basis, a modified basis for in-process projects, or a retrospective basis. Early adoption is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements and related disclosures.
In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements, which more closely aligns hedge accounting with the economics of an entity’s risk management activities to better reflect those strategies in financial reporting by enabling entities to achieve and maintain hedge accounting for highly effective economic hedges of forecasted transactions. The amendment is effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements and related disclosures.
v3.25.4
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Allocation of Consideration to Identifiable Assets Acquired and Liabilities Assumed
The following table summarizes the allocation of consideration for all businesses acquired in 2025 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for certain of these acquisitions is preliminary, and amounts assigned to acquired assets and liabilities assumed are subject to change as information necessary to complete the analysis is obtained.
TMIC/AdicompAll OthersTotal
Accounts receivable$22.8 $29.6 $52.4 
Inventories34.4 30.2 64.6 
Other current assets4.7 3.3 8.0 
Property, plant and equipment30.8 12.8 43.6 
Goodwill99.6 261.8 361.4 
Other intangible assets80.6 106.0 186.6 
Other assets0.1 7.3 7.4 
Total current liabilities(54.1)(37.3)(91.4)
Deferred tax liabilities(22.7)(14.4)(37.1)
Other noncurrent liabilities(3.0)(4.9)(7.9)
Total consideration$193.2 $394.4 $587.6 
The following table summarizes the allocation of consideration for all businesses acquired in 2024 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Purchase accounting for all 2024 acquisitions is complete.
ILC DoverFriulairAPSCOAll othersTotal Consideration
Accounts receivable$41.2 $14.2 $6.4 $37.3 $99.1 
Inventories78.1 13.2 7.5 45.0 143.8 
Other current assets37.5 0.5 0.5 4.7 43.2 
Property, plant and equipment89.2 7.2 2.3 18.5 117.2 
Goodwill1,300.0 69.2 51.6 251.0 1,671.8 
Other intangible assets972.6 84.5 48.1 80.5 1,185.7 
Other noncurrent assets15.8 — 3.5 5.9 25.2 
Total current liabilities(32.4)(11.6)(3.7)(55.7)(103.4)
Deferred tax liabilities(131.2)(24.6)— (17.2)(173.0)
Other noncurrent liabilities(21.1)(2.8)(3.0)(5.8)(32.7)
Total consideration$2,349.7 $149.8 $113.2 $364.2 $2,976.9 
The following table summarizes the allocation of consideration for all businesses acquired in 2023 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Purchase accounting for all 2023 acquisitions is complete.
Air TreatmentRootsAll OthersTotal
Accounts receivable$26.1 $14.5 $11.7 $52.3 
Inventories43.9 34.2 21.0 99.1 
Other current assets2.1 2.9 6.2 11.2 
Property, plant and equipment18.4 42.0 5.0 65.4 
Goodwill279.9 105.6 126.7 512.2 
Other intangible assets238.6 116.9 25.4 380.9 
Other noncurrent assets7.6 3.1 0.4 11.1 
Total current liabilities(35.9)(26.9)(19.5)(82.3)
Deferred tax liabilities(54.8)— (3.9)(58.7)
Other noncurrent liabilities(6.9)(2.3)(4.5)(13.7)
Total consideration$519.0 $290.0 $168.5 $977.5 
v3.25.4
Restructuring (Tables)
12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Activity
For the years ended December 31, 2025, 2024 and 2023, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following.
202520242023
Industrial Technologies and Services$37.7 $20.6 $15.1 
Precision and Science Technologies10.5 7.9 4.1 
Corporate3.2 2.7 0.7 
Restructuring charges, net$51.4 $31.2 $19.9 
The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2025 and 2024.
20252024
Balance at beginning of period$22.3 $15.5 
Charged to expense - termination benefits48.8 27.1 
Charged to expense - other(1)
2.6 2.5 
Payments(35.5)(21.6)
Foreign currency translation and other1.7 (1.2)
Balance at end of period$39.9 $22.3 
(1)Excludes $1.6 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the year ended December 31, 2024.
v3.25.4
Allowance for Credit Losses (Tables)
12 Months Ended
Dec. 31, 2025
Receivables [Abstract]  
Schedule of Allowance for Credit Losses
The following table summarized the activity associated with allowance for credit losses for the years ended December 31, 2025, 2024 and 2023.
202520242023
Balance at beginning of period$57.3 $53.8 $47.2 
Provision charged to expense11.6 7.5 9.4 
Write-offs, net of recoveries(5.7)(3.3)(3.3)
Foreign currency translation and other3.6 (0.7)0.5 
Balance at end of period$66.8 $57.3 $53.8 
v3.25.4
Inventories (Tables)
12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventories
Inventories as of December 31, 2025 and 2024 consisted of the following.
20252024
Raw materials, including parts and subassemblies$737.3 $675.1 
Work-in-process128.7 116.3 
Finished goods403.9 342.8 
1,269.9 1,134.2 
LIFO reserve(97.0)(79.2)
Inventories$1,172.9 $1,055.0 
v3.25.4
Property, Plant, and Equipment (Tables)
12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Property, plant and equipment, net as of December 31, 2025 and 2024 consisted of the following.
20252024
Land and land improvements$70.0 $62.3 
Buildings436.1 385.6 
Machinery and equipment909.6 792.6 
Office furniture and equipment87.9 76.8 
Construction in progress116.3 92.3 
1,619.9 1,409.6 
Accumulated depreciation(689.6)(567.5)
Property, plant and equipment, net$930.3 $842.1 
v3.25.4
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2025 and 2024 are as follows.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
Balance as of December 31, 2023
$4,753.5 $1,856.2 $6,609.7 
Acquisitions263.9 1,404.3 1,668.2 
Foreign currency translation and other(1)
(86.7)(43.1)(129.8)
Balance as of December 31, 2024
4,930.7 3,217.4 8,148.1 
Acquisitions310.1 51.3 361.4 
Impairments— (229.7)(229.7)
Foreign currency translation and other(1)
144.7 59.6 204.3 
Balance as of December 31, 2025
$5,385.5 $3,098.6 $8,484.1 
(1)Includes measurement period adjustments.
Schedule of Goodwill by Acquisition The goodwill attributable to these businesses is as follows. 
2025 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
TMIC/Adicomp$99.6 $— $99.6 
Other acquisitions210.5 51.3 261.8 
$310.1 $51.3 $361.4 
The goodwill attributable to these businesses is as follows. 
2024 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
ILC Dover$— $1,309.8 $1,309.8 
Friulair69.2 — 69.2 
APSCO51.6 — 51.6 
Other acquisitions143.1 94.5 237.6 
$263.9 $1,404.3 $1,668.2 
Schedule of Other Intangible Assets
Other intangible assets as of December 31, 2025 and 2024 consisted of the following.
December 31, 2025December 31, 2024
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Amortized intangible assets:
Customer lists and relationships$4,292.9 $(2,186.3)$2,106.6 $4,010.1 $(1,830.1)$2,180.0 
Technology573.5 (325.2)248.3 549.1 (243.3)305.8 
Tradenames327.6 (53.1)274.5 63.6 (32.4)31.2 
Backlog— — — 4.3 (4.2)0.1 
Other163.4 (125.0)38.4 128.5 (112.1)16.4 
Unamortized intangible assets:
Tradenames1,572.5 — 1,572.5 1,839.3 — 1,839.3 
Total other intangible assets$6,929.9 $(2,689.6)$4,240.3 $6,594.9 $(2,222.1)$4,372.8 
v3.25.4
Supply Chain Finance Program (Tables)
12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Schedule of Supplier Finance Obligations
The following table summarizes the activity associated with the Company’s SCF Program for the years ended December 31, 2025 and 2024.
20252024
Confirmed obligations outstanding at beginning of period$24.5 $24.3 
Invoices confirmed122.8 117.0 
Confirmed invoices paid(119.0)(116.8)
Confirmed obligations outstanding at end of period$28.2 $24.5 
v3.25.4
Accrued Liabilities (Tables)
12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities
Accrued liabilities as of December 31, 2025 and 2024 consisted of the following:
20252024
Salaries, wages and related fringe benefits$238.1 $229.5 
Contract liabilities347.2 318.6 
Product warranty54.1 67.9 
Operating lease liabilities64.8 56.3 
Restructuring39.9 22.3 
Taxes108.5 72.5 
Accrued interest33.1 33.2 
Other183.1 171.9 
Total accrued liabilities$1,068.8 $972.2 
Schedule of Product Warranty Liability
A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2025 and 2024 is as follows.
20252024
Balance at beginning of period$67.9 $61.9 
Product warranty accruals11.8 37.5 
Acquired warranty6.5 0.7 
Settlements(34.6)(30.7)
Foreign currency translation and other2.5 (1.5)
Balance at end of period$54.1 $67.9 
v3.25.4
Debt (Tables)
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Debt
Debt as of December 31, 2025 and 2024 consisted of the following.
20252024
Short-term borrowings$— $1.7 
Long-term debt
5.197% Senior Notes due June 2027(1)
$700.0 $699.9 
5.400% Senior Notes due August 2028(1)
499.0 498.6 
5.176% Senior Notes due June 2029(1)
750.0 750.0 
5.314% Senior Notes due June 2031(1)
500.0 500.0 
5.700% Senior Notes due August 2033(1)
994.1 993.4 
5.450% Senior Notes due June 2034(1)
749.6 749.5 
5.700% Senior Notes due June 2054(1)
597.7 597.6 
Finance leases and other long-term debt13.2 14.1 
Swap valuation adjustments19.8 (0.3)
Unamortized debt issuance costs(38.7)(47.0)
Total long-term debt, net, including current maturities4,784.7 4,755.8 
Current maturities of long-term debt1.4 1.4 
Total long-term debt, net$4,783.3 $4,754.4 
(1)This amount is net of unamortized discounts. Total unamortized discounts were $9.7 million and $11.0 million as of December 31, 2025 and 2024, respectively.
v3.25.4
Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Reconciliation of Benefit Obligations
The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202520242025202420252024
Reconciliation of Benefit Obligations:
Beginning balance$264.7 $294.0 $251.4 $263.2 $5.9 $18.3 
Service cost0.1 0.1 3.2 2.9 — — 
Interest cost13.5 13.4 11.6 10.7 0.2 0.8 
Participant contributions— — 0.3 0.2 — — 
Plan amendments— — — — — (10.9)
Actuarial losses (gains)(1)
9.0 (18.1)(14.7)(11.3)0.4 0.2 
Benefit payments(24.9)(22.2)(13.2)(14.5)(2.3)(2.4)
Acquisitions— — — 10.2 — — 
Plan settlements— (2.5)(6.7)— — — 
Other— — 1.0 0.6 — — 
Effect of foreign currency exchange rate changes— — 24.9 (10.6)0.1 (0.1)
Benefit obligations ending balance$262.4 $264.7 $257.8 $251.4 $4.3 $5.9 
Reconciliation of Fair Value of Plan Assets:
Beginning balance$206.9 $237.5 $194.6 $206.0 
Actual return on plan assets17.4 (6.0)5.4 (7.1)
Employer contributions10.3 0.1 7.6 6.5 
Participant contributions— — 0.3 0.2 
Acquisitions— — — 8.5 
Benefit payments(24.9)(22.2)(13.2)(14.5)
Plan settlements— (2.5)(6.7)— 
Other— — 1.0 0.6 
Effect of foreign currency exchange rate changes— — 16.8 (5.6)
Fair value of plan assets ending balance$209.7 $206.9 $205.8 $194.6 
Funded Status as of Period End$(52.7)$(57.8)$(52.0)$(56.8)$(4.3)$(5.9)
(1)Actuarial losses (gains) primarily resulted from changes in discount rates.
Schedule of Component of Accumulated Other Comprehensive (Loss) Income
Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2025 and 2024 that have not been recognized as a component of net periodic benefit cost are presented in the following table.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202520242025202420252024
Net actuarial losses (gains)$(8.3)$(10.8)$(2.0)$7.6 $(2.2)$(3.2)
Prior service cost— — 2.7 2.7 — (10.9)
Amounts included in accumulated other comprehensive income (loss)$(8.3)$(10.8)$0.7 $10.3 $(2.2)$(14.1)
Schedule of Pension and Other Postretirement Benefit Liabilities included in Balance Sheets
Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2025 and 2024.
20252024
Other assets$23.5 $18.5 
Accrued liabilities(4.6)(6.4)
Pension and other postretirement benefits(127.9)(132.6)
Schedule of Pension plans with an Accumulated Benefit Obligation in Excess of Plan Assets
The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2025 and 2024.
U.S. Pension PlansNon-U.S. Pension Plans
2025202420252024
Projected benefit obligations$262.3 $264.7 $116.3 $119.7 
Accumulated benefit obligation262.3 264.7 109.0 112.7 
Fair value of plan assets209.7 206.9 39.0 42.8 
Schedule of Components of Net Periodic Benefit Cost (Income) and Other Amounts Recognized in Other Comprehensive (Loss) Income, Before Income Tax Effects
The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2025, 2024 and 2023.
U.S. Pension Plans
202520242023
Net Periodic Benefit Cost:
Service cost$0.1 $0.1 $0.1 
Interest cost13.5 13.4 15.7 
Expected return on plan assets(11.0)(12.7)(13.2)
Amortization of net actuarial loss0.1 — 0.1 
Net periodic benefit cost2.7 0.8 2.7 
Loss (gain) due to settlement— 0.4 (0.4)
Total net periodic benefit cost recognized$2.7 $1.2 $2.3 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss$2.6 $0.6 $0.5 
Amortization of net actuarial gain (loss)(0.1)(0.4)0.3 
Total recognized in other comprehensive income (loss)$2.5 $0.2 $0.8 
Total recognized in net periodic benefit cost and other comprehensive income (loss)$5.2 $1.4 $3.1 
Non-U.S. Pension Plans
202520242023
Net Periodic Benefit Cost:
Service cost$3.2 $2.9 $2.6 
Interest cost11.6 10.7 11.1 
Expected return on plan assets(9.7)(11.2)(11.0)
Amortization of prior service cost0.2 0.2 0.1 
Amortization of net actuarial gain(1.0)(1.3)(1.7)
Net periodic benefit cost4.3 1.3 1.1 
Loss due to settlements(0.2)— — 
Total net periodic benefit cost recognized$4.1 $1.3 $1.1 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$(10.4)$7.0 $7.5 
Amortization of net actuarial gain1.2 1.3 1.7 
Prior service cost— — 0.3 
Amortization of prior service cost(0.2)(0.2)(0.1)
Effect of foreign currency exchange rate changes(0.2)0.4 0.3 
Total recognized in other comprehensive income (loss)$(9.6)$8.5 $9.7 
Total recognized in net periodic benefit cost and other comprehensive income (loss)$(5.5)$9.8 $10.8 
Other Postretirement Benefits
202520242023
Net Periodic Benefit Cost (Income):
Interest cost$0.2 $0.8 $0.9 
Amortization of prior service cost(10.9)0.1 0.1 
Amortization of net actuarial gain(0.6)(0.8)(1.1)
Total net periodic benefit cost (income) recognized$(11.3)$0.1 $(0.1)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$0.4 $0.2 $(1.0)
Amortization of net actuarial loss0.6 0.8 1.1 
Prior service cost— (10.9)— 
Amortization of prior service cost10.9 (0.1)(0.1)
Total recognized in other comprehensive income (loss)$11.9 $(10.0)$— 
Total recognized in net periodic benefit cost (income) and other comprehensive income (loss)$0.6 $(9.9)$(0.1)
Schedule of Assumptions Used
The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2025, 2024 and 2023.
U.S. Pension PlansNon-U.S. Pension Plans
202520242023202520242023
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate5.5 %5.0 %5.2 %4.5 %4.2 %4.5 %
Expected long-term rate of return on plan assets5.7 %5.8 %5.4 %4.8 %5.5 %5.5 %
Rate of compensation increasesN/AN/A— %5.0 %5.0 %4.3 %
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate5.1 %5.5 %5.0 %4.6 %4.5 %4.2 %
Rate of compensation increasesN/AN/AN/A5.0 %5.0 %5.0 %
The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2025, 2024 and 2023.
Other Postretirement Benefits
202520242023
Discount rate used to determine net periodic benefit cost
4.4% - 5.4%
4.9% - 5.1%
4.9% - 5.2%
Discount rate used to determine benefit obligations
4.5% - 5.1%
4.4% - 5.4%
4.9% - 5.1%
Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations:
Healthcare cost trend rate assumed for next year4.4 %5.1 %6.8 %
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)4.0 %4.0 %4.4 %
Year that the date reaches the ultimate trend rate204020402035
Schedule of Expected Benefit Payments
The following table reflects the estimated benefit payments for the next five years and for the years 2031 through 2035. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2025.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
2026$24.7 $16.4 $0.4 
202725.0 15.4 0.4 
202823.8 16.0 0.4 
202923.7 17.9 0.3 
203023.9 17.9 0.3 
Aggregate 2031-2035
98.5 92.1 1.4 
Schedule of Allocation of Plan Assets The following table presents the long-term target allocations for these plans as of December 31, 2025.
U.S. PlansUK Plan
Asset category:
Equity32 %11 %
Fixed income66 %58 %
Real estate and other%31 %
Total100 %100 %
Schedule of Changes in Fair Value of Plan Assets
The following tables present the fair values of the Company’s pension plan assets as of December 31, 2025 and 2024 by asset category within the ASC 820 hierarchy (as defined in Note 20 “Fair Value Measurements”).
December 31, 2025
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$3.5 $— $— $— $3.5 
Equity funds:
U.S. mid-cap— — — 1.7 1.7 
U.S. large-cap— 3.7 — 18.3 22.0 
International equity(2)
— 25.2 — 54.9 80.1 
Total equity funds— 28.9 — 74.9 103.8 
Fixed income funds:
Corporate bonds - international— 25.3 — 17.7 43.0 
UK index-linked gilts— 71.8 — — 71.8 
U.S. fixed income - government securities— — — 47.5 47.5 
U.S. fixed income - short duration— — — 1.7 1.7 
U.S. fixed income - intermediate duration— — — 24.5 24.5 
U.S. fixed income - long duration— — — 58.8 58.8 
Global fixed income— — — 2.4 2.4 
Total fixed income funds— 97.1 — 152.6 249.7 
Other types of investments:
International real estate(3)
— 12.5 — — 12.5 
Other(4)
— 39.6 6.4 46.0 
Total$3.5 $138.5 $39.6 $233.9 $415.5 
December 31, 2024
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$5.1 $— $— $— $5.1 
Equity funds:
U.S. small-cap— — — 0.9 0.9 
U.S. mid-cap— — — 2.6 2.6 
U.S. large-cap— 2.5 — 11.6 14.1 
International equity(2)
— 23.2 — 26.5 49.7 
Total equity funds— 25.7 — 41.6 67.3 
Fixed income funds:
Corporate bonds - international— 23.8 — 15.8 39.6 
UK index-linked gilts— 66.0 — — 66.0 
U.S. fixed income - government securities— — — 20.5 20.5 
U.S. fixed income - short duration— — — 1.8 1.8 
U.S. fixed income - intermediate duration— — — 25.2 25.2 
U.S. fixed income - long corporate— — — 122.7 122.7 
Global fixed income— — — 1.8 1.8 
Total fixed income funds— 89.8 — 187.8 277.6 
Other types of investments:
International real estate(3)
— 11.6 — — 11.6 
Other(4)
— 38.1 1.8 39.9 
Total$5.1 $127.1 $38.1 $231.2 $401.5 
(1)Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets.
(2)The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors.
(3)International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties.
(4)Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services.
(5)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.
v3.25.4
Accumulated Other Comprehensive Income (Loss) (Tables)
12 Months Ended
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of Before Tax Income (Loss) and Related Income Tax Effect
The before tax income (loss) and related income tax effect are as follows.
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Before tax income (loss)23.0 (5.1)(10.5)7.4 
Income tax effect11.8 1.3 3.6 16.7 
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Before tax income (loss)(218.6)(14.1)1.3 (231.4)
Income tax effect(13.0)5.0 (1.5)(9.5)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
Before tax income (loss)294.4 (5.8)(5.2)283.4 
Income tax effect36.1 — 0.7 36.8 
Other comprehensive income (loss)330.5 (5.8)(4.5)320.2 
Balance as of December 31, 2025$(149.1)$(2.7)$3.5 $(148.3)
Schedule of Changes in Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table(1).
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Other comprehensive income (loss) before reclassifications49.0 7.9 (4.7)52.2 
Amounts reclassified from accumulated other comprehensive income (loss)(14.2)(11.7)(2.2)(28.1)
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Other comprehensive income (loss) before reclassifications(218.3)2.7 0.8 (214.8)
Amounts reclassified from accumulated other comprehensive income (loss)(13.3)(11.8)(1.0)(26.1)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
Other comprehensive income (loss) before reclassifications344.1 (1.5)4.8 347.4 
Amounts reclassified from accumulated other comprehensive income (loss)(13.6)(4.3)(9.3)(27.2)
Other comprehensive income (loss)330.5 (5.8)(4.5)320.2 
Balance as of December 31, 2025$(149.1)$(2.7)$3.5 $(148.3)
(1)All amounts are net of tax. Amounts in parentheses indicate debits.
Schedule of Reclassification out of Accumulated Other Comprehensive Income (Loss)
Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2025, 2024 and 2023 are presented in the following table.
Amount Reclassified from Accumulated Other Comprehensive Income (Loss)
Details about Accumulated Other Comprehensive Income (Loss) Components202520242023Affected Line(s) in the Statement Where Net Income is Presented
Cash flow hedges (interest rate swaps and caps)$(5.8)$(15.7)$(15.6)Interest expense
Provision for income taxes1.5 3.9 3.9 Provision for income taxes
Cash flow hedges (interest rate swaps and caps), net of tax$(4.3)$(11.8)$(11.7)
Net investment hedges$(18.2)$(17.7)$(19.0)Interest expense
Provision for income taxes4.6 4.4 4.8 Provision for income taxes
Net investment hedges, net of tax$(13.6)$(13.3)$(14.2)
Amortization of defined benefit pension and other postretirement benefit items(1)
$(12.4)$(1.4)$(2.9)
Cost of sales and Selling and administrative expenses
Provision for income taxes3.1 0.4 0.7 Provision for income taxes
Amortization of defined benefit pension and other postretirement benefit items, net of tax$(9.3)$(1.0)$(2.2)
Total reclassifications for the period$(27.2)$(26.1)$(28.1)
(1)These components are included in the computation of net periodic benefit cost. See Note 12 “Benefit Plans” for additional details.
v3.25.4
Revenue from Contracts with Customers (Tables)
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2025 and 2024.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202520242025202420252024
Primary Geographic Markets
United States$2,473.5 $2,461.2 $716.4 $651.1 $3,189.9 $3,112.3 
Other Americas488.5 452.9 123.6 88.3 612.1 541.2 
Total Americas2,962.0 2,914.1 840.0 739.4 3,802.0 3,653.5 
EMEIA2,008.0 1,854.9 593.5 520.0 2,601.5 2,374.9 
China672.3 680.8 117.2 113.8 789.5 794.6 
Other Asia Pacific414.1 368.3 43.8 43.7 457.9 412.0 
Total Asia Pacific1,086.4 1,049.1 161.0 157.5 1,247.4 1,206.6 
Total$6,056.4 $5,818.1 $1,594.5 $1,416.9 $7,650.9 $7,235.0 
Product Categories
Original equipment(1)
$3,595.3 $3,494.0 $1,266.5 $1,110.2 $4,861.8 $4,604.2 
Aftermarket(2)
2,461.1 2,324.1 328.0 306.7 2,789.1 2,630.8 
Total$6,056.4 $5,818.1 $1,594.5 $1,416.9 $7,650.9 $7,235.0 
Pattern of Revenue Recognition
Revenue recognized at point in time(3)
$5,432.0 $5,295.6 $1,495.9 $1,376.4 $6,927.9 $6,672.0 
Revenue recognized over time(4)
624.4 522.5 98.6 40.5 723.0 563.0 
Total$6,056.4 $5,818.1 $1,594.5 $1,416.9 $7,650.9 $7,235.0 
(1)Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment.
(2)Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment.
(3)Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered.
(4)Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed.
Schedule of Contract Balances
The following table provides the contract balances as of December 31, 2025 and 2024 presented in the Consolidated Balance Sheets.
December 31, 2025December 31, 2024
Accounts receivable, net$1,518.0 $1,335.4 
Contract assets163.9 111.2 
Contract liabilities - current347.2 318.6 
Contract liabilities - noncurrent1.1 0.9 
v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) Before Income Taxes
Income before income taxes for the years ended December 31, 2025, 2024 and 2023 consisted of the following.
202520242023
U.S.$220.3 $383.7 $356.0 
Non-U.S.715.0 749.1 675.1 
Income before income taxes$935.3 $1,132.8 $1,031.1 
Schedule of Components of Provision (Benefit) for Income Taxes
The following table details the components of the Provision for income taxes for the years ended December 31, 2025, 2024 and 2023.
202520242023
Current:
U.S. federal$81.2 $87.5 $111.5 
U.S. state and local24.0 22.8 23.7 
Non-U.S.193.6 185.3 181.7 
Deferred:
U.S. federal(26.2)(9.7)(44.0)
U.S. state and local(6.5)(5.7)(6.9)
Non-U.S.(46.7)(17.7)(26.0)
Provision for income taxes$219.4 $262.5 $240.0 
Schedule of Effective Income Tax Rate Reconciliation
The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the year ended December 31, 2025 after the adoption of ASU 2023-09 as follows.
2025
U.S. federal corporate statutory rate$196.4 21.0 %
State and local taxes, less federal tax benefit (1)
13.3 1.4 
Foreign tax effects
China
Withholding tax16.6 1.8 
Other4.9 0.5 
India10.3 1.1 
Malta
Interest on equity(24.2)(2.6)
Other7.6 0.8 
Switzerland(13.4)(1.4)
Other foreign jurisdictions16.4 1.7 
Effect of cross-border tax laws
Foreign Derived Intangible Income (“FDII”) deduction(14.4)(1.5)
Repatriation cost2.5 0.3 
Global Intangible Low-Tax Income (“GILTI”)13.0 1.4 
Tax credits
Foreign tax credits(23.8)(2.5)
Other(3.8)(0.4)
Changes in valuation allowances4.4 0.5 
Nontaxable and nondeductible items18.7 2.0 
Changes in unrecognized tax benefits4.2 0.4 
Other adjustments(9.3)(1.0)
Effective income tax rate$219.4 23.5 %
(1)During the year ended December 31, 2025, state taxes in California, Florida, Georgia, Illinois, Indiana, Minnesota, Pennsylvania, Tennessee and Texas comprised greater than 50% of the tax effect in this category.
The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2024 and 2023, prior to the adoption of ASU 2023-09 as follows.
20242023
U.S. federal corporate statutory rate21.0 %21.0 %
State and local taxes, less federal tax benefit1.4 1.3 
Net effects of foreign tax rate differential2.5 1.8 
Withholding tax1.3 1.5 
Repatriation cost(1.5)(2.0)
Global Intangible Low-Tax Income (“GILTI”)0.4 0.7 
ASC 740-30 (formerly APB 23)1.5 1.7 
Changes in valuation allowances0.4 1.7 
Changes in unrecognized tax benefits0.9 0.9 
Equity compensation(1.3)(0.6)
Nondeductible acquisition costs0.3 0.4 
Foreign Derived Intangible Income (“FDII”) deduction(1.1)(1.4)
Tax credits(0.6)(0.7)
Income not subject to tax(0.3)(1.6)
Amortization of goodwill and other intangible assets(1.3)(0.8)
Interest on equity(1.8)(0.7)
Return to provision adjustment(0.2)0.1 
Loss on sale1.1 — 
Other, net0.5 — 
Effective income tax rate23.2 %23.3 %
Schedule of Deferred Tax Assets and Liabilities
The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2025 and 2024 are as follows.
20252024
Deferred Tax Assets:
Reserves and accruals$95.3 $83.4 
Allowance for credit losses9.8 7.4 
Inventory reserve9.6 9.0 
Pension and postretirement benefit plans
18.6 20.0 
Tax loss carryforwards94.1 112.4 
Deferred taxes recorded in other comprehensive income36.2 1.4 
Foreign tax credit carryforwards50.9 50.7 
Other12.7 22.4 
Total deferred tax assets327.2 306.7 
Valuation allowance(107.4)(125.6)
Deferred Tax Liabilities:
LIFO inventory(19.6)(20.3)
Investment in partnership— (30.2)
Property, plant and equipment(44.3)(50.0)
Intangible assets(763.7)(770.4)
Unremitted foreign earnings(50.4)(41.8)
Total deferred tax liabilities(878.0)(912.7)
Net deferred income tax liability$(658.2)$(731.6)
Schedule of Tax Attributes and Related Valuation Allowance Tax attributes and related valuation allowances as of December 31, 2025 were as follows.
Tax BenefitValuation AllowanceCarryforward Period Ends
Tax Attributes to be Carried Forward
U.S. federal net operating loss$1.9 $(0.1)2032-2038
U.S. federal capital loss0.6 (0.6)2028
U.S. federal tax credit50.9 (50.9)2026-2035
Alternative minimum tax credit0.4 (0.4)Unlimited
U.S. state and local net operating losses6.2 (0.7)2027-2042
U.S. state capital loss0.3 (0.1)2028
Non U.S. net operating losses70.3 (36.8)2026-Unlimited
Non U.S. capital losses0.7 — Unlimited
Excess interest14.1 (12.9)Unlimited
Other deferred tax assets4.9 (4.9)Unlimited
Total tax carryforwards$150.3 $(107.4)
Schedule of Valuation Allowance
A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2025, 2024 and 2023 are as follows.
202520242023
Beginning balance$125.6 $115.7 $107.3 
Revaluation or additions due to acquisitions or mergers(1)
(15.6)22.9 — 
Charged to tax expense (benefit)(5.9)(10.8)6.4 
Charged to other accounts3.3 (2.2)2.0 
Ending balance$107.4 $125.6 $115.7 
(1)Revaluation for the tax year ended December 31, 2024 relates to the inclusion of ILC Dover’s opening balance sheet beginning valuation allowance.
Schedule of Unrecognized Tax Benefits Roll Forward Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2025, 2024 and 2023.
202520242023
Beginning balance$26.4 $19.1 $10.8 
Gross increases for tax positions of prior years0.1 0.8 0.4 
Gross decreases for tax positions of prior years— (0.3)— 
Gross increases for tax positions of current year4.6 8.1 7.9 
Lapse of statute of limitations(0.1)(0.6)(0.2)
Changes due to currency fluctuations1.8 (0.7)0.2 
Ending balance$32.8 $26.4 $19.1 
Schedule of U.S. Federal Corporate Statutory Rate
The amounts of cash income taxes paid by the Company were as follows:
2025
Federal$40.3 
State and local22.7 
Foreign
China54.2 
France18.4 
India23.5 
Italy30.7 
All other foreign79.5 
Cash paid for income taxes, net of refunds$269.3 
v3.25.4
Leases (Tables)
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Schedule of Components of Lease Expense
The components of lease expense for the years ended December 31, 2025 and 2024 are as follows.
20252024
Operating lease cost$78.6 $64.5 
Finance lease cost
Amortization of right-of-use assets$1.4 $1.5 
Interest on lease liabilities0.8 0.9 
Total finance lease cost$2.2 $2.4 
Short-term lease cost$2.5 $2.2 
Schedule of Supplemental Cash Flow Information Related to Leases
Supplemental cash flow information related to leases for the years ended December 31, 2025 and 2024 is as follows.
20252024
Supplemental Cash Flows Information
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases$77.4 $63.8 
Operating cash flows from finance leases0.8 0.9 
Financing cash flows from finance leases1.3 1.3 
Leased Assets Obtained in Exchange for New Operating Lease Liabilities55.0 96.2 
Schedule of Supplemental Balance Sheet Information Related to Leases
Supplemental balance sheet information related to leases is as follows.
December 31, 2025December 31, 2024
Operating leases
Other assets$236.4 $226.6 
Accrued liabilities$64.8 $56.3 
Other liabilities168.0 165.5 
Total operating lease liabilities$232.8 $221.8 
Finance Leases
Property, plant and equipment$9.7 $11.1 
Short-term borrowings and current maturities of long-term debt$1.3 $1.3 
Long-term debt, less current maturities11.2 12.6 
Total finance lease liabilities$12.5 $13.9 
Weighted Average Remaining Lease Term (in years)
Operating leases5.05.2
Finance leases8.79.4
Weighted Average Discount Rate
Operating leases4.2 %4.1 %
Finance leases6.5 %6.5 %
Schedule of Maturities of Operating Lease Liabilities
Maturities of lease liabilities as of December 31, 2025 are as follows.
Operating LeasesFinance Leases
2026$73.3 $2.1 
202757.9 2.1 
202842.9 2.1 
202927.9 2.1 
203018.0 2.1 
Thereafter38.9 6.3 
Total lease payments$258.9 $16.8 
Less imputed interest(26.1)(4.3)
Total$232.8 $12.5 
Schedule of Maturities of Finance Lease Liabilities
Maturities of lease liabilities as of December 31, 2025 are as follows.
Operating LeasesFinance Leases
2026$73.3 $2.1 
202757.9 2.1 
202842.9 2.1 
202927.9 2.1 
203018.0 2.1 
Thereafter38.9 6.3 
Total lease payments$258.9 $16.8 
Less imputed interest(26.1)(4.3)
Total$232.8 $12.5 
v3.25.4
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Awards
A summary of the Company’s stock option activity for the year ended December 31, 2025 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Exercise Price
(per share)
Wtd. Avg. Remaining Contractual Term (years)Aggregate Intrinsic Value of In-The-Money Options
(in millions)
Outstanding at December 31, 20244,185 $43.33 
Granted
700 83.15 
Exercised or Settled(454)33.76 
Forfeited
(104)78.33 
Expired
(13)85.72 
Outstanding at December 31, 20254,314 49.83 5.3$135.5 
Vested at December 31, 20252,765 34.60 3.7$124.7 
Schedule of Fair Value Assumptions
The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2025, 2024 and 2023.
202520242023
Expected life of options (in years)
6.3 - 7.5
6.3 - 7.5
6.3 - 7.5
Risk-free interest rate
3.8% - 4.2%
3.7% - 4.3%
3.8% - 4.6%
Assumed volatility
34.0% - 34.3%
34.9% - 35.2%
35.6% - 36.6%
Expected dividend rate
0.1%
0.0% - 0.1%
0.0% - 0.1%
The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2025, 2024 and 2023 using the Monte Carlo simulation pricing model.
202520242023
Expected term (in years)
2.4 - 2.8
2.8
2.9
Risk-free interest rate
3.6% - 4.0%
4.5%
4.4%
Assumed volatility
28.2% - 28.6%
28.9%
31.8%
Expected dividend rate0.1 %0.1 %0.1 %
Schedule of Restricted Stock Unit Activity
A summary of the Company’s restricted stock unit activity for the year ended December 31, 2025 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 2024834 $73.00 
Granted491 82.40 
Vested(334)63.87 
Forfeited(99)82.40 
Non-vested as of December 31, 2025892 80.55 
Schedule of Performance Stock Unit Activity
A summary of the Company’s performance stock unit activity for the year ended December 31, 2025 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 20241,339 $54.28 
Granted152 69.69 
Change in units based on performance127 63.39 
Vested(255)63.39 
Forfeited(16)94.27 
Non-vested as of December 31, 20251,347 54.67 
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk (Tables)
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2025 and 2024.
December 31, 2025
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsFair value$1,000.0 $4.5 $15.3 $— $— 
Cross-currency interest rate swap contractsNet investment1,332.7 10.7 — — 130.5 
Derivatives Not Designated as Hedging Instruments
Foreign currency forwardsFair value$15.3 $— $— $— $— 
Foreign currency forwardsFair value171.6 — — 0.9 — 
December 31, 2024
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsCash flow$750.0 $— $1.4 $0.9 $0.9 
Cross-currency interest rate swap contractsNet investment1,074.3 11.5 15.8 — — 
Derivatives Not Designated as Hedging Instruments
Foreign currency forwardsFair value$124.3 $1.8 $— $— $— 
Foreign currency forwardsFair value69.0 — — 1.2 — 
(1)Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively.
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location
December 31, 2025December 31, 2024
Long-term debt:
Carrying amount of hedged debt$1,019.8 $749.7 
Cumulative hedging adjustments, included in carrying amount19.8 (0.3)
Schedule of Cash Flow Hedges Included in Comprehensive (Loss) Income
Gains on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2025, 2024 and 2023 are presented in the table below.
202520242023
Gain recognized in OCI on derivatives$— $1.6 $10.5 
Gain reclassified from AOCI into income (effective portion)(1)
5.8 15.7 15.6 
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)
Gains (losses) on derivatives designated as net investment hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2025, 2024 and 2023 are presented in the table below.
202520242023
Gain (loss) recognized in OCI on derivatives$(128.9)$72.5 $(17.5)
Gain reclassified from AOCI into income (effective portion)(1)
18.2 17.7 19.0 
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Schedule of Gains (Losses) on Derivative Instruments Not Designated as Accounting Hedges and Total Net Foreign Currency (Losses) Gains
The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2025, 2024 and 2023 were as follows.
202520242023
Foreign currency forward contracts gains4.5 0.1 0.3 
Total foreign currency transaction losses, net(18.6)(3.2)(5.1)
v3.25.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis.
December 31, 2025
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$24.4 $— $— $24.4 
Interest rate swaps(2)
— 19.8 — 19.8 
Cross-currency interest rate swaps(3)
— 10.7 — 10.7 
Foreign currency forwards(4)
— — — — 
Total$24.4 $30.5 $— $54.9 
Financial Liabilities
Deferred compensation plan(1)
$30.8 $— $— $30.8 
Cross-currency interest rate swaps(3)
— 130.5 — 130.5 
Contingent consideration(5)
— — 44.0 44.0 
Foreign currency forwards(4)
— 0.9 — 0.9 
Total$30.8 $131.4 $44.0 $206.2 
December 31, 2024
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$21.0 $— $— $21.0 
Interest rate swaps(2)
— 1.4 — 1.4 
Cross-currency interest rate swaps(3)
— 27.3 — 27.3 
Foreign currency forwards(4)
— 1.8 — 1.8 
Total$21.0 $30.5 $— $51.5 
Financial Liabilities
Deferred compensation plan(1)
$28.7 $— $— $28.7 
Interest rate swaps(2)
— 1.8 — 1.8 
Contingent consideration(5)
— — 22.2 22.2 
Foreign currency forwards(4)
— 1.2 — 1.2 
Total$28.7 $3.0 $22.2 $53.9 
(1)Based on the quoted price of publicly traded mutual funds and other equity securities which are classified as trading securities and accounted for using the mark-to-market method.
(2)Measured as the present value of all expected future cash flows based on the SOFR-based swap yield curves. The present value calculation uses discount rates that have been adjusted to reflect the credit quality of the Company and its counterparties.
(3)Measured as the present value of all expected future cash flows on each leg of the contracts. The model utilizes inputs of observable market data including interest yield curves and foreign currency exchange rates. The present value calculation uses cross-currency basis-adjusted discount factors that have been adjusted to reflect the credit quality of the Company and its counterparties.
(4)Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates.
(5)Measured as the present value of expected consideration payable for completed acquisitions, generally derived using probability-weighted analysis of achieving projected revenue or EBITDA targets.
Schedule of Activity for Contingent Consideration
The following table provides a reconciliation of the activity for contingent consideration for the years ended December 31, 2025 and 2024.
20252024
Balance at beginning of period$22.2 $42.2 
Acquisitions36.7 6.7 
Changes in fair value(16.7)(15.3)
Payments— (10.0)
Foreign currency translation and other1.8 (1.4)
Balance at end of period$44.0 $22.2 
v3.25.4
Contingencies (Tables)
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Impacts of Divestiture
The following table summarizes the impacts of the divestiture.
Assets divested:
Cash and cash equivalents$153.5 
Insurance recovery receivable13.9 
Liabilities divested:
Asbestos indemnity liability - current(12.3)
Asbestos indemnity liability - noncurrent(111.4)
Loss on Asbestos Sale, before transaction costs43.7 
Transaction costs15.1 
Loss on Asbestos Sale58.8 
Income tax benefit(7.6)
Loss on Asbestos Sale, net of tax$51.2 
v3.25.4
Other Operating Expense, Net (Tables)
12 Months Ended
Dec. 31, 2025
Other Income and Expenses [Abstract]  
Schedule of Other Operating Expense, Net
The components of “Other operating expense, net” for the years ended December 31, 2025, 2024 and 2023 were as follows.
202520242023
Other Operating Expense, Net
Foreign currency transaction losses, net$18.6 $3.2 $5.1 
Restructuring charges, net(1)
51.4 31.2 19.9 
Acquisition and other transaction related expenses(2)
22.0 47.1 52.2 
Loss on asbestos sale(3)
— 58.8 — 
Other, net
(0.5)(1.7)0.5 
Total other operating expense, net$91.5 $138.6 $77.7 
(1)See Note 4 “Restructuring.”
(2)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(3)See Note 21 “Contingencies.”
v3.25.4
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Results
The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income Before Income Taxes for the years ended December 31, 2025, 2024 and 2023.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202520242023202520242023202520242023
Revenue$6,056.4 $5,818.1 $5,632.8 1,594.5 1,416.9 1,243.3 $7,650.9 $7,235.0 $6,876.1 
Segment cost of sales(1)
3,346.8 3,193.3 3,225.0 825.6 736.2 648.8 4,172.4 3,929.5 3,873.8 
Segment selling and administrative expenses(2)
963.5 868.5 818.5 291.2 264.6 222.5 1,254.7 1,133.1 1,041.0 
Other segment items(3)
(1.8)1.5 2.0 (0.3)(2.7)(0.8)(2.1)(1.2)1.2 
Segment Adjusted EBITDA$1,747.9 $1,754.8 $1,587.3 478.0 418.8 372.8 2,225.9 2,173.6 1,960.1 
(1)Segment cost of sales excludes adjustments to LIFO inventories, depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(2)Segment selling and administrative expenses excludes depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(3)Other miscellaneous segment expenses.
202520242023
Total Segment Adjusted EBITDA$2,225.9 $2,173.6 $1,960.1 
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes:
Corporate expenses not allocated to segments
132.1 155.5 173.3 
Interest expense253.9 213.2 156.7 
Depreciation and amortization expense(1)
501.3 478.0 455.4 
Impairment of goodwill and other intangible assets273.4 13.9 — 
Restructuring and related business transformation costs(2)
51.7 32.3 22.9 
Acquisition and other transaction related expenses and non-cash charges(3)
26.0 59.8 63.9 
Stock-based compensation
53.0 58.8 51.9 
Foreign currency transaction losses, net18.6 3.2 5.1 
Loss on extinguishment of debt
— 3.0 13.5 
Adjustments to LIFO inventories17.8 6.7 12.0 
Cybersecurity incident costs(4)
(1.3)0.5 2.3 
Loss on asbestos sale— 58.8 — 
Interest income on cash and cash equivalents(30.0)(43.3)(28.8)
Other adjustments(5)
(5.9)0.4 0.8 
Income Before Income Taxes$935.3 $1,132.8 $1,031.1 
(1)Depreciation and amortization expense excludes $4.5 million, $4.0 million and $3.7 million of depreciation of rental equipment for the years ended December 31, 2025, 2024 and 2023, respectively.
(2)Restructuring and related business transformation costs consist of the following.
202520242023
Restructuring charges$51.4 $31.2 $19.9 
Facility reorganization, relocation and other costs0.3 1.1 3.0 
Total restructuring and related business transformation costs$51.7 $32.3 $22.9 
(3)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(4)Represents expected non-recoverable costs associated with a cybersecurity event, net of insurance recoveries.
(5)Includes (i) pension and other postretirement benefits (“OPEB”) plan costs other than service cost and (ii) other miscellaneous adjustments.
The following tables provide summarized information about the Company’s reportable segments.
Depreciation and Amortization Expense
202520242023
Industrial Technologies and Services$282.1 $296.0 $313.8 
Precision and Science Technologies219.1 177.1 135.4 
Corporate and other4.6 8.9 9.9 
Total depreciation and amortization expense$505.8 $482.0 $459.1 
Capital Expenditures
202520242023
Industrial Technologies and Services$92.5 $83.0 $83.9 
Precision and Science Technologies36.9 21.3 18.5 
Corporate and other6.2 44.8 3.0 
Total capital expenditures$135.6 $149.1 $105.4 
Identifiable Assets
20252024
Industrial Technologies and Services$11,266.4 $10,369.6 
Precision and Science Technologies5,656.4 5,884.1 
Corporate and other1,374.4 1,756.1 
Total identifiable assets$18,297.2 $18,009.8 
Scheduled of Property, Plant and Equipment by Geographic Region
The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2025, and 2024.
20252024
United States$383.8 $381.8 
Other Americas50.1 38.1 
Total Americas433.9 419.9 
EMEIA(1)
328.3 256.5 
China149.9 152.3 
Other Asia Pacific18.2 13.4 
Total Asia Pacific168.1 165.7 
Total$930.3 $842.1 
(1)Europe, Middle East, India and Africa (“EMEIA”)
v3.25.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share The number of weighted-average shares outstanding used in the computations of basic and diluted earnings per share for the years ended December 31, 2025, 2024 and 2023 were as follows.
202520242023
Weighted-average shares outstanding - Basic398.1 403.4 404.8 
Dilutive effect of outstanding share-based compensation awards2.9 3.8 4.2 
Weighted-average shares outstanding - Diluted401.0 407.2 409.0 
v3.25.4
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents      
Restricted cash and cash equivalents $ 8.1 $ 10.5  
Goodwill and Indefinite-Lived Intangible Assets      
Fair value percentage of reporting units using income approach 75.00%    
Fair value percentage of reporting units using market approach 25.00%    
Warranty Reserves      
Warranty period after time of sale (in months) 12 months    
Income Taxes      
Income tax expense under the Tax Act $ 13.0    
Research and Development      
Research and development expense $ 114.3 $ 116.6 $ 108.2
Buildings | Minimum      
Property, Plant and Equipment      
Estimated useful lives of property, plant and equipment (in years) 10 years    
Buildings | Maximum      
Property, Plant and Equipment      
Estimated useful lives of property, plant and equipment (in years) 30 years    
Machinery and Equipment | Minimum      
Property, Plant and Equipment      
Estimated useful lives of property, plant and equipment (in years) 7 years    
Machinery and Equipment | Maximum      
Property, Plant and Equipment      
Estimated useful lives of property, plant and equipment (in years) 10 years    
Office Furniture and Equipment | Minimum      
Property, Plant and Equipment      
Estimated useful lives of property, plant and equipment (in years) 3 years    
Office Furniture and Equipment | Maximum      
Property, Plant and Equipment      
Estimated useful lives of property, plant and equipment (in years) 10 years    
v3.25.4
Acquisitions - Narrative (Details)
$ in Millions
12 Months Ended
Nov. 03, 2025
USD ($)
Aug. 04, 2025
USD ($)
Jul. 01, 2025
USD ($)
Jun. 03, 2025
USD ($)
Apr. 01, 2025
USD ($)
Feb. 03, 2025
USD ($)
Oct. 31, 2024
USD ($)
Oct. 01, 2024
USD ($)
Jun. 03, 2024
USD ($)
Jun. 01, 2024
USD ($)
May 31, 2024
USD ($)
May 01, 2024
USD ($)
Apr. 02, 2024
USD ($)
Apr. 01, 2024
USD ($)
Feb. 01, 2024
USD ($)
Aug. 18, 2023
USD ($)
Apr. 01, 2023
USD ($)
Feb. 01, 2023
USD ($)
Jan. 03, 2023
USD ($)
Dec. 31, 2025
USD ($)
acquisition
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
business
Business Combination [Line Items]                                            
Contingent consideration                                       $ 44.0 $ 22.2  
Amount allocated to goodwill                                       8,484.1 8,148.1 $ 6,609.7
Industrial Technologies and Services                                            
Business Combination [Line Items]                                            
Amount allocated to goodwill                                       5,385.5 4,930.7 4,753.5
Precision and Science Technologies                                            
Business Combination [Line Items]                                            
Amount allocated to goodwill                                       3,098.6 3,217.4 $ 1,856.2
SSI Aeration                                            
Business Combination [Line Items]                                            
Cash consideration           $ 97.8                                
Excelsior Blower Systems                                            
Business Combination [Line Items]                                            
Cash consideration           17.5                                
Cullum & Brown of Kansas City                                            
Business Combination [Line Items]                                            
Cash consideration           50.7                                
Contingent consideration           $ 10.0                                
G & D Chillers, Inc.                                            
Business Combination [Line Items]                                            
Cash consideration         $ 20.9                                  
Lead Fluid                                            
Business Combination [Line Items]                                            
Cash consideration       $ 18.0                                    
Contingent consideration       $ 4.2                                    
Termomeccanica Industrial Compressors S.P.A                                            
Business Combination [Line Items]                                            
Cash consideration     $ 193.2                                      
Dave Barry Plastics                                            
Business Combination [Line Items]                                            
Cash consideration   $ 26.9                                        
Contingent consideration   $ 8.2                                        
Transvac Systems Ltd                                            
Business Combination [Line Items]                                            
Cash consideration $ 71.0                                          
Contingent consideration $ 56.5                                          
All others                                            
Business Combination [Line Items]                                            
Number of businesses acquired | business                                           10
Aggregate consideration                                       56.9 55.4 $ 83.3
Amount of goodwill deductible                                           159.9
Amount allocated to goodwill                                       $ 261.8 251.0 126.7
All others | Industrial Technologies and Services                                            
Business Combination [Line Items]                                            
Number of acquisitions | acquisition                                       7    
All others | Precision and Science Technologies                                            
Business Combination [Line Items]                                            
Number of acquisitions | acquisition                                       1    
Acquisitions in 2025                                            
Business Combination [Line Items]                                            
Revenue from acquisition date                                       $ 172.4    
Operating income from acquisition date                                       16.1    
Amount allocated to goodwill                                       361.4    
Friulair                                            
Business Combination [Line Items]                                            
Cash consideration                             $ 143.3              
Contingent consideration                             11.0              
Amount of goodwill deductible                             $ 0.0              
Amount allocated to goodwill                                         69.2  
Controlled Fluidics                                            
Business Combination [Line Items]                                            
Cash consideration                           $ 49.9                
Contingent consideration                           $ 2.0                
Ethafilter s.r.l.                                            
Business Combination [Line Items]                                            
Cash consideration                         $ 15.5                  
Air Systems, LLC                                            
Business Combination [Line Items]                                            
Cash consideration                       $ 34.9                    
Complete Air And Power Solutions                                            
Business Combination [Line Items]                                            
Cash consideration                     $ 99.3                      
Fruvac Ltd.                                            
Business Combination [Line Items]                                            
Cash consideration                     $ 28.0                      
Del PD Pumps & Gear Pvt Ltd.                                            
Business Combination [Line Items]                                            
Cash consideration                   $ 25.2                        
ILC Dover                                            
Business Combination [Line Items]                                            
Cash consideration                 $ 2,349.7                          
Contingent consideration                 75.0                          
Amount of goodwill deductible                 0.0                          
Amount allocated to goodwill                 1,300.0                       1,300.0  
ILC Dover | Customer Relationships                                            
Business Combination [Line Items]                                            
Amount allocated to definite-lived intangible assets                 $ 620.5                          
Acquired finite-lived intangible assets, weighted average useful life                 14 years                          
ILC Dover | Acquired Technology                                            
Business Combination [Line Items]                                            
Amount allocated to definite-lived intangible assets                 $ 142.0                          
Acquired finite-lived intangible assets, weighted average useful life                 8 years                          
ILC Dover | Tradenames                                            
Business Combination [Line Items]                                            
Amount allocated to indefinite-lived intangible assets                 $ 207.5                          
APSCO                                            
Business Combination [Line Items]                                            
Cash consideration               $ 113.2                            
Amount allocated to goodwill                                         51.6  
Blutek                                            
Business Combination [Line Items]                                            
Cash consideration               10.3                            
UT Pumps & Systems Private Ltd                                            
Business Combination [Line Items]                                            
Cash consideration               $ 11.9                            
Penn Valley Pump Co LLC                                            
Business Combination [Line Items]                                            
Cash consideration             $ 33.5                              
Acquisitions in 2024                                            
Business Combination [Line Items]                                            
Revenue from acquisition date                                       627.4 349.6  
Operating income from acquisition date                                       49.4 5.6  
Amount allocated to goodwill                                         1,671.8  
Air Treatment                                            
Business Combination [Line Items]                                            
Cash consideration                                     $ 519.0      
Amount of goodwill deductible                                     $ 0.0      
Amount allocated to goodwill                                           279.9
Paragon Tank Truck Equipment                                            
Business Combination [Line Items]                                            
Cash consideration                                   $ 42.2        
EcoPlant Technological Innovation Ltd                                            
Business Combination [Line Items]                                            
Cash consideration                                 $ 29.5          
Contingent consideration                                 $ 17.0          
Roots                                            
Business Combination [Line Items]                                            
Cash consideration                               $ 292.5            
Amount allocated to goodwill                                           105.6
Acquisitions in 2023                                            
Business Combination [Line Items]                                            
Revenue from acquisition date                                       429.3 408.0 293.7
Operating income from acquisition date                                       $ 93.0 $ 58.8 16.1
Amount allocated to goodwill                                           $ 512.2
v3.25.4
Acquisitions - Schedule of Allocation of Consideration to Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Jun. 03, 2024
Dec. 31, 2023
Business Combination [Line Items]        
Goodwill $ 8,484.1 $ 8,148.1   $ 6,609.7
Acquisitions in 2025        
Business Combination [Line Items]        
Accounts receivable 52.4      
Inventories 64.6      
Other current assets 8.0      
Property, plant and equipment 43.6      
Goodwill 361.4      
Other intangible assets 186.6      
Other noncurrent assets 7.4      
Total current liabilities (91.4)      
Deferred tax liabilities (37.1)      
Other noncurrent liabilities (7.9)      
Total consideration 587.6      
TMIC/Adicomp        
Business Combination [Line Items]        
Accounts receivable 22.8      
Inventories 34.4      
Other current assets 4.7      
Property, plant and equipment 30.8      
Goodwill 99.6      
Other intangible assets 80.6      
Other noncurrent assets 0.1      
Total current liabilities (54.1)      
Deferred tax liabilities (22.7)      
Other noncurrent liabilities (3.0)      
Total consideration 193.2      
Acquisitions in 2024        
Business Combination [Line Items]        
Accounts receivable   99.1    
Inventories   143.8    
Other current assets   43.2    
Property, plant and equipment   117.2    
Goodwill   1,671.8    
Other intangible assets   1,185.7    
Other noncurrent assets   25.2    
Total current liabilities   (103.4)    
Deferred tax liabilities   (173.0)    
Other noncurrent liabilities   (32.7)    
Total consideration   2,976.9    
ILC Dover        
Business Combination [Line Items]        
Accounts receivable   41.2    
Inventories   78.1    
Other current assets   37.5    
Property, plant and equipment   89.2    
Goodwill   1,300.0 $ 1,300.0  
Other intangible assets   972.6    
Other noncurrent assets   15.8    
Total current liabilities   (32.4)    
Deferred tax liabilities   (131.2)    
Other noncurrent liabilities   (21.1)    
Total consideration   2,349.7    
Friulair        
Business Combination [Line Items]        
Accounts receivable   14.2    
Inventories   13.2    
Other current assets   0.5    
Property, plant and equipment   7.2    
Goodwill   69.2    
Other intangible assets   84.5    
Other noncurrent assets   0.0    
Total current liabilities   (11.6)    
Deferred tax liabilities   (24.6)    
Other noncurrent liabilities   (2.8)    
Total consideration   149.8    
APSCO        
Business Combination [Line Items]        
Accounts receivable   6.4    
Inventories   7.5    
Other current assets   0.5    
Property, plant and equipment   2.3    
Goodwill   51.6    
Other intangible assets   48.1    
Other noncurrent assets   3.5    
Total current liabilities   (3.7)    
Deferred tax liabilities   0.0    
Other noncurrent liabilities   (3.0)    
Total consideration   113.2    
Acquisitions in 2023        
Business Combination [Line Items]        
Accounts receivable       52.3
Inventories       99.1
Other current assets       11.2
Property, plant and equipment       65.4
Goodwill       512.2
Other intangible assets       380.9
Other noncurrent assets       11.1
Total current liabilities       (82.3)
Deferred tax liabilities       (58.7)
Other noncurrent liabilities       (13.7)
Total consideration       977.5
Air Treatment        
Business Combination [Line Items]        
Accounts receivable       26.1
Inventories       43.9
Other current assets       2.1
Property, plant and equipment       18.4
Goodwill       279.9
Other intangible assets       238.6
Other noncurrent assets       7.6
Total current liabilities       (35.9)
Deferred tax liabilities       (54.8)
Other noncurrent liabilities       (6.9)
Total consideration       519.0
Roots        
Business Combination [Line Items]        
Accounts receivable       14.5
Inventories       34.2
Other current assets       2.9
Property, plant and equipment       42.0
Goodwill       105.6
Other intangible assets       116.9
Other noncurrent assets       3.1
Total current liabilities       (26.9)
Deferred tax liabilities       0.0
Other noncurrent liabilities       (2.3)
Total consideration       290.0
All others        
Business Combination [Line Items]        
Accounts receivable 29.6 37.3   11.7
Inventories 30.2 45.0   21.0
Other current assets 3.3 4.7   6.2
Property, plant and equipment 12.8 18.5   5.0
Goodwill 261.8 251.0   126.7
Other intangible assets 106.0 80.5   25.4
Other noncurrent assets 7.3 5.9   0.4
Total current liabilities (37.3) (55.7)   (19.5)
Deferred tax liabilities (14.4) (17.2)   (3.9)
Other noncurrent liabilities (4.9) (5.8)   (4.5)
Total consideration $ 394.4 $ 364.2   $ 168.5
v3.25.4
Restructuring - Schedule of Restructuring Charges Net (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]      
Restructuring charges, net $ 51.4 $ 31.2 $ 19.9
Corporate      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges, net 3.2 2.7 0.7
Industrial Technologies and Services | Operating segments      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges, net 37.7 20.6 15.1
Precision and Science Technologies | Operating segments      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges, net $ 10.5 $ 7.9 $ 4.1
v3.25.4
Restructuring - Schedule of Activity in Restructuring Programs (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Restructuring Reserve [Roll Forward]    
Balance at beginning of period $ 22.3 $ 15.5
Charged to expense - termination benefits 48.8 27.1
Charged to expense - other 2.6 2.5
Payments (35.5) (21.6)
Foreign currency translation and other 1.7 (1.2)
Balance at end of period $ 39.9 22.3
Other operating income (expense)    
Restructuring Reserve [Roll Forward]    
Non-cash charges   $ 1.6
v3.25.4
Allowance for Credit Losses (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]      
Balance at beginning of the period $ 57.3 $ 53.8 $ 47.2
Provision charged to expense 11.6 7.5 9.4
Write-offs, net of recoveries (5.7) (3.3) (3.3)
Foreign currency translation and other 3.6 (0.7) 0.5
Balance at end of the period $ 66.8 $ 57.3 $ 53.8
v3.25.4
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Raw materials, including parts and subassemblies $ 737.3 $ 675.1
Work-in-process 128.7 116.3
Finished goods 403.9 342.8
Inventories, gross 1,269.9 1,134.2
LIFO reserve (97.0) (79.2)
Inventories $ 1,172.9 $ 1,055.0
v3.25.4
Inventories - Narrative (Details)
Dec. 31, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Percentage of inventory 32.00% 34.00%
v3.25.4
Property, Plant, and Equipment (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Abstract]    
Land and land improvements $ 70.0 $ 62.3
Buildings 436.1 385.6
Machinery and equipment 909.6 792.6
Office furniture and equipment 87.9 76.8
Construction in progress 116.3 92.3
Property, plant and equipment, gross 1,619.9 1,409.6
Accumulated depreciation (689.6) (567.5)
Property, plant and equipment, net $ 930.3 $ 842.1
v3.25.4
Goodwill and Other Intangible Assets - Schedule of Goodwill by Segment (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Goodwill [Roll Forward]        
Balance at beginning of period   $ 8,148,100,000 $ 6,609,700,000  
Acquisitions   361,400,000 1,668,200,000  
Impairments $ 0 (229,700,000) 0 $ 0
Foreign currency translation and other   204,300,000 (129,800,000)  
Balance at end of period 8,484,100,000 8,484,100,000 8,148,100,000 6,609,700,000
Industrial Technologies and Services        
Goodwill [Roll Forward]        
Balance at beginning of period   4,930,700,000 4,753,500,000  
Acquisitions   310,100,000 263,900,000  
Impairments   0    
Foreign currency translation and other   144,700,000 (86,700,000)  
Balance at end of period 5,385,500,000 5,385,500,000 4,930,700,000 4,753,500,000
Precision and Science Technologies        
Goodwill [Roll Forward]        
Balance at beginning of period   3,217,400,000 1,856,200,000  
Acquisitions   51,300,000 1,404,300,000  
Impairments   (229,700,000)    
Foreign currency translation and other   59,600,000 (43,100,000)  
Balance at end of period $ 3,098,600,000 $ 3,098,600,000 $ 3,217,400,000 $ 1,856,200,000
v3.25.4
Goodwill and Other Intangible Assets - Schedule of Goodwill by Acquisition (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired $ 361.4 $ 1,668.2
TMIC/Adicomp    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired 99.6  
ILC Dover    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   1,309.8
Friulair    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   69.2
APSCO    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   51.6
Other acquisitions    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired 261.8 237.6
Industrial Technologies and Services    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired 310.1 263.9
Industrial Technologies and Services | TMIC/Adicomp    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired 99.6  
Industrial Technologies and Services | ILC Dover    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   0.0
Industrial Technologies and Services | Friulair    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   69.2
Industrial Technologies and Services | APSCO    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   51.6
Industrial Technologies and Services | Other acquisitions    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired 210.5 143.1
Precision and Science Technologies    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired 51.3 1,404.3
Precision and Science Technologies | TMIC/Adicomp    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired 0.0  
Precision and Science Technologies | ILC Dover    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   1,309.8
Precision and Science Technologies | Friulair    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   0.0
Precision and Science Technologies | APSCO    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired   0.0
Precision and Science Technologies | Other acquisitions    
Business Combination, Goodwill, Reportable Segment Assignment [Line Items]    
Goodwill acquired $ 51.3 $ 94.5
v3.25.4
Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2025
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Goodwill [Line Items]            
Percentage of impairment test using income approach   75.00%        
Percentage of impairment test using market approach   25.00%        
Impairment of goodwill $ 0     $ 229,700,000 $ 0 $ 0
Amortization of intangible assets       387,500,000 373,000,000.0 367,500,000
Anticipated amortization of intangible assets in 2026 390,000,000     390,000,000    
Anticipated amortization of intangible assets in 2027 385,000,000     385,000,000    
Anticipated amortization of intangible assets in 2028 350,000,000     350,000,000    
Anticipated amortization of intangible assets in 2029 255,000,000     255,000,000    
Anticipated amortization of intangible assets in 2030 220,000,000     220,000,000    
Acquired Technology            
Goodwill [Line Items]            
Carrying value of finite-lived intangible assets 248,300,000   $ 305,800,000 248,300,000 305,800,000  
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]     Impairment of Intangible Assets (Excluding Goodwill)      
Impairment of finite-lived intangible assets     $ 13,900,000      
Tradenames            
Goodwill [Line Items]            
Carrying value of finite-lived intangible assets 274,500,000   31,200,000 274,500,000 31,200,000  
Tradenames | Reclassification, Brand Architecture Assessment            
Goodwill [Line Items]            
Carrying value of finite-lived intangible assets $ 255,100,000     $ 255,100,000    
Tradenames | Minimum | Reclassification, Brand Architecture Assessment            
Goodwill [Line Items]            
Remaining useful lives 3 years     3 years    
Tradenames | Maximum | Reclassification, Brand Architecture Assessment            
Goodwill [Line Items]            
Remaining useful lives 10 years     10 years    
Tradenames            
Goodwill [Line Items]            
Carrying value of indefinite lived intangible assets $ 1,572,500,000   1,839,300,000 $ 1,572,500,000 1,839,300,000  
Impairment of indefinite-lived intangible assets $ 7,600,000     0 0 $ 0
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment of Intangible Assets (Excluding Goodwill)          
Tradenames | Reclassification, Brand Architecture Assessment            
Goodwill [Line Items]            
Carrying value of indefinite lived intangible assets $ (255,100,000)     (255,100,000)    
Biopharma            
Goodwill [Line Items]            
Impairment of goodwill   $ 170,300,000        
Aerospace & Defense            
Goodwill [Line Items]            
Impairment of goodwill   59,400,000        
Industrial Technologies and Services            
Goodwill [Line Items]            
Accumulated impairment loss of goodwill 220,600,000   220,600,000 220,600,000 220,600,000  
Impairment of goodwill       0    
Precision and Science Technologies            
Goodwill [Line Items]            
Accumulated impairment loss of goodwill $ 229,700,000   $ 0.0 229,700,000 $ 0.0  
Impairment of goodwill       $ 229,700,000    
Precision and Science Technologies | Tradenames            
Goodwill [Line Items]            
Impairment of indefinite-lived intangible assets   $ 36,100,000        
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]   Impairment of Intangible Assets (Excluding Goodwill)        
v3.25.4
Goodwill and Other Intangible Assets - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Amortized intangible assets:    
Accumulated Amortization $ (2,689.6) $ (2,222.1)
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Gross Carrying Amount 6,929.9 6,594.9
Accumulated Amortization (2,689.6) (2,222.1)
Net Carrying Amount 4,240.3 4,372.8
Tradenames    
Unamortized intangible assets:    
Carrying amount 1,572.5 1,839.3
Customer lists and relationships    
Amortized intangible assets:    
Gross Carrying Amount 4,292.9 4,010.1
Accumulated Amortization (2,186.3) (1,830.1)
Net Carrying Amount 2,106.6 2,180.0
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (2,186.3) (1,830.1)
Technology    
Amortized intangible assets:    
Gross Carrying Amount 573.5 549.1
Accumulated Amortization (325.2) (243.3)
Net Carrying Amount 248.3 305.8
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (325.2) (243.3)
Tradenames    
Amortized intangible assets:    
Gross Carrying Amount 327.6 63.6
Accumulated Amortization (53.1) (32.4)
Net Carrying Amount 274.5 31.2
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (53.1) (32.4)
Backlog    
Amortized intangible assets:    
Gross Carrying Amount 0.0 4.3
Accumulated Amortization 0.0 (4.2)
Net Carrying Amount 0.0 0.1
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization 0.0 (4.2)
Other    
Amortized intangible assets:    
Gross Carrying Amount 163.4 128.5
Accumulated Amortization (125.0) (112.1)
Net Carrying Amount 38.4 16.4
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ (125.0) $ (112.1)
v3.25.4
Supply Chain Finance Program (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Payables and Accruals [Abstract]    
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Accounts payable Accounts payable
Supplier Finance Program, Obligation [Roll Forward]    
Confirmed obligations outstanding at beginning of period $ 24.5 $ 24.3
Invoices confirmed 122.8 117.0
Confirmed invoices paid (119.0) (116.8)
Confirmed obligations outstanding at end of period $ 28.2 $ 24.5
v3.25.4
Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]      
Salaries, wages and related fringe benefits $ 238.1 $ 229.5  
Contract liabilities 347.2 318.6  
Product warranty 54.1 67.9 $ 61.9
Operating lease liabilities 64.8 56.3  
Restructuring 39.9 22.3  
Taxes 108.5 72.5  
Accrued interest 33.1 33.2  
Other 183.1 171.9  
Total accrued liabilities $ 1,068.8 $ 972.2  
v3.25.4
Accrued Liabilities - Schedule of Accrued Product Warranty Liability (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Movement in Standard Product Warranty Accrual [Roll Forward]    
Balance at the beginning of period $ 67.9 $ 61.9
Product warranty accruals 11.8 37.5
Acquired warranty 6.5 0.7
Settlements (34.6) (30.7)
Foreign currency translation and other 2.5 (1.5)
Balance at the end of period $ 54.1 $ 67.9
v3.25.4
Debt - Schedule of Debt (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
May 10, 2024
Aug. 14, 2023
Debt Instrument [Line Items]        
Short-term borrowings $ 0.0 $ 1.7    
Long-term debt:        
Finance leases and other long-term debt 13.2 14.1    
Swap valuation adjustments 19.8 (0.3)    
Unamortized debt issuance costs (38.7) (47.0)    
Total long-term debt, net, including current maturities 4,784.7 4,755.8    
Current maturities of long-term debt 1.4 1.4    
Total long-term debt, net 4,783.3 4,754.4    
Original issue discounts 9.7 11.0    
5.197% Senior Notes Due 2027 | Senior Notes        
Long-term debt:        
Long-term debt $ 700.0 $ 699.9    
Stated interest rate of debt instrument (as a percent) 5.197% 5.197% 5.197%  
5.400% Senior Notes Due 2028 | Senior Notes        
Long-term debt:        
Long-term debt $ 499.0 $ 498.6    
Stated interest rate of debt instrument (as a percent) 5.40% 5.40%   5.40%
5.176% Senior Notes Due 2029 | Senior Notes        
Long-term debt:        
Long-term debt $ 750.0 $ 750.0    
Stated interest rate of debt instrument (as a percent) 5.176% 5.176% 5.176%  
5.314% Senior Notes Due 2031 | Senior Notes        
Long-term debt:        
Long-term debt $ 500.0 $ 500.0    
Stated interest rate of debt instrument (as a percent) 5.314% 5.314% 5.314%  
5.700% Senior Notes Due 2033 | Senior Notes        
Long-term debt:        
Long-term debt $ 994.1 $ 993.4    
Stated interest rate of debt instrument (as a percent) 5.70% 5.70%   5.70%
5.450% Senior Notes Due 2034 | Senior Notes        
Long-term debt:        
Long-term debt $ 749.6 $ 749.5    
Stated interest rate of debt instrument (as a percent) 5.45% 5.45% 5.45%  
5.700% Senior Notes Due 2054 | Senior Notes        
Long-term debt:        
Long-term debt $ 597.7 $ 597.6    
Stated interest rate of debt instrument (as a percent) 5.70% 5.70% 5.70%  
v3.25.4
Debt - Senior Notes (Details) - Senior Notes - USD ($)
May 10, 2024
Dec. 31, 2025
Dec. 31, 2024
Aug. 14, 2023
Debt Instrument [Line Items]        
Aggregate principal amount $ 3,300,000,000     $ 1,500,000,000
Debt Instrument, Redemption, Period One        
Debt Instrument [Line Items]        
Redemption price, percentage 100.00%      
Debt Instrument, Redemption, Period Two        
Debt Instrument [Line Items]        
Redemption price, percentage 101.00%      
5.197% Senior Notes Due 2027        
Debt Instrument [Line Items]        
Aggregate principal amount $ 700,000,000      
Stated interest rate of debt instrument (as a percent) 5.197% 5.197% 5.197%  
5.176% Senior Notes Due 2029        
Debt Instrument [Line Items]        
Aggregate principal amount $ 750,000,000      
Stated interest rate of debt instrument (as a percent) 5.176% 5.176% 5.176%  
5.314% Senior Notes Due 2031        
Debt Instrument [Line Items]        
Aggregate principal amount $ 500,000,000      
Stated interest rate of debt instrument (as a percent) 5.314% 5.314% 5.314%  
5.450% Senior Notes Due 2034        
Debt Instrument [Line Items]        
Aggregate principal amount $ 750,000,000      
Stated interest rate of debt instrument (as a percent) 5.45% 5.45% 5.45%  
5.700% Senior Notes Due 2054        
Debt Instrument [Line Items]        
Aggregate principal amount $ 600,000,000      
Stated interest rate of debt instrument (as a percent) 5.70% 5.70% 5.70%  
5.400% Senior Notes Due 2028        
Debt Instrument [Line Items]        
Aggregate principal amount       $ 500,000,000
Stated interest rate of debt instrument (as a percent)   5.40% 5.40% 5.40%
5.700% Senior Notes Due 2033        
Debt Instrument [Line Items]        
Aggregate principal amount       $ 1,000,000,000
Stated interest rate of debt instrument (as a percent)   5.70% 5.70% 5.70%
v3.25.4
Debt - Revolving Credit Facility (Details) - New Revolving Credit Facility
May 10, 2024
USD ($)
extensionOption
Dec. 31, 2025
USD ($)
Debt Instrument [Line Items]    
Letters of credit outstanding   $ 0
Revolving Credit Facility    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 2,600,000,000 2,600,000,000
Debt instrument, extension options | extensionOption 2  
Debt instrument, extension term 1 year  
Basis spread on variable rate (as a percent) 0.10%  
Debt instrument, covenant, adjusted consolidated total net debt to consolidated adjusted ebitda ratio, maximum 3.50  
Debt instrument, covenant, following a qualified acquisition, adjusted consolidated total net debt to consolidated adjusted ebitda ratio, maximum 4.00  
Long-term debt obligations   0
Unused borrowing capacity   2,600,000,000
Letter of Credit    
Debt Instrument [Line Items]    
Maximum borrowing capacity   $ 200,000,000.0
v3.25.4
Debt - Former Senior Secured Credit Facilities (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 21, 2023
Dec. 31, 2024
Dec. 31, 2023
Apr. 20, 2023
Revolving Credit Facility        
Debt Instrument [Line Items]        
Unused borrowing capacity $ 2,000.0     $ 1,100.0
Write-off of unamortized debt issuance costs $ 0.9      
Dollar Term Loan B, due 2027        
Debt Instrument [Line Items]        
Write-off of unamortized debt issuance costs   $ 3.0 $ 12.6  
v3.25.4
Debt - Commercial Paper Program (Details) - USD ($)
$ in Millions
Aug. 13, 2024
Dec. 31, 2025
Debt Instrument [Line Items]    
Line of credit facility, amount outstanding   $ 0.0
Commercial Paper | Commercial Paper Notes    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 2,600.0  
Line of credit facility, expiration period 397 days  
v3.25.4
Debt - Fair Value of Debt and Total Debt Maturities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Debt Disclosure [Abstract]    
Fair value of debt $ 5,000.0 $ 4,900.0
Debt maturities, next twelve months 1.4  
Debt maturities, year two 702.1  
Debt maturities, year three 501.6  
Debt maturities, year four 751.6  
Debt maturities, year five 1.6  
Debt maturities, after year five $ 2,855.0  
v3.25.4
Benefit Plans - Schedule of Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reconciliation of Fair Value of Plan Assets:      
Beginning balance $ 401.5    
Fair value of plan assets ending balance 415.5 $ 401.5  
Pension Benefits | U.S. Plans      
Reconciliation of Benefit Obligations:      
Beginning balance 264.7 294.0  
Service cost 0.1 0.1 $ 0.1
Interest cost 13.5 13.4 15.7
Participant contributions 0.0 0.0  
Plan amendments 0.0 0.0  
Actuarial losses (gains) 9.0 (18.1)  
Benefit payments (24.9) (22.2)  
Acquisitions 0.0 0.0  
Plan settlements 0.0 (2.5)  
Other 0.0 0.0  
Effect of foreign currency exchange rate changes 0.0 0.0  
Benefit obligations ending balance 262.4 264.7 294.0
Reconciliation of Fair Value of Plan Assets:      
Beginning balance 206.9 237.5  
Actual return on plan assets 17.4 (6.0)  
Employer contributions 10.3 0.1  
Participant contributions 0.0 0.0  
Acquisitions 0.0 0.0  
Benefit payments (24.9) (22.2)  
Plan settlements 0.0 (2.5)  
Other 0.0 0.0  
Effect of foreign currency exchange rate changes 0.0 0.0  
Fair value of plan assets ending balance 209.7 206.9 237.5
Funded Status as of Period End (52.7) (57.8)  
Pension Benefits | Non-U.S. Plans      
Reconciliation of Benefit Obligations:      
Beginning balance 251.4 263.2  
Service cost 3.2 2.9 2.6
Interest cost 11.6 10.7 11.1
Participant contributions 0.3 0.2  
Plan amendments 0.0 0.0  
Actuarial losses (gains) (14.7) (11.3)  
Benefit payments (13.2) (14.5)  
Acquisitions 0.0 10.2  
Plan settlements (6.7) 0.0  
Other 1.0 0.6  
Effect of foreign currency exchange rate changes 24.9 (10.6)  
Benefit obligations ending balance 257.8 251.4 263.2
Reconciliation of Fair Value of Plan Assets:      
Beginning balance 194.6 206.0  
Actual return on plan assets 5.4 (7.1)  
Employer contributions 7.6 6.5  
Participant contributions 0.3 0.2  
Acquisitions 0.0 8.5  
Benefit payments (13.2) (14.5)  
Plan settlements (6.7) 0.0  
Other 1.0 0.6  
Effect of foreign currency exchange rate changes 16.8 (5.6)  
Fair value of plan assets ending balance 205.8 194.6 206.0
Funded Status as of Period End (52.0) (56.8)  
Other Postretirement Benefits      
Reconciliation of Benefit Obligations:      
Beginning balance 5.9 18.3  
Service cost 0.0 0.0  
Interest cost 0.2 0.8 0.9
Participant contributions 0.0 0.0  
Plan amendments 0.0 (10.9)  
Actuarial losses (gains) 0.4 0.2  
Benefit payments (2.3) (2.4)  
Acquisitions 0.0 0.0  
Plan settlements 0.0 0.0  
Other 0.0 0.0  
Effect of foreign currency exchange rate changes 0.1 (0.1)  
Benefit obligations ending balance 4.3 5.9 $ 18.3
Reconciliation of Fair Value of Plan Assets:      
Funded Status as of Period End $ (4.3) $ (5.9)  
v3.25.4
Benefit Plans - Schedule of Recognized as Component of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Pension Benefits | U.S. Plans    
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]    
Net actuarial losses (gains) $ (8.3) $ (10.8)
Prior service cost 0.0 0.0
Amounts included in accumulated other comprehensive income (loss) (8.3) (10.8)
Pension Benefits | Non-U.S. Plans    
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]    
Net actuarial losses (gains) (2.0) 7.6
Prior service cost 2.7 2.7
Amounts included in accumulated other comprehensive income (loss) 0.7 10.3
Other Postretirement Benefits    
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]    
Net actuarial losses (gains) (2.2) (3.2)
Prior service cost 0.0 (10.9)
Amounts included in accumulated other comprehensive income (loss) $ (2.2) $ (14.1)
v3.25.4
Benefit Plans - Schedule of Pension and Other Postretirement Benefit Liabilities in Consolidated Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Total Pension and Other Postretirement Benefit Liabilities Included in Balance Sheets [Abstract]    
Other assets $ 23.5 $ 18.5
Accrued liabilities (4.6) (6.4)
Pension and other postretirement benefits $ (127.9) $ (132.6)
v3.25.4
Benefit Plans - Schedule of Accumulated Benefit Obligation in Excess of Plan Assets (Details) - Pension Benefits - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
U.S. Plans    
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]    
Projected benefit obligations $ 262.3 $ 264.7
Accumulated benefit obligation 262.3 264.7
Fair value of plan assets 209.7 206.9
Accumulated benefit obligation 262.3 264.7
Non-U.S. Plans    
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]    
Projected benefit obligations 116.3 119.7
Accumulated benefit obligation 109.0 112.7
Fair value of plan assets 39.0 42.8
Accumulated benefit obligation $ 249.4 $ 243.3
v3.25.4
Benefit Plans - Schedule of Net Periodic Benefit Cost and Other Comprehensive (Loss) Income, Before Income Tax Effects (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Pension Benefits | U.S. Plans      
Net Periodic Benefit Cost:      
Service cost $ 0.1 $ 0.1 $ 0.1
Interest cost 13.5 13.4 15.7
Expected return on plan assets (11.0) (12.7) (13.2)
Amortization of net actuarial (loss) gain 0.1 0.0 0.1
Net periodic benefit cost 2.7 0.8 2.7
Loss (gain) due to settlement 0.0 0.4 (0.4)
Total net periodic benefit cost recognized 2.7 1.2 2.3
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Net actuarial loss (gain) 2.6 0.6 0.5
Amortization of net actuarial gain (0.1) (0.4) 0.3
Total recognized in other comprehensive income (loss) 2.5 0.2 0.8
Total recognized in net periodic benefit cost and other comprehensive income (loss) 5.2 1.4 3.1
Pension Benefits | Non-U.S. Plans      
Net Periodic Benefit Cost:      
Service cost 3.2 2.9 2.6
Interest cost 11.6 10.7 11.1
Expected return on plan assets (9.7) (11.2) (11.0)
Amortization of prior-service cost 0.2 0.2 0.1
Amortization of net actuarial (loss) gain (1.0) (1.3) (1.7)
Net periodic benefit cost 4.3 1.3 1.1
Loss (gain) due to settlement (0.2) 0.0 0.0
Total net periodic benefit cost recognized 4.1 1.3 1.1
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Net actuarial loss (gain) (10.4) 7.0 7.5
Amortization of net actuarial gain 1.2 1.3 1.7
Prior service cost 0.0 0.0 0.3
Amortization of prior service cost (0.2) (0.2) (0.1)
Effect of foreign currency exchange rate changes (0.2) 0.4 0.3
Total recognized in other comprehensive income (loss) (9.6) 8.5 9.7
Total recognized in net periodic benefit cost and other comprehensive income (loss) (5.5) 9.8 10.8
Other Postretirement Benefits      
Net Periodic Benefit Cost:      
Service cost 0.0 0.0  
Interest cost 0.2 0.8 0.9
Amortization of prior-service cost (10.9) 0.1 0.1
Amortization of net actuarial (loss) gain (0.6) (0.8) (1.1)
Total net periodic benefit cost recognized (11.3) 0.1 (0.1)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Net actuarial loss (gain) 0.4 0.2 (1.0)
Amortization of net actuarial gain 0.6 0.8 1.1
Prior service cost 0.0 (10.9) 0.0
Amortization of prior service cost 10.9 (0.1) (0.1)
Total recognized in other comprehensive income (loss) 11.9 (10.0) 0.0
Total recognized in net periodic benefit cost and other comprehensive income (loss) $ 0.6 $ (9.9) $ (0.1)
v3.25.4
Benefit Plans - Schedule of Weighted Average Actuarial Assumptions (Details)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Pension Benefits | U.S. Plans      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 5.50% 5.00% 5.20%
Expected long-term rate of return on plan assets (as a percent) 5.70% 5.80% 5.40%
Rate of compensation increases (as a percent)     0.00%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 5.10% 5.50% 5.00%
Pension Benefits | Non-U.S. Plans      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 4.50% 4.20% 4.50%
Expected long-term rate of return on plan assets (as a percent) 4.80% 5.50% 5.50%
Rate of compensation increases (as a percent) 5.00% 5.00% 4.30%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 4.60% 4.50% 4.20%
Rate of compensation increases (as a percent) 5.00% 5.00% 5.00%
Other Postretirement Benefits | Minimum      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 4.40% 4.90% 4.90%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 4.50% 4.40% 4.90%
Other Postretirement Benefits | Maximum      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 5.40% 5.10% 5.20%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 5.10% 5.40% 5.10%
v3.25.4
Benefit Plans - Schedule of Assumed Health Care Cost Trend Rate (Details) - Other Postretirement Benefits
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations:      
Healthcare cost trend rate assumed for next year (as a percent) 4.40% 5.10% 6.80%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) (as a percent) 4.00% 4.00% 4.40%
v3.25.4
Benefit Plans - Schedule of Estimated Benefit Payments for the Next Five Years (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Pension Benefits | U.S. Plans  
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]  
2026 $ 24.7
2027 25.0
2028 23.8
2029 23.7
2030 23.9
Aggregate 2031-2035 98.5
Expected future employer contributions in the next year 8.7
Pension Benefits | Non-U.S. Plans  
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]  
2026 16.4
2027 15.4
2028 16.0
2029 17.9
2030 17.9
Aggregate 2031-2035 92.1
Expected future employer contributions in the next year 7.8
Other Postretirement Benefits  
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]  
2026 0.4
2027 0.4
2028 0.4
2029 0.3
2030 0.3
Aggregate 2031-2035 1.4
Expected future employer contributions in the next year $ 0.4
v3.25.4
Benefit Plans - Schedule of Long-Term Target Allocations (Details)
12 Months Ended
Dec. 31, 2025
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]  
Proportion of U.S. and U.K pension plans in total benefit obligation (as a percent) 75.00%
Proportion of U.S. and U.K pension plans in total plan assets (as a percent) 87.00%
U.S. Plans  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 100.00%
U.S. Plans | Equity  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 32.00%
U.S. Plans | Fixed income  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 66.00%
U.S. Plans | Real estate and other  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 2.00%
UK Plan  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 100.00%
UK Plan | Equity  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 11.00%
UK Plan | Fixed income  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 58.00%
UK Plan | Real estate and other  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 31.00%
v3.25.4
Benefit Plans - Schedule of Fair Values of Pension Plan Assets by Asset Category (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets $ 415.5 $ 401.5
Cash and cash equivalents    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 3.5 5.1
Total equity funds    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 103.8 67.3
U.S. small-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets   0.9
U.S. mid-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 1.7 2.6
U.S. large-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 22.0 14.1
International equity    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 80.1 49.7
Fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 249.7 277.6
Corporate bonds - international    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 43.0 39.6
UK index-linked gilts    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 71.8 66.0
U.S. fixed income - government securities    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 47.5 20.5
U.S. fixed income - short duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 1.7 1.8
U.S. fixed income - intermediate duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 24.5 25.2
U.S. fixed income - long duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 58.8 122.7
Global fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 2.4 1.8
International real estate    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 12.5 11.6
Other    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 46.0 39.9
Investments Measured at NAV    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 233.9 231.2
Investments Measured at NAV | Cash and cash equivalents    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Investments Measured at NAV | Total equity funds    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 74.9 41.6
Investments Measured at NAV | U.S. small-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets   0.9
Investments Measured at NAV | U.S. mid-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 1.7 2.6
Investments Measured at NAV | U.S. large-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 18.3 11.6
Investments Measured at NAV | International equity    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 54.9 26.5
Investments Measured at NAV | Fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 152.6 187.8
Investments Measured at NAV | Corporate bonds - international    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 17.7 15.8
Investments Measured at NAV | UK index-linked gilts    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Investments Measured at NAV | U.S. fixed income - government securities    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 47.5 20.5
Investments Measured at NAV | U.S. fixed income - short duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 1.7 1.8
Investments Measured at NAV | U.S. fixed income - intermediate duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 24.5 25.2
Investments Measured at NAV | U.S. fixed income - long duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 58.8 122.7
Investments Measured at NAV | Global fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 2.4 1.8
Investments Measured at NAV | International real estate    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Investments Measured at NAV | Other    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 6.4 1.8
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 3.5 5.1
Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash and cash equivalents    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 3.5 5.1
Quoted Prices in Active Markets for Identical Assets (Level 1) | Total equity funds    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. small-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets   0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. mid-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. large-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | International equity    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate bonds - international    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | UK index-linked gilts    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - government securities    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - short duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - intermediate duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - long duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Global fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | International real estate    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets
Significant Observable Inputs (Level 2)    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 138.5 127.1
Significant Observable Inputs (Level 2) | Cash and cash equivalents    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Observable Inputs (Level 2) | Total equity funds    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 28.9 25.7
Significant Observable Inputs (Level 2) | U.S. small-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets   0.0
Significant Observable Inputs (Level 2) | U.S. mid-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Observable Inputs (Level 2) | U.S. large-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 3.7 2.5
Significant Observable Inputs (Level 2) | International equity    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 25.2 23.2
Significant Observable Inputs (Level 2) | Fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 97.1 89.8
Significant Observable Inputs (Level 2) | Corporate bonds - international    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 25.3 23.8
Significant Observable Inputs (Level 2) | UK index-linked gilts    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 71.8 66.0
Significant Observable Inputs (Level 2) | U.S. fixed income - government securities    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Observable Inputs (Level 2) | U.S. fixed income - short duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Observable Inputs (Level 2) | U.S. fixed income - intermediate duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Observable Inputs (Level 2) | U.S. fixed income - long duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Observable Inputs (Level 2) | Global fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Observable Inputs (Level 2) | International real estate    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 12.5 11.6
Significant Observable Inputs (Level 2) | Other    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3)    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 39.6 38.1
Significant Unobservable Inputs (Level 3) | Cash and cash equivalents    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | Total equity funds    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | U.S. small-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets   0.0
Significant Unobservable Inputs (Level 3) | U.S. mid-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | U.S. large-cap    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | International equity    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | Fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | Corporate bonds - international    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | UK index-linked gilts    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - government securities    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - short duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - intermediate duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - long duration    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | Global fixed income    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | International real estate    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets 0.0 0.0
Significant Unobservable Inputs (Level 3) | Other    
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]    
Fair value of plan assets $ 39.6 $ 38.1
v3.25.4
Benefit Plans - Defined Contribution Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Retirement Benefits [Abstract]      
Total contribution to defined contribution plans $ 53.5 $ 49.1 $ 47.0
v3.25.4
Stockholders' Equity and Noncontrolling Interests (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
May 01, 2025
Apr. 25, 2024
Aug. 24, 2021
Noncontrolling Interest [Line Items]            
Voting common stock authorized (in shares) 1,000,000,000 1,000,000,000        
Voting common stock outstanding (in shares) 391,121,689 402,880,079        
Voting common stock, par value (in USD per share) $ 0.01 $ 0.01        
2021 Repurchase Program            
Noncontrolling Interest [Line Items]            
Amount authorized for repurchase           $ 750.0
Stock repurchased (in shares) 12,687,461 2,665,262 3,963,243      
Weighted average exercise price (in shares) $ 79.40 $ 93.80 $ 62.98      
Stock repurchased $ 1,007.4 $ 250.0 $ 249.6      
2024 Repurchase Program            
Noncontrolling Interest [Line Items]            
Amount authorized for repurchase         $ 1,000.0  
2025 Repurchase Program            
Noncontrolling Interest [Line Items]            
Amount authorized for repurchase       $ 1,000.0    
IR India Limited            
Noncontrolling Interest [Line Items]            
Ownership interest by parent (as a percent) 75.00%          
v3.25.4
Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) and Related Income Tax Effect (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period $ 10,245.3 $ 9,846.7 $ 9,257.2
Other comprehensive income (loss) 317.8 (238.2) 25.8
Balance at end of period 10,154.0 10,245.3 9,846.7
Total      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period (468.5) (227.6) (251.7)
Before tax income (loss) 283.4 (231.4) 7.4
Income tax effect 36.8 (9.5) 16.7
Other comprehensive income (loss) 320.2 (240.9) 24.1
Balance at end of period (148.3) (468.5) (227.6)
Foreign Currency Translation Adjustments, Net      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period (479.6) (248.0) (282.8)
Before tax income (loss) 294.4 (218.6) 23.0
Income tax effect 36.1 (13.0) 11.8
Other comprehensive income (loss) 330.5 (231.6) 34.8
Balance at end of period (149.1) (479.6) (248.0)
Cash Flow Hedges      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period 3.1 12.2 16.0
Before tax income (loss) (5.8) (14.1) (5.1)
Income tax effect 0.0 5.0 1.3
Other comprehensive income (loss) (5.8) (9.1) (3.8)
Balance at end of period (2.7) 3.1 12.2
Pension and Other Postretirement Benefit Plans      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period 8.0 8.2 15.1
Before tax income (loss) (5.2) 1.3 (10.5)
Income tax effect 0.7 (1.5) 3.6
Other comprehensive income (loss) (4.5) (0.2) (6.9)
Balance at end of period $ 3.5 $ 8.0 $ 8.2
v3.25.4
Accumulated Other Comprehensive Income (Loss) - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Foreign currency translation adjustments attributable to noncontrolling interest holders $ (2.4) $ 2.7 $ 1.7
v3.25.4
Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period $ 10,245.3 $ 9,846.7 $ 9,257.2
Other comprehensive income (loss) 317.8 (238.2) 25.8
Balance at end of period 10,154.0 10,245.3 9,846.7
Total      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period (468.5) (227.6) (251.7)
Other comprehensive income (loss) before reclassifications 347.4 (214.8) 52.2
Amounts reclassified from accumulated other comprehensive income (loss) (27.2) (26.1) (28.1)
Other comprehensive income (loss) 320.2 (240.9) 24.1
Balance at end of period (148.3) (468.5) (227.6)
Foreign Currency Translation Adjustments, Net      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period (479.6) (248.0) (282.8)
Other comprehensive income (loss) before reclassifications 344.1 (218.3) 49.0
Amounts reclassified from accumulated other comprehensive income (loss) (13.6) (13.3) (14.2)
Other comprehensive income (loss) 330.5 (231.6) 34.8
Balance at end of period (149.1) (479.6) (248.0)
Cash Flow Hedges      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period 3.1 12.2 16.0
Other comprehensive income (loss) before reclassifications (1.5) 2.7 7.9
Amounts reclassified from accumulated other comprehensive income (loss) (4.3) (11.8) (11.7)
Other comprehensive income (loss) (5.8) (9.1) (3.8)
Balance at end of period (2.7) 3.1 12.2
Pension and Other Postretirement Benefit Plans      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period 8.0 8.2 15.1
Other comprehensive income (loss) before reclassifications 4.8 0.8 (4.7)
Amounts reclassified from accumulated other comprehensive income (loss) (9.3) (1.0) (2.2)
Other comprehensive income (loss) (4.5) (0.2) (6.9)
Balance at end of period $ 3.5 $ 8.0 $ 8.2
v3.25.4
Accumulated Other Comprehensive Income (Loss) - Schedule of Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Interest expense $ 253.9 $ 213.2 $ 156.7
Provision for income taxes 219.4 262.5 240.0
Total reclassifications for the period (588.8) (846.3) (785.1)
Reclassification out of Accumulated Other Comprehensive (Loss) Income      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Total reclassifications for the period (27.2) (26.1) (28.1)
Reclassification out of Accumulated Other Comprehensive (Loss) Income | Cash Flow Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Interest expense (5.8) (15.7) (15.6)
Provision for income taxes 1.5 3.9 3.9
Total reclassifications for the period (4.3) (11.8) (11.7)
Reclassification out of Accumulated Other Comprehensive (Loss) Income | Net Investments Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Interest expense (18.2) (17.7) (19.0)
Provision for income taxes 4.6 4.4 4.8
Total reclassifications for the period (13.6) (13.3) (14.2)
Reclassification out of Accumulated Other Comprehensive (Loss) Income | Defined Benefit Pension and Other Postretirement Benefits      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Cost of sales and Selling and administrative expenses (12.4) (1.4) (2.9)
Provision for income taxes 3.1 0.4 0.7
Total reclassifications for the period $ (9.3) $ (1.0) $ (2.2)
v3.25.4
Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Revenues $ 7,650.9 $ 7,235.0 $ 6,876.1
Revenue recognized at point in time      
Disaggregation of Revenue [Line Items]      
Revenues 6,927.9 6,672.0  
Revenue recognized at point over time      
Disaggregation of Revenue [Line Items]      
Revenues 723.0 563.0  
Original equipment      
Disaggregation of Revenue [Line Items]      
Revenues 4,861.8 4,604.2  
Aftermarket      
Disaggregation of Revenue [Line Items]      
Revenues 2,789.1 2,630.8  
Americas      
Disaggregation of Revenue [Line Items]      
Revenues 3,802.0 3,653.5  
United States      
Disaggregation of Revenue [Line Items]      
Revenues 3,189.9 3,112.3  
Other Americas      
Disaggregation of Revenue [Line Items]      
Revenues 612.1 541.2  
EMEIA      
Disaggregation of Revenue [Line Items]      
Revenues 2,601.5 2,374.9  
Total Asia Pacific      
Disaggregation of Revenue [Line Items]      
Revenues 1,247.4 1,206.6  
China      
Disaggregation of Revenue [Line Items]      
Revenues 789.5 794.6  
Other Asia Pacific      
Disaggregation of Revenue [Line Items]      
Revenues 457.9 412.0  
Industrial Technologies and Services      
Disaggregation of Revenue [Line Items]      
Revenues 6,056.4 5,818.1  
Industrial Technologies and Services | Revenue recognized at point in time      
Disaggregation of Revenue [Line Items]      
Revenues 5,432.0 5,295.6  
Industrial Technologies and Services | Revenue recognized at point over time      
Disaggregation of Revenue [Line Items]      
Revenues 624.4 522.5  
Industrial Technologies and Services | Original equipment      
Disaggregation of Revenue [Line Items]      
Revenues 3,595.3 3,494.0  
Industrial Technologies and Services | Aftermarket      
Disaggregation of Revenue [Line Items]      
Revenues 2,461.1 2,324.1  
Industrial Technologies and Services | Americas      
Disaggregation of Revenue [Line Items]      
Revenues 2,962.0 2,914.1  
Industrial Technologies and Services | United States      
Disaggregation of Revenue [Line Items]      
Revenues 2,473.5 2,461.2  
Industrial Technologies and Services | Other Americas      
Disaggregation of Revenue [Line Items]      
Revenues 488.5 452.9  
Industrial Technologies and Services | EMEIA      
Disaggregation of Revenue [Line Items]      
Revenues 2,008.0 1,854.9  
Industrial Technologies and Services | Total Asia Pacific      
Disaggregation of Revenue [Line Items]      
Revenues 1,086.4 1,049.1  
Industrial Technologies and Services | China      
Disaggregation of Revenue [Line Items]      
Revenues 672.3 680.8  
Industrial Technologies and Services | Other Asia Pacific      
Disaggregation of Revenue [Line Items]      
Revenues 414.1 368.3  
Precision and Science Technologies      
Disaggregation of Revenue [Line Items]      
Revenues 1,594.5 1,416.9  
Precision and Science Technologies | Revenue recognized at point in time      
Disaggregation of Revenue [Line Items]      
Revenues 1,495.9 1,376.4  
Precision and Science Technologies | Revenue recognized at point over time      
Disaggregation of Revenue [Line Items]      
Revenues 98.6 40.5  
Precision and Science Technologies | Original equipment      
Disaggregation of Revenue [Line Items]      
Revenues 1,266.5 1,110.2  
Precision and Science Technologies | Aftermarket      
Disaggregation of Revenue [Line Items]      
Revenues 328.0 306.7  
Precision and Science Technologies | Americas      
Disaggregation of Revenue [Line Items]      
Revenues 840.0 739.4  
Precision and Science Technologies | United States      
Disaggregation of Revenue [Line Items]      
Revenues 716.4 651.1  
Precision and Science Technologies | Other Americas      
Disaggregation of Revenue [Line Items]      
Revenues 123.6 88.3  
Precision and Science Technologies | EMEIA      
Disaggregation of Revenue [Line Items]      
Revenues 593.5 520.0  
Precision and Science Technologies | Total Asia Pacific      
Disaggregation of Revenue [Line Items]      
Revenues 161.0 157.5  
Precision and Science Technologies | China      
Disaggregation of Revenue [Line Items]      
Revenues 117.2 113.8  
Precision and Science Technologies | Other Asia Pacific      
Disaggregation of Revenue [Line Items]      
Revenues $ 43.8 $ 43.7  
v3.25.4
Revenue from Contracts with Customers - Performance Obligations (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Revenue, Performance Obligation [Abstract]  
Remaining performance obligation $ 743.2
Remaining performance obligation, expected timing of satisfaction 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01  
Revenue, Performance Obligation [Abstract]  
Remaining performance obligation $ 807.9
Remaining performance obligation, expected timing of satisfaction
v3.25.4
Revenue from Contracts with Customers - Schedule of Contract Balances (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]    
Accounts receivable, net $ 1,518.0 $ 1,335.4
Contract assets 163.9 111.2
Contract liabilities - current 347.2 318.6
Contract liabilities - noncurrent $ 1.1 $ 0.9
v3.25.4
Revenue from Contracts with Customers - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Contract liabilities   $ 319.5
Minimum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Period for which payments from customer are due 30 days  
Maximum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Period for which payments from customer are due 60 days  
v3.25.4
Income Taxes - Schedule of Income (Loss) Before Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]      
U.S. $ 220.3 $ 383.7 $ 356.0
Non-U.S. 715.0 749.1 675.1
Income Before Income Taxes $ 935.3 $ 1,132.8 $ 1,031.1
v3.25.4
Income Taxes - Schedule of Provision (Benefit) for Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current:      
U.S. federal $ 81.2 $ 87.5 $ 111.5
U.S. state and local 24.0 22.8 23.7
Non-U.S. 193.6 185.3 181.7
Deferred:      
U.S. federal (26.2) (9.7) (44.0)
U.S. state and local (6.5) (5.7) (6.9)
Non-U.S. (46.7) (17.7) (26.0)
Provision for income taxes $ 219.4 $ 262.5 $ 240.0
v3.25.4
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Amount      
U.S. federal corporate statutory rate $ 196.4    
State and local taxes, less federal tax benefit 13.3    
Foreign Derived Intangible Income (“FDII”) deduction (14.4)    
Repatriation cost 2.5    
Global Intangible Low-Tax Income (“GILTI”) 13.0    
Foreign tax credits (23.8)    
Other tax credits (3.8)    
Changes in valuation allowances 4.4    
Nontaxable and nondeductible items 18.7    
Changes in unrecognized tax benefits 4.2    
Provision for income taxes $ 219.4 $ 262.5 $ 240.0
Percent      
U.S. federal corporate statutory rate 21.00% 21.00% 21.00%
State and local taxes, less federal tax benefit 1.40% 1.40% 1.30%
Statutory tax rate difference   2.50% 1.80%
Interest on equity   (1.80%) (0.70%)
Foreign Derived Intangible Income (“FDII”) deduction (1.50%) (1.10%) (1.40%)
Repatriation cost 0.30%    
Global Intangible Low-Tax Income (“GILTI”) 1.40% 0.40% 0.70%
Foreign tax credits (2.50%)    
Other tax credits (0.40%)    
Changes in valuation allowances 0.50% 0.40% 1.70%
Nontaxable and nondeductible items 2.00%    
Changes in unrecognized tax benefits 0.40% 0.90% 0.90%
Withholding tax   1.30% 1.50%
Repatriation cost   (1.50%) (2.00%)
ASC 740-30 (formerly APB 23)   1.50% 1.70%
Equity compensation   (1.30%) (0.60%)
Nondeductible acquisition costs   0.30% 0.40%
Tax credits   (0.60%) (0.70%)
Income not subject to tax   (0.30%) (1.60%)
Amortization of goodwill and other intangible assets   (1.30%) (0.80%)
Return to provision adjustment   (0.20%) 0.10%
Loss on sale   1.10% 0.00%
Other, net   0.50% 0.00%
Effective income tax rate 23.50% 23.20% 23.30%
China      
Amount      
Withholding tax $ 16.6    
Other adjustments $ 4.9    
Percent      
Withholding tax 1.80%    
Other adjustments 0.50%    
India      
Amount      
Statutory tax rate difference $ 10.3    
Percent      
Statutory tax rate difference 1.10%    
Malta      
Amount      
Other adjustments $ 7.6    
Interest on equity $ (24.2)    
Percent      
Other adjustments 0.80%    
Interest on equity (2.60%)    
Switzerland      
Amount      
Statutory tax rate difference $ (13.4)    
Percent      
Statutory tax rate difference (1.40%)    
Other foreign jurisdictions      
Amount      
Statutory tax rate difference $ 16.4    
Percent      
Statutory tax rate difference 1.70%    
United States      
Amount      
Other adjustments $ (9.3)    
Percent      
Other adjustments (1.00%)    
v3.25.4
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Deferred Tax Assets:    
Reserves and accruals $ 95.3 $ 83.4
Allowance for credit losses 9.8 7.4
Inventory reserve 9.6 9.0
Pension and postretirement benefit plans 18.6 20.0
Tax loss carryforwards 94.1 112.4
Deferred taxes recorded in other comprehensive income 36.2 1.4
Foreign tax credit carryforwards 50.9 50.7
Other 12.7 22.4
Total deferred tax assets 327.2 306.7
Valuation allowance (107.4) (125.6)
Deferred Tax Liabilities:    
LIFO inventory (19.6) (20.3)
Investment in partnership 0.0 (30.2)
Property, plant and equipment (44.3) (50.0)
Intangible assets (763.7) (770.4)
Unremitted foreign earnings (50.4) (41.8)
Total deferred tax liabilities (878.0) (912.7)
Net deferred income tax liability $ (658.2) $ (731.6)
v3.25.4
Income Taxes - Schedule of Net Operating Loss and Tax Credit Carryforwards (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Tax Credit Carryforward [Line Items]  
Excess interest $ 14.1
Other deferred tax assets 4.9
Total tax carryforwards 150.3
Valuation Allowance  
Excess interest (12.9)
Other deferred tax assets (4.9)
Total tax carryforwards (107.4)
U.S.  
Tax Credit Carryforward [Line Items]  
Net operating loss subject to expiration 1.9
Tax credit carryforward 50.9
Alternative minimum tax credit 0.4
Valuation Allowance  
Net operating loss subject to expiration (0.1)
Tax credit carryforward (50.9)
Alternative minimum tax credit (0.4)
U.S. | Capital Loss Carryforward  
Tax Credit Carryforward [Line Items]  
Capital loss 0.6
Valuation Allowance  
Capital loss (0.6)
State and Local  
Tax Credit Carryforward [Line Items]  
Net operating loss subject to expiration 6.2
Valuation Allowance  
Net operating loss subject to expiration (0.7)
State and Local | Capital Loss Carryforward  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0.3
Valuation Allowance  
Tax credit carryforward (0.1)
Non U.S.  
Tax Credit Carryforward [Line Items]  
Net operating loss not subject to expiration 70.3
Valuation Allowance  
Net operating loss not subject to expiration (36.8)
Non U.S. | Capital Loss Carryforward  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0.7
Valuation Allowance  
Tax credit carryforward $ 0.0
v3.25.4
Income Taxes - Schedule of Valuation Allowance for Deferred Tax Assets (Details) - Valuation allowance for deferred tax assets - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Beginning balance $ 125.6 $ 115.7 $ 107.3
Revaluation or additions due to acquisitions or mergers (15.6)    
Revaluation or additions due to acquisitions or mergers   22.9 0.0
Charged to tax expense (benefit) (5.9) (10.8) 6.4
Charged to other accounts 3.3 (2.2) 2.0
Ending balance $ 107.4 $ 125.6 $ 115.7
v3.25.4
Income Taxes - Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
jurisdiction
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Income Tax Disclosure [Abstract]        
Unrecognized tax benefits $ 32.8 $ 26.4 $ 19.1 $ 10.8
Unrecognized tax benefits, that would effect effective tax rate if recognized 32.8      
Interest and penalties accrued $ 5.9 3.2    
Number of jurisdictions outside U.S. | jurisdiction 49      
Income tax reconciliation withholding tax $ 50.4      
Cash income taxes paid $ 269.3 $ 276.7 $ 302.0  
v3.25.4
Income Taxes - Schedule of Unrecognized Tax Benefits and Other Disclosures (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Unrecognized Tax Benefits [Roll Forward]      
Beginning balance $ 26.4 $ 19.1 $ 10.8
Gross increases for tax positions of prior years 0.1 0.8 0.4
Gross decreases for tax positions of prior years 0.0 (0.3) 0.0
Gross increases for tax positions of current year 4.6 8.1 7.9
Lapse of statute of limitations (0.1) (0.6) (0.2)
Changes due to currency fluctuations 1.8   0.2
Changes due to currency fluctuations   (0.7)  
Ending balance $ 32.8 $ 26.4 $ 19.1
v3.25.4
Income Taxes - Schedule of Cash Income Taxes Paid (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Effective Income Tax Rate Reconciliation [Line Items]      
Federal $ 40.3    
State and local 22.7    
Foreign      
Cash paid for income taxes, net of refunds 269.3 $ 276.7 $ 302.0
China      
Foreign      
Foreign 54.2    
France      
Foreign      
Foreign 18.4    
India      
Foreign      
Foreign 23.5    
Italy      
Foreign      
Foreign 30.7    
All other foreign      
Foreign      
Foreign $ 79.5    
v3.25.4
Leases - Schedule of Components of Lease Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Lease, Cost [Abstract]    
Operating lease cost $ 78.6 $ 64.5
Finance lease cost    
Amortization of right-of-use assets 1.4 1.5
Interest on lease liabilities 0.8 0.9
Total finance lease cost 2.2 2.4
Short-term lease cost $ 2.5 $ 2.2
v3.25.4
Leases - Schedule of Supplemental Cash Flows Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Paid for Amounts Included in the Measurement of Lease Liabilities    
Operating cash flows from operating leases $ 77.4 $ 63.8
Operating cash flows from finance leases 0.8 0.9
Financing cash flows from finance leases 1.3 1.3
Leased Assets Obtained in Exchange for New Operating Lease Liabilities $ 55.0 $ 96.2
v3.25.4
Leases - Schedule of Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Operating leases    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other assets Other assets
Other assets $ 236.4 $ 226.6
Operating Lease Liabilities, Gross Difference, Amount [Abstract]    
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued liabilities Accrued liabilities
Accrued liabilities $ 64.8 $ 56.3
Operating lease, liability, noncurrent, statement of financial position Other liabilities Other liabilities
Other liabilities $ 168.0 $ 165.5
Total operating lease liabilities $ 232.8 $ 221.8
Finance Leases    
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Property, plant and equipment, net of accumulated depreciation of $689.6 and $567.5, respectively Property, plant and equipment, net of accumulated depreciation of $689.6 and $567.5, respectively
Property, plant and equipment $ 9.7 $ 11.1
Finance Lease Liabilities, Gross Difference, Amount [Abstract]    
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Short-term borrowings and current maturities of long-term debt Short-term borrowings and current maturities of long-term debt
Short-term borrowings and current maturities of long-term debt $ 1.3 $ 1.3
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Long-term debt, less current maturities Long-term debt, less current maturities
Long-term debt, less current maturities $ 11.2 $ 12.6
Total finance lease liabilities $ 12.5 $ 13.9
Weighted Average Remaining Lease Term (in years)    
Operating leases 5 years 5 years 2 months 12 days
Finance leases 8 years 8 months 12 days 9 years 4 months 24 days
Weighted Average Discount Rate    
Operating leases (as a percent) 4.20% 4.10%
Finance leases (as a percent) 6.50% 6.50%
v3.25.4
Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Operating Leases    
2026 $ 73.3  
2027 57.9  
2028 42.9  
2029 27.9  
2030 18.0  
Thereafter 38.9  
Total lease payments 258.9  
Less imputed interest (26.1)  
Total operating lease liabilities 232.8 $ 221.8
Finance Leases    
2026 2.1  
2027 2.1  
2028 2.1  
2029 2.1  
2030 2.1  
Thereafter 6.3  
Total lease payments 16.8  
Less imputed interest (4.3)  
Total finance lease liabilities $ 12.5 $ 13.9
v3.25.4
Stock-Based Compensation Plans - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2025
Sep. 30, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
May 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation expense     $ 53.0 $ 58.8 $ 51.9  
Unrecognized compensation expense     $ 98.9      
Weighted average grant date fair value of stock options granted (in USD per share)     $ 34.93 $ 38.97 $ 25.28  
Grant date and recognized in compensation expense over   4 years 3 months 18 days        
Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Issuance of common stock for stock-based compensation plans (in shares)   100,000        
Total intrinsic value of stock options exercised     $ 22.0 $ 114.8 $ 75.0  
Performance Share Units            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period (in years) 3 years 5 years        
Volume-weighted average closing   60 days        
Closing price per share (in USD per share)   $ 81.85        
Omnibus Incentive Plan 2017 | Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award expiration period (in years)     10 years      
2013 Stock Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Capital stock reserved for future issuance (in shares)     20,900,000      
2013 Stock Incentive Plan | Tranche One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rate (as a percent)     50.00%      
2013 Stock Incentive Plan | Tranche Two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rate (as a percent)     50.00%      
2013 Stock Incentive Plan | Tranche Three            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rate (as a percent)     50.00%      
2013 Stock Incentive Plan | Performance Share Units | Tranche One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rate (as a percent)     50.00%      
2013 Stock Incentive Plan | Performance Share Units | Tranche Two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rate (as a percent)     50.00%      
2013 Stock Incentive Plan | Performance Share Units | Tranche Three            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rate (as a percent)     50.00%      
Share-Based Payment Arrangement, Option, Five Year Vesting            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period (in years)     5 years      
Share-Based Payment Arrangement, Option, Four Year Vesting            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period (in years)     4 years      
Share-Based Payment Arrangement, Option, Three Year Vesting            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period (in years)     3 years      
Minimum | Omnibus Incentive Plan 2017 | Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period (in years)     4 years      
Maximum | Omnibus Incentive Plan 2017            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Capital stock reserved for future issuance (in shares)           19,600,000
Maximum | Omnibus Incentive Plan 2017 | Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period (in years)     5 years      
v3.25.4
Stock-Based Compensation Plans - Schedule of Stock Option Awards (Details) - Stock Options
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
shares
Shares  
Balance at beginning of period (in shares) | shares 4,185
Granted (in shares) | shares 700
Exercised or settled (in shares) | shares (454)
Forfeited (in shares) | shares (104)
Expired (in shares) | shares (13)
Balance at end of period (in shares) | shares 4,314
Vested (in shares) | shares 2,765
Weighted-Average Exercise Price (per share)  
Balance at beginning of period (in USD per share) | $ / shares $ 43.33
Granted (in USD per share) | $ / shares 83.15
Exercised or settled (in USD per share) | $ / shares 33.76
Forfeited (in USD per share) | $ / shares 78.33
Expired (in USD per share) | $ / shares 85.72
Balance at end of period (in USD per share) | $ / shares 49.83
Vested (in USD per share) | $ / shares $ 34.60
Weighted average remaining contractual term of options outstanding (in years) 5 years 3 months 18 days
Weighted average remaining contractual term of options vested (in years) 3 years 8 months 12 days
Aggregate intrinsic value of in-the-money options outstanding | $ $ 135.5
Aggregate intrinsic value of in-the-money options vested | $ $ 124.7
v3.25.4
Stock-Based Compensation Plans - Schedule of Assumptions Used to Estimate Fair Value (Details)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate, minimum 3.80% 3.70% 3.80%
Risk-free interest rate, maximum 4.20% 4.30% 4.60%
Assumed volatility, minimum 34.00% 34.90% 35.60%
Assumed volatility, maximum 34.30% 35.20% 36.60%
Expected dividend rate 0.10%    
Stock Options | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life of options (in years) 6 years 3 months 18 days 6 years 3 months 18 days 6 years 3 months 18 days
Expected dividend rate   0.00% 0.00%
Stock Options | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life of options (in years) 7 years 6 months 7 years 6 months 7 years 6 months
Expected dividend rate   0.10% 0.10%
Performance Share Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life of options (in years)   2 years 9 months 18 days 2 years 10 months 24 days
Risk-free interest rate, minimum 3.60%    
Risk-free interest rate, maximum 4.00%    
Risk-free interest rate   4.50% 4.40%
Assumed volatility, minimum 28.20%    
Assumed volatility, maximum 28.60%    
Assumed volatility   28.90% 31.80%
Expected dividend rate 0.10% 0.10% 0.10%
Performance Share Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life of options (in years) 2 years 4 months 24 days    
Performance Share Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life of options (in years) 2 years 9 months 18 days    
v3.25.4
Stock-Based Compensation Plans - Schedule of Restricted Stock Unit Awards (Details) - Restricted Stock Units
shares in Thousands
12 Months Ended
Dec. 31, 2025
$ / shares
shares
Shares  
Balance at beginning of period (in shares) | shares 834
Granted (in shares) | shares 491
Vested (in shares) | shares (334)
Forfeited (in shares) | shares (99)
Balance at end of period (in shares) | shares 892
Weighted-Average Grant-Date Fair Value  
Balance at beginning of period (in USD per share) | $ / shares $ 73.00
Granted (in USD per share) | $ / shares 82.40
Vested (in USD per share) | $ / shares 63.87
Forfeited (in USD per share) | $ / shares 82.40
Balance at end of period (in USD per share) | $ / shares $ 80.55
v3.25.4
Stock-Based Compensation Plans - Schedule of Performance Share Unit Awards (Details) - Performance Share Units
shares in Thousands
12 Months Ended
Dec. 31, 2025
$ / shares
shares
Shares  
Balance at beginning of period (in shares) | shares 1,339
Granted (in shares) | shares 152
Change in units based on performance (in shares) | shares 127
Vested (in shares) | shares (255)
Forfeited (in shares) | shares (16)
Balance at end of period (in shares) | shares 1,347
Weighted-Average Grant-Date Fair Value  
Balance at beginning of period (in USD per share) | $ / shares $ 54.28
Granted (in USD per share) | $ / shares 69.69
Change in units based on performance (in USD per share) | $ / shares 63.39
Vested (in USD per share) | $ / shares 63.39
Forfeited (in USD per share) | $ / shares 94.27
Balance at end of period (in USD per share) | $ / shares $ 54.67
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk - Narrative (Details)
€ in Millions
12 Months Ended
May 10, 2024
USD ($)
contract
Dec. 31, 2025
USD ($)
contract
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2025
EUR (€)
contract
Feb. 28, 2025
USD ($)
Feb. 28, 2025
EUR (€)
May 31, 2024
USD ($)
contract
May 10, 2024
EUR (€)
contract
Aug. 31, 2023
Derivatives, Fair Value [Line Items]                    
Off-balance sheet derivative instruments   $ 0 $ 0              
Payments of interest rate cap premiums   $ 0 19,900,000 $ 0            
Foreign currency forwards                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   10     10          
Foreign currency forwards | Minimum                    
Derivatives, Fair Value [Line Items]                    
Notional amount   $ 4,400,000                
Foreign currency forwards | Maximum                    
Derivatives, Fair Value [Line Items]                    
Term of derivative contract (in years)   1 year                
Notional amount   $ 73,400,000                
Interest rate swap contracts                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract               2    
Interest rate swap contracts | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Loss expected to be reclassified into earnings   $ 300,000                
Interest rate swap contracts | Fair Value Hedge | 5.176% Senior Notes Due 2029                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   4     4          
Interest rate swap contracts | Fair Value Hedge | 5.314% Senior Notes Due 2031                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   2     2          
Interest rate swap contracts | Fair Value Hedge | 5.700% Senior Notes Due 2033                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   2     2          
Interest rate swap contracts | Fair Value Hedge | 5.450% Senior Notes Due 2034                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   1     1          
Interest rate swap contracts | Fair Value Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount   $ 1,000,000,000                
Interest rate swap contracts | Fair Value Hedge | Derivatives Designated as Hedging Instruments | 5.176% Senior Notes Due 2029                    
Derivatives, Fair Value [Line Items]                    
Notional amount   400,000,000.0                
Interest rate swap contracts | Fair Value Hedge | Derivatives Designated as Hedging Instruments | 5.314% Senior Notes Due 2031                    
Derivatives, Fair Value [Line Items]                    
Notional amount   250,000,000.0                
Interest rate swap contracts | Fair Value Hedge | Derivatives Designated as Hedging Instruments | 5.700% Senior Notes Due 2033                    
Derivatives, Fair Value [Line Items]                    
Notional amount   250,000,000.0                
Interest rate swap contracts | Fair Value Hedge | Derivatives Designated as Hedging Instruments | 5.450% Senior Notes Due 2034                    
Derivatives, Fair Value [Line Items]                    
Notional amount   100,000,000.0                
Interest rate swap contracts | Cash Flow Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount     $ 750,000,000.0         $ 528,500,000    
Unrecognized loss in AOCI   $ 3,900,000                
Fixed interest rate (as a percent)               3.20%    
Interest rate swap contracts | Cash Flow Hedge | Derivatives Designated as Hedging Instruments | 5.450% Senior Notes Due 2034                    
Derivatives, Fair Value [Line Items]                    
Notional amount $ 750,000,000.0                  
Interest rate swap contracts | Cash Flow Hedge | Derivatives Designated as Hedging Instruments | 5.700% Senior Notes Due 2054                    
Derivatives, Fair Value [Line Items]                    
Notional amount $ 500,000,000.0                  
Interest rate cap contracts | Cash Flow Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Derivative, cap interest rate                   4.00%
Cross Currency Interest Rate Contract One                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract 2               2  
Cross Currency Interest Rate Contract One | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount | €                 € 500.0  
Fixed interest rate (as a percent) 1.60%               1.60%  
Payments of interest rate cap premiums $ 10,000,000                  
Cross Currency Interest Rate Contract Two                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract 3               3  
Cross Currency Interest Rate Contract Two | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount $ 525,700,000               € 500.0  
Payments of interest rate cap premiums 9,900,000                  
Cross Currency Interest Rate Contract, 5.2% Fixed Rate | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount           $ 129,200,000        
Fixed interest rate (as a percent)           5.20% 5.20%      
Cross Currency Interest Rate Contract, Expiring February 2028 | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount | €             € 125.0      
Fixed interest rate (as a percent)           3.10% 3.10%      
Cross Currency Interest Rate Contract, 5.3% Fixed Rate | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount           $ 129,200,000        
Fixed interest rate (as a percent)           5.30% 5.30%      
Cross Currency Interest Rate Contract, Expiring February 2030 | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount | €             € 125.0      
Fixed interest rate (as a percent)           3.40% 3.40%      
Cross Currency Interest Rate Contract, Expiring May 2027                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   3     3          
Cross Currency Interest Rate Contract, Expiring May 2027 | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount | €         € 400.0          
Fixed interest rate (as a percent)   3.70%     3.70%          
Cross Currency Interest Rate Contract, 5.4% Fixed Rate | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount   $ 428,900,000                
Fixed interest rate (as a percent)   5.40%     5.40%          
Cross Currency Interest Rate Contract, Expiring May 2029                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   3     3          
Cross Currency Interest Rate Contract, Expiring May 2029 | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount | €         € 300.0          
Fixed interest rate (as a percent)   4.10%     4.10%          
Cross Currency Interest Rate Contract, 5.7% Fixed Rate One | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount   $ 322,700,000                
Fixed interest rate (as a percent)   5.70%     5.70%          
Cross Currency Interest Rate Contract, Expiring May 2031                    
Derivatives, Fair Value [Line Items]                    
Number of instruments held | contract   3     3          
Cross Currency Interest Rate Contract, Expiring May 2031 | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount | €         € 300.0          
Fixed interest rate (as a percent)   4.10%     4.10%          
Cross Currency Interest Rate Contract, 5.7% Fixed Rate Two | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount   $ 322,700,000                
Fixed interest rate (as a percent)   5.70%     5.70%          
Cross Currency Interest Rate Contract, 3.2% Fixed Rate | Net Investment Hedge | Derivatives Designated as Hedging Instruments                    
Derivatives, Fair Value [Line Items]                    
Notional amount $ 528,500,000                  
Fixed interest rate (as a percent) 3.20%               3.20%  
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk - Summary of Derivative Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
May 31, 2024
Interest rate swap contracts | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Notional Amount $ 1,000.0    
Interest rate swap contracts | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Notional Amount   $ 750.0 $ 528.5
Interest rate swap contracts | Other Current Assets | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 4.5    
Interest rate swap contracts | Other Current Assets | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Assets fair value   0.0  
Interest rate swap contracts | Other Assets | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 15.3    
Interest rate swap contracts | Other Assets | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Assets fair value   1.4  
Interest rate swap contracts | Accrued Liabilities | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0    
Interest rate swap contracts | Accrued Liabilities | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Liabilities fair value   0.9  
Interest rate swap contracts | Other Liabilities | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0    
Interest rate swap contracts | Other Liabilities | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Liabilities fair value   0.9  
Cross-currency interest rate swap contracts | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Notional Amount 1,332.7 1,074.3  
Cross-currency interest rate swap contracts | Other Current Assets | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Assets fair value 10.7 11.5  
Cross-currency interest rate swap contracts | Other Assets | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0 15.8  
Cross-currency interest rate swap contracts | Accrued Liabilities | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0 0.0  
Cross-currency interest rate swap contracts | Other Liabilities | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 130.5 0.0  
Foreign currency forwards | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Notional Amount 15.3 124.3  
Foreign currency forwards | Other Current Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0 1.8  
Foreign currency forwards | Other Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0 0.0  
Foreign currency forwards | Accrued Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0 0.0  
Foreign currency forwards | Other Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0 0.0  
Foreign currency forwards | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Notional Amount 171.6 69.0  
Foreign currency forwards | Other Current Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0 0.0  
Foreign currency forwards | Other Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0 0.0  
Foreign currency forwards | Accrued Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.9 1.2  
Foreign currency forwards | Other Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value $ 0.0 $ 0.0  
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk - Schedule of Long Term Hedge (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Hedged Liability, Statement of Financial Position [Extensible Enumeration] Long-term debt, less current maturities Long-term debt, less current maturities
Carrying amount of hedged debt $ 1,019.8 $ 749.7
Cumulative hedging adjustments, included in carrying amount $ 19.8 $ (0.3)
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk - Schedule of Cash Flow Hedges included in Comprehensive Income (Loss) (Details) - Interest rate swap contracts - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Gains and Losses on Derivatives Designated as Cash Flow Hedges [Abstract]      
Gain recognized in OCI on derivatives $ 0.0 $ 1.6 $ 10.5
Gain reclassified from AOCI into income (effective portion) $ 5.8 $ 15.7 $ 15.6
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk - Schedule of Net Investment Hedges included in Comprehensive Income (Loss) (Details) - Cross-currency interest rate swap contracts - Net investment - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Gain (loss) recognized in OCI on derivatives $ (128.9) $ 72.5 $ (17.5)
Gain reclassified from AOCI into income (effective portion) $ 18.2 $ 17.7 $ 19.0
v3.25.4
Hedging Activities, Derivative Instruments and Credit Risk - Schedule of Derivative Instruments not Designated as Accounting Hedges (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Derivatives, Fair Value [Line Items]      
Foreign currency gains (loss) $ (18.6) $ (3.2) $ (5.1)
Foreign currency forwards      
Derivatives, Fair Value [Line Items]      
Foreign currency gains (loss) $ 4.5 $ 0.1 $ 0.3
v3.25.4
Fair Value Measurements - Schedule of Fair Value Measurements (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Financial Assets    
Trading securities held in deferred compensation plan $ 24.4 $ 21.0
Total 54.9 51.5
Financial Liabilities    
Deferred compensation plan 30.8 28.7
Contingent consideration 44.0 22.2
Total 206.2 53.9
Interest rate swaps    
Financial Assets    
Derivative assets 19.8 1.4
Financial Liabilities    
Derivative liabilities   1.8
Cross-currency interest rate swaps    
Financial Assets    
Derivative assets 10.7 27.3
Financial Liabilities    
Derivative liabilities 130.5  
Foreign currency forwards    
Financial Assets    
Derivative assets 0.0 1.8
Financial Liabilities    
Derivative liabilities 0.9 1.2
Level 1    
Financial Assets    
Trading securities held in deferred compensation plan 24.4 21.0
Total 24.4 21.0
Financial Liabilities    
Deferred compensation plan 30.8 28.7
Contingent consideration 0.0 0.0
Total 30.8 28.7
Level 1 | Interest rate swaps    
Financial Assets    
Derivative assets 0.0 0.0
Financial Liabilities    
Derivative liabilities   0.0
Level 1 | Cross-currency interest rate swaps    
Financial Assets    
Derivative assets 0.0 0.0
Financial Liabilities    
Derivative liabilities 0.0  
Level 1 | Foreign currency forwards    
Financial Assets    
Derivative assets 0.0 0.0
Financial Liabilities    
Derivative liabilities 0.0 0.0
Level 2    
Financial Assets    
Trading securities held in deferred compensation plan 0.0 0.0
Total 30.5 30.5
Financial Liabilities    
Deferred compensation plan 0.0 0.0
Contingent consideration 0.0 0.0
Total 131.4 3.0
Level 2 | Interest rate swaps    
Financial Assets    
Derivative assets 19.8 1.4
Financial Liabilities    
Derivative liabilities   1.8
Level 2 | Cross-currency interest rate swaps    
Financial Assets    
Derivative assets 10.7 27.3
Financial Liabilities    
Derivative liabilities 130.5  
Level 2 | Foreign currency forwards    
Financial Assets    
Derivative assets 0.0 1.8
Financial Liabilities    
Derivative liabilities 0.9 1.2
Level 3    
Financial Assets    
Trading securities held in deferred compensation plan 0.0 0.0
Total 0.0 0.0
Financial Liabilities    
Deferred compensation plan 0.0 0.0
Contingent consideration 44.0 22.2
Total 44.0 22.2
Level 3 | Interest rate swaps    
Financial Assets    
Derivative assets 0.0 0.0
Financial Liabilities    
Derivative liabilities   0.0
Level 3 | Cross-currency interest rate swaps    
Financial Assets    
Derivative assets 0.0 0.0
Financial Liabilities    
Derivative liabilities 0.0  
Level 3 | Foreign currency forwards    
Financial Assets    
Derivative assets 0.0 0.0
Financial Liabilities    
Derivative liabilities $ 0.0 $ 0.0
v3.25.4
Fair Value Measurements - Schedule of Contingent Consideration (Details) - Contingent Consideration - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance at beginning of period $ 22.2 $ 42.2
Acquisitions 36.7 6.7
Changes in fair value (16.7) (15.3)
Payments 0.0 (10.0)
Foreign currency translation and other 1.8 (1.4)
Balance at end of period $ 44.0 $ 22.2
v3.25.4
Fair Value Measurements - Narrative (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Fair Value Disclosures [Abstract]  
Contingent consideration included in accrued liabilities $ 3.5
Contingent consideration included in other liabilities $ 40.5
v3.25.4
Contingencies - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Jun. 05, 2024
USD ($)
subsidiary
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2025
USD ($)
Loss Contingencies [Line Items]        
Undiscounted accrual liabilities for environmental loss contingencies     $ 13.6 $ 10.6
Insurance recovery receivable included in other assets       $ 1.7
Number of subsidiaries that hold asbestos liabilities and assets | subsidiary 3      
Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag   after-tax loss    
Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses $ 188.5      
Pre tax loss     58.8  
Income tax benefit   $ 7.6 7.6  
Loss after tax   $ 51.2 $ 51.2  
Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale | Insurance Settlement        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses 143.5      
Delticus Holdings LLC | Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses 35.0      
Ingersoll Rand | Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses $ 10.0      
InTelCo | Onyx TopCo LLC        
Loss Contingencies [Line Items]        
Ownership interest 100.00%      
v3.25.4
Contingencies - Schedule of Impacts of Divestiture (Details) - Discontinued Operations, Disposed of by Sale - Asbestos Portfolio Sale - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2024
Assets divested:    
Cash and cash equivalents   $ 153.5
Insurance recovery receivable   13.9
Liabilities divested:    
Asbestos indemnity liability - current   (12.3)
Asbestos indemnity liability - noncurrent   (111.4)
Loss on Asbestos Sale, before transaction costs   43.7
Transaction costs   15.1
Loss on Asbestos Sale   58.8
Income tax benefit $ (7.6) (7.6)
Loss on Asbestos Sale, net of tax $ 51.2 $ 51.2
v3.25.4
Other Operating Expense, Net (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Other Income and Expenses [Abstract]      
Foreign currency transaction losses, net $ 18.6 $ 3.2 $ 5.1
Restructuring charges, net 51.4 31.2 19.9
Acquisition and other transaction related expenses 22.0 47.1 52.2
Loss on asbestos sale 0.0 58.8 0.0
Other, net (0.5) (1.7) 0.5
Total other operating expense, net $ 91.5 $ 138.6 $ 77.7
v3.25.4
Segment Reporting - Narrative (Details)
12 Months Ended
Dec. 31, 2025
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.25.4
Segment Reporting - Schedule of Segment Results (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Revenues $ 7,650.9 $ 7,235.0 $ 6,876.1
Segment cost of sales 4,314.6 4,065.0 3,993.9
Segment selling and administrative expenses 1,439.3 1,344.4 1,272.7
Other segment items (91.5) (138.6) (77.7)
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes:      
Interest expense 253.9 213.2 156.7
Impairment of goodwill and other intangible assets 273.4 13.9 0.0
Restructuring and related business transformation costs 51.7 32.3 22.9
Stock-based compensation 53.0 58.8 51.9
Foreign currency transaction losses, net 18.6 3.2 5.1
Loss on extinguishment of debt 0.0 3.0 13.5
Adjustments to LIFO inventories 17.8 6.7 12.0
Loss on asbestos sale 0.0 58.8 0.0
Income Before Income Taxes 935.3 1,132.8 1,031.1
Depreciation of rental equipment 4.5 4.0 3.7
Restructuring and related business transformation costs      
Restructuring charges 51.4 31.2 19.9
Facility reorganization, relocation and other costs 0.3 1.1 3.0
Total restructuring and related business transformation costs 51.7 32.3 22.9
Total depreciation and amortization expense 505.8 482.0 459.1
Total capital expenditures 135.6 149.1 105.4
Total identifiable assets 18,297.2 18,009.8  
Industrial Technologies and Services      
Segment Reporting Information [Line Items]      
Revenues 6,056.4 5,818.1  
Precision and Science Technologies      
Segment Reporting Information [Line Items]      
Revenues 1,594.5 1,416.9  
Operating segments      
Segment Reporting Information [Line Items]      
Revenues 7,650.9 7,235.0 6,876.1
Segment cost of sales 4,172.4 3,929.5 3,873.8
Segment selling and administrative expenses 1,254.7 1,133.1 1,041.0
Other segment items (2.1) (1.2) 1.2
Segment Adjusted EBITDA 2,225.9 2,173.6 1,960.1
Operating segments | Industrial Technologies and Services      
Segment Reporting Information [Line Items]      
Revenues 6,056.4 5,818.1 5,632.8
Segment cost of sales 3,346.8 3,193.3 3,225.0
Segment selling and administrative expenses 963.5 868.5 818.5
Other segment items (1.8) 1.5 2.0
Segment Adjusted EBITDA 1,747.9 1,754.8 1,587.3
Restructuring and related business transformation costs      
Restructuring charges 37.7 20.6 15.1
Total depreciation and amortization expense 282.1 296.0 313.8
Total capital expenditures 92.5 83.0 83.9
Total identifiable assets 11,266.4 10,369.6  
Operating segments | Precision and Science Technologies      
Segment Reporting Information [Line Items]      
Revenues 1,594.5 1,416.9 1,243.3
Segment cost of sales 825.6 736.2 648.8
Segment selling and administrative expenses 291.2 264.6 222.5
Other segment items (0.3) (2.7) (0.8)
Segment Adjusted EBITDA 478.0 418.8 372.8
Restructuring and related business transformation costs      
Restructuring charges 10.5 7.9 4.1
Total depreciation and amortization expense 219.1 177.1 135.4
Total capital expenditures 36.9 21.3 18.5
Total identifiable assets 5,656.4 5,884.1  
Corporate expenses not allocated to segments      
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes:      
Corporate expenses not allocated to segments 132.1 155.5 173.3
Restructuring and related business transformation costs      
Restructuring charges 3.2 2.7 0.7
Total depreciation and amortization expense 4.6 8.9 9.9
Total capital expenditures 6.2 44.8 3.0
Total identifiable assets 1,374.4 1,756.1  
Reconciling items excluding corporate expenses      
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes:      
Interest expense 253.9 213.2 156.7
Depreciation and amortization expense 501.3 478.0 455.4
Impairment of goodwill and other intangible assets 273.4 13.9 0.0
Restructuring and related business transformation costs 51.7 32.3 22.9
Acquisition and other transaction related expenses and non-cash charges 26.0 59.8 63.9
Stock-based compensation 53.0 58.8 51.9
Foreign currency transaction losses, net 18.6 3.2 5.1
Loss on extinguishment of debt 0.0 3.0 13.5
Adjustments to LIFO inventories 17.8 6.7 12.0
Cybersecurity incident costs (1.3) 0.5 2.3
Loss on asbestos sale 0.0 58.8 0.0
Interest income on cash and cash equivalents (30.0) (43.3) (28.8)
Other adjustments (5.9) 0.4 0.8
Restructuring and related business transformation costs      
Total restructuring and related business transformation costs $ 51.7 $ 32.3 $ 22.9
v3.25.4
Segment Reporting - Schedule of Property, Plant and Equipment by Geographic Region (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net $ 930.3 $ 842.1
Reportable geographical components | Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 433.9 419.9
Reportable geographical components | United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 383.8 381.8
Reportable geographical components | Other Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 50.1 38.1
Reportable geographical components | EMEIA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 328.3 256.5
Reportable geographical components | Total Asia Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 168.1 165.7
Reportable geographical components | China    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 149.9 152.3
Reportable geographical components | Other Asia Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net $ 18.2 $ 13.4
v3.25.4
Earnings Per Share - Schedule of Basic and Diluted Earnings Per Share (Details) - shares
shares in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]      
Weighted-average shares outstanding - Basic (in shares) 398.1 403.4 404.8
Dilutive effect of outstanding share-based compensation awards (in shares) 2.9 3.8 4.2
Weighted-average shares outstanding - Diluted (in shares) 401.0 407.2 409.0
v3.25.4
Earnings Per Share - Narrative (Details) - shares
shares in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings (loss) per share (in shares) 1.1 0.5 1.3
v3.25.4
Equity Method Investment (Details) - High Pressure Solutions - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Schedule of Equity Method Investments [Line Items]      
Ownership percentage   45.00%  
Impairment charge $ 120.9    
Equity method investment   $ 0.0 $ 128.6